Advertisement

Nierenkrankheiten pp 1673-1831 | Cite as

Die Gefäßerkrankungen der Niere

  • P. Cottier
Part of the Handbuch der Inneren Medizin book series (INNEREN, volume 8 / 0)

Zusammenfassung

Unter Nephrosklerose wird im deutschen Sprachgebiet die Arteriolosklerose der Niere verstanden. Währenddem die Angelsachsen unter dem Begriff Nephrosklerose sowohl die arteriolosklerotischen als auch die arteriosklerotischen Gefäßveränderungen der Niere einschließen, wird im deutschen Sprachgebiet die Arteriosklerose der Niere nicht dem engeren Begriff der Nephrosklerose untergeordnet. Die Franzosen sprechen von „néphroangiosclérose“. Im Hinblick auf die interessanten Untersuchungen von McCormick(1958) und Imhof(1960) ist es sehr fraglich, ob eine Trennung zwischen Nephrosklerose (Arteriolosklerose der Niere) einerseits und Arteriosklerose der Niere andererseits noch angebracht ist. Diese Autoren konnten zeigen, daß in Fällen mit erfolgreich behandelter maligner Hypertonie die arteriolären Gefäßveränderungen einer Arteriosklerose und subintimalen Fibroplasie der Arteriae interlobares und arcuatae Platz gemacht haben. Die Senkung des arteriellen Blutdruckes war demnach nicht in der Lage, den Gefäßprozeß im arteriellen Gefäßgebiet vollständig zum Stillstand zu bringen. Solche Patienten kamen nach einem längeren zeitlichen Intervall zum Teil auch unter dem Bild der Urämie ad exitum. Der autoptische Befund entsprach einer arteriosklerotischen „Nephrosklerose“. In unseren weiteren Ausführungen halten wir uns an den Begriff: Nephrosklerose = vorwiegend Arteriolosklerose der Niere.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Pathologische Anatomie

  1. Castleman, B., and R. H. Smithwick: Relation of vascular disease to hypertensive state based on study of renal biopsies from 100 hypertensive patients. J. Amer. med. Ass. 121, 1256 (1942).Google Scholar
  2. Evans, W.: The aetiology of systemic hypertension. Brit. Heart J. 22, 17–36 (1960).CrossRefGoogle Scholar
  3. Heptinstall, R. H.: Renal biopsies in hypertension. Brit. Heart J. 16, 133–141 (1954).CrossRefGoogle Scholar
  4. I. H. Page u. H.P. Dustan: Die Gefäßerkrankung bei der Hypertonie. Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier), S. 381. Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  5. Kincaid-Smith, P., J. McMichael, and E. A. Murphy: The clinical course and pathology of hypertension with papilledema (malignant hypertension). Quart. J. Med., N. S. 27, 117–153 (1958).Google Scholar
  6. Lefebre, R., and J. Genest: Study of renal ischaemic tubular atrophy in 79 patients with arterial hypertension. Canad. med. Ass. J. 82, 1249–1253 (1960).Google Scholar
  7. Masson, G. M. C., L. J. MeCormack, H. P. Dustan, and A. C. Corcoran: Hypertensive vascular disease as a consequence of increased arterial pressure. Qualitative study in rats with hydralazine treated renal hypertension. Amer. J. Path. 34, 817–833 (1958).PubMedGoogle Scholar
  8. McCormack, L. J., J. E. Belaud, R. E. Schneckloth, and A. C. Corcoran: Effects of antihypertensive treatment on the evolution of the renal lesions in malignant nephrosclerosis. Amer. J. Path. 34, 1011 (1958).PubMedGoogle Scholar
  9. McGee, W. G., and C. T. Ashworth: Fine structure of chronic hypertensive arteriopathy in the human kidney. J. nat. Cancer Inst. 43, 273–299 (1963).Google Scholar
  10. McManus, J. F. A., and C. H. Lupton jr.: Ischemic obsolescence of renal glomeruli. The natural history of the lesions and their relation to hypertension. J. Lab. Invest. 9, 413–434 (1960).Google Scholar
  11. Roland, A. S., E. A. Hildreth, and A. M Sellers: Occult primary renal disease in the hypertensive patient. Arch, intern. Med. 113, 101–110 (1964).CrossRefGoogle Scholar
  12. Salomon, M. I, P. Narasimhan, M. S. Bruno, and W. B. Ober: Renal lesions in essential hypertension. The problem of correlation between renal biopsy and clinical parameters. Angiology 13, 216–225 (1962).Google Scholar
  13. Saltz, M., S. C. Sommers, and R. H. Smithwiek: Clinico- pathologic correlations of renal biopsies from essential hypertensive patients. Circulation 16, 207–212 (1957).PubMedCrossRefGoogle Scholar
  14. Schaffenburg, C., and H. Goldblatt: Pathogenesis of arteriolar necrosis of malignant hypertension. Proc. Soc. exp. Biol (N.Y.) 96, 421–423 (1957).CrossRefGoogle Scholar
  15. Smith, J. P.: Hyaline arteriosclerosis in the kidney. J. Path. 69, 147–168 (1955).CrossRefGoogle Scholar
  16. Smythe, G. M., W. S. Bradham, E. J. Dennis, F. A. Mclver, and H. G. Howe: Renal arteriolar disease in young primiparas. J. Lab. din. Med. 63, 562–573 (1964).Google Scholar
  17. Sommers, S. C., R. J. McLaughlin, and R. L. McAuIey: Pathology of diastolic hypertension as a generalized vascular disease. Symposium. Amer. J. Cardiol. 9, 653–658 (1962).CrossRefGoogle Scholar
  18. Sommers, S. C., A S. Rebman, and R. H. Smithwiek: Histologic studies of kidney biopsy specimens from patients with hyper-tension. Amer. J. Path. 34, 685 (1958).PubMedGoogle Scholar
  19. Zollinger, H. U.: Differentialdiagnose der Schrumpfnieren. Dtsch. med. Wschr. 87, 2457–2464 u. Abb., 2473–2474, 2491 (1962).PubMedCrossRefGoogle Scholar
  20. Zollinger, H. U.: Mere und ableitende Harnwege. In: Spezielle pathologische Anatomie (ed. W. Doerr u. E. Uehlinger). Berlin-Heidelberg-New York: Springer 1966.Google Scholar

Ätiologie und Pathogenese

  1. Bohr, D. F.: Univ. Mich. med. Bull. 27, 196 (1961).PubMedGoogle Scholar
  2. Boss, M.: Kleine und große Psychotherapie der essentiellen Hypertoniker. Documenta Geigy 3 (1959).Google Scholar
  3. Braun-Menendez, E,: Hypertension and the relation between body weight and kidney weight. Acta physiol. lat.- amer. 2, 2 (1952).PubMedGoogle Scholar
  4. Brunjes, S.: Catechol amine metabolism in essential hypertension. New Eng. J. Med. 271, 120 (1964).Google Scholar
  5. Conn, J. W.: Primary aldosteronism, a new clinical syndrome. J. Lab. din. Med. 45, 3–17 (1955).Google Scholar
  6. Conway, J.: Univ. Mich. med. Bull. 27, 198 (1961).PubMedGoogle Scholar
  7. Cottier, P. T.: Renale Haemodynamik, Wasser- und Elektrolytausscheidung bei Hypertonie. Helv. med. Acta, Suppl. 39, 1–180 (1960).Google Scholar
  8. Cottier, F. T., u. E. Blaser: Die Nierenfunktion bei einem Fall von akuter Porphyrie mit Hypertonie. Helv. med. Acta 22, 502–508 (1955).PubMedGoogle Scholar
  9. Cottier, P. T., H. A. Kunz u. H. U. Zollinger: Experimenteller Beitrag zur Frage der Bleihypertonie. Helv. med. Acta 20, 443–449 (1953).PubMedGoogle Scholar
  10. Cottier, P. T., A. F. Muller u. A. Schmidt Natriurese und Aldosteronausscheidung bei essentieller Hypertonie. Schweiz, med. Wschr. 89, 376–388 (1959).Google Scholar
  11. Cottier, P. T., E. Wildbolz u. H. Cottier: Hypertonie als Unfallfolge. Z. Urol. 51, 441–456 (1958).PubMedGoogle Scholar
  12. Dahl, L.: Der mögliche Einfluß der Salzzufuhr auf die Entwicklung der essentiellen Hypertonie. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. T. Cottier), S. 61–75. Berlin-Göttingen-Heidelberg: Springer 1960.CrossRefGoogle Scholar
  13. Dahl, L. K., M. Heine,and L. Tassinari: Effects of chronic excess salt ingestion. Role of genetic factors in both DOCA-salt and renal hypertension. J. exp. Med. 118, 605–617 (1963).PubMedCrossRefGoogle Scholar
  14. Dahl, L. K., M. Heine,and L. Tassinari: Effects of chronic excess salt injection. Vascular reactivity in two strains of rats with opposite genetic susceptibility to experimental hypertension. Circulation 30, Suppl. II, 11–22 (1964)PubMedGoogle Scholar
  15. Daniel, E. E., and O. Dawkins: Aorta and smooth muscle electrolytes during early and late hypertension. Amer. J. Physiol. 190, 71–76 (1957).Google Scholar
  16. Farnsworth, E. B., and M H. Barker: Tubular resorption of chloride in essential arterial hypertension. Intensive study of one case. Proc. Soc. exp. Biol. (N.Y.) 53, 160–162 (1943).CrossRefGoogle Scholar
  17. Freis, E D.: Observations on cardiac output, peripheral blood flow and blood volume in hypertension before and during treatment. In: Hypertension. First Hahneman Symp. (ed. J. Moyer), p. 123–126. Philadelphia: W. B. Saunders Co. 1959.Google Scholar
  18. Gardner, D. L., and P. W. Brooks: Prevention of vascular necrosis in rats with adrenal regeneration hypertension by incomplete control of raised blood pressure. Brit. J. exp. Path. 43, 276–287 (1962).PubMedGoogle Scholar
  19. Gamier, B., J. Gloor, Ph. Grandjean u. B. Steinmann: Blutdruck und Harnverhaltung. Helv. med. Acta 31, 484–490 (1964).Google Scholar
  20. Genest, J., W. Novaczynski, E. Koiw, T. Sandor u. P. Biron: Nebennierenrindenfunktion bei essentieller Hypertonie. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. T. Cottier), p. 143–164. Berlin-Göttingen-Heidelberg: Springer 1960.CrossRefGoogle Scholar
  21. Goldblatt, H.: Experimental renal hypertension. Mechanism of production and maintenance. Circulation 17, 642–647 (1958).PubMedCrossRefGoogle Scholar
  22. Gross, F.: Nebennierenrindenfunktion und renale Pressor-Mechanismen bei experimenteller Hypertension. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. T. Cottier), S. 105–126. Berlin-Göttingen-Heidelberg: Springer 1960.CrossRefGoogle Scholar
  23. Gross, F.: Hormonale Faktoren bei der essentiellen Hypertonie. Verh. dtsch. Ges. Kreisl.-Forsch. 28, 11–26 (1962).Google Scholar
  24. Helmer, O. M.: Presence of renin in plasma of patients with arterial hypertension. Circulation 25, 169–173 (1962).PubMedCrossRefGoogle Scholar
  25. Heptinstall, R. H.: Mahgnant hypertension. A study of fifty-one cases. J. Path. 65, 423–439 (1953).CrossRefGoogle Scholar
  26. Hoobler, S. W.: Univ. Mich. med. Bull. 27, 219 (1961).Google Scholar
  27. Humerfelt, S., and F. Wedervang: Relation between blood pressure, marital status and number of children in woman 40–42 years old. A statistical analysis. Acta med. scand. 159, 489 (1957).PubMedCrossRefGoogle Scholar
  28. Kinsey, D., and G. P. Whitelaw: The hypertensive patient. Method of study. Amer. J. Surg. 107, 5–13 (1964).CrossRefGoogle Scholar
  29. Klaus, D., H. Kaffarnik u. H. Pfeil: Untersuchungen über die Serum-Angiotensinase. II. Klinische Ergebnisse beim Hochdruck und bei Lebererkrankungen. Klin. Wschr. 41, 380–385 (1963).PubMedCrossRefGoogle Scholar
  30. Koletsky, S.: Pathogenesis of experimental hypertension induced by salt. Amer. J. Cardiol. 8, 576–581 (1961).CrossRefGoogle Scholar
  31. Kolff, W. J., L. H. Page, and A. C. Corcoran: Pathogenesis of renoprival cardiovascular disease in dogs. Amer. J. Physiol. 178, 237 (1954).PubMedGoogle Scholar
  32. Laidlaw, J. C., E. R. Yendt, and A. G. Gornall: Hypertension caused by renal artery occlusion simulating primary aldosteronism. Metabolism 9, 612 (1960).PubMedGoogle Scholar
  33. Lang, G. F.: Hiper- tonicheskaia Bolezor. (Hypertensive disease.) Moscow (Medgis) 30,496 (1950).Google Scholar
  34. Laragh, J. H, S. Ulick, W. Januszewicz, Q. B. Deming, W. G. Kelly, and S. Lieberman: Aldosterone secretion and arterial hypertension. Circulation 20, 725 (1959).Google Scholar
  35. Levy, R. L., C. C. Hillman, W. D. Stroud, and P. D. White: Transient hypertension. Its significance in terms of later development of sustained hypertension and cardiovascular-renal diseases. J. Amer. med. Ass. 126, 829 (1944).CrossRefGoogle Scholar
  36. Losse, H., u. H. Wehmeyer: Die Bedeutung des Natriumchlorids in der Pathogenese der Hypertonie. In: Hypertonie. Symp. Münster (ed. W. Hauss u. H. Losse), S. 112–119. Stuttgart: Georg Thieme 1964.Google Scholar
  37. Losse, H., H. Wehmeyer, and H. Zumkley: The behaviour of the intracellular electrolytes in arterial hypertension investigations on erythrocytes. Electrolytes and cardiovascular diseases (ed. Bajusz), vol. 2, p. 174–197. Basel: S. Karger 1966.Google Scholar
  38. Magakian, G. O., D. T. Miminoshvici, G. I. Kokaia: Klin. Med. (Mosk.) Russisch 37, 30 (1959).Google Scholar
  39. E. Simonson u. J. Brozek: Ann. intern. Med. 50, 129–193 (1959).PubMedCrossRefGoogle Scholar
  40. Masson, G. M. C., G. Plahl, A. C. Corcoran, and L H. Page: Accelerated hypertensive vascular disease from saline and renin in nephrectomized dogs. Arch. Path. 55, 97 (1953).Google Scholar
  41. Mendlowitz, M., N. E. Naftchi, R. L. Wolf, and S. E. Gitlow: Vascular reactivity in the patient with essential hypertension and hypertension of renal origin. Amer. J. Cardiol. 9, 680–684 (1962).CrossRefGoogle Scholar
  42. Merrill, J. P., C. Giordano, and D. R. Heetderks: The role of the kidney in human hypertension. I. Failure of hypertension to develop in the renoprival subject. Amer. J. Med. 31, 931–940 (1961).Google Scholar
  43. Miall, W. H., and P. O. Oldham: Clin. Sei. 17, 409 (1958).Google Scholar
  44. Miasnikov, A. L.: Isk. Akad. Med. Nauk. Moskow 1951, 1–11.Google Scholar
  45. Moser, M.: Epidemiology of primary hypertension with particular reference to racial susceptibility. In: Hypertension. I. Hahnemann-Symp. (ed. J. Moyer), p. 72–84. Philadelphia: W. B. Saunders Co. 1959.Google Scholar
  46. Moses, L., G. E. Daniels, and J L. Nickerion: Psychosom. Med. 18, 471 (1956).PubMedGoogle Scholar
  47. Page, I. H.: Neural and humoral control of blood vessels. Ciba Foundation Sympos. on Hypertension (ed. G. E. W. Wolstenholme, and M. P. Cameron), p. 3–25. London: J. A. Churchill 1954.Google Scholar
  48. Page, I. H.: The nature of arterial hypertension. Arch, intern. Med. I, 103 (1963).CrossRefGoogle Scholar
  49. Peart, W. S.: Hypertension and the kidney. I. Clinical, pathological, and functional disorders especially in man. Brit. med. J. 1959 II, 1353–1359.Google Scholar
  50. Peart, W. S.: Hypertension and the kidney. II. Experimental basis of renal hypertension. Brit. med. J. 1959 II, 1421–1429.Google Scholar
  51. Pickering, G,: The nature of essential hypertension, p. 1–144. London: J. & A. Churchill 1961.Google Scholar
  52. Piatt, R.: Das Wesen der essentiellen Hypertonie. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. T. Cottier), S. 45–51. Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  53. Renbi, F.: Les vaisseaux et les glandes endocrines dans la neurofibromatose. Schweiz, med. Wschr. 1945, 463.Google Scholar
  54. Renbi, F.: Physiopathologie de l’hypertension arterielle. Brüx. med. 38, 1 (1953).Google Scholar
  55. Renbi, F.: Nierenkrankheiten, S. 578. Bern: Hans Huber 1960.Google Scholar
  56. Sapirstein, L. A,: Sodium and water ratios in the pathogenesis of hypertension. In: Hypertension. I. Hahnemann Symp. (ed. J. Moyer), p. 273–277. Philadelphia: W. B. Saunders Co. 1959.Google Scholar
  57. Sarre, H., u. F. Moser: Hypertonie, Nephritis und Nephrofibrose (-Zirrhose) nach Bestrahlung der Nieren. Med. Klin. 57, 1526–1531 (1962).PubMedGoogle Scholar
  58. Schmid, A., u. R. Sauter: Pathogenetischer Deutungsversuch gewisser Hypertonieformen auf Grund einer Anpassungsstörung der Arteriolen. Helv. med. Acta 21, 223–248 (1954).PubMedGoogle Scholar
  59. Schmid, A., R. Sauter u. F. Reubi: Der Zusammenhang zwischen Blutdruckperiodik und Nierendurchblutung. Schweiz, med. Wschr. 84, 760 (1954).Google Scholar
  60. Schroeder, H. A., and H. M. Perry jr.: Antihypertensive effects of metal binding agents. J. Lab. din. Med. 46, 416–422 (1955).Google Scholar
  61. Skeggs, L.. T., and J. R. Kahn: Renal pressor system in hypertension. Evidence of circulating hypertension in chronic renal hypertension. Nature and activity of purified hypertensin. Circulation 17, 658 (1958).PubMedCrossRefGoogle Scholar
  62. Skelton, F. R.: Experimental hypertensive vascular disease in the rat. Arch. Path. 60, 190 (1955).Google Scholar
  63. Thurau, K., P. Deetjen u. Kramer: Nierendurchblutung und Diurese. Zit. bei B. Ochwadt. In: Diuresis and diuretics. Internat. Symp. (ed. E. Buchborn u. K. D. Bock), S. 1–13. Berlin-Göttingen-Heidelberg: Springer 1959.Google Scholar
  64. Tobian, L., and J. T. Binion: Tissue cations and water in arterial hypertension. Circulation 5, 754–758 (1952).PubMedCrossRefGoogle Scholar
  65. Tobian, L., and J. T. Binion: Artery wall electrolytes in renal and DOCA hypertension. J. din. Invest. 33, 1407 (1954).Google Scholar
  66. Tobian, L., and P. D. Redleaf: Ionic composition of the aorta in renal and adrenal hypertension. Amer. J. Physiol. 192, 325–330 (1958).PubMedGoogle Scholar
  67. Wakerlin, G. E.: A summary of the laboratory observations on humoral agents as a cause of hypertension. In: Herpertension. I. Hahnemann Symp. (ed. J. Moyer), p. 201–211. Philadelphia: W. B. Saunders Co. 1959.Google Scholar
  68. Wilson, C.: Univ. Mich. med. Bull. 27, 192 (1961).PubMedGoogle Scholar
  69. Wilson, J. G. M.: Brit. J. prev. soc. Med. 12, 204 (1958).Google Scholar
  70. Wolf, R. L., M. Mendlowitz, S. E. Gitlow, and N. Naftchi: Metabolism of angiotensin II-Ji normo- tensive and hypertensive human subjects. Circulation 23, 754–758 (1961).PubMedCrossRefGoogle Scholar
  71. Wolf, R. L., M. Mendlowitz, J. Pick, S. E. Gitlow, and N. Naftchi: In vitro degradation of Ji labeled angiotensin II by normotensive and hypertensive human serum. Proc. Soc. exp. Biol. (N.Y.) 109, 308–313 (1962).CrossRefGoogle Scholar
  72. Wollheim, E., u. J. Moeller: Hypertonie. In: Mohr-Staehelin-Bergmann-Frey-Schwiegk, Handbuch der inneren Medizin, 4. Aufl. IX. Berlin-Göttingen- Heidelberg: Springer 1960.Google Scholar
  73. Zimmerli, B., P. T. Cottier u. F. Wüthrich: Experimentelle Untersuchungen zur Wirkung langdauernder Ephedringaben auf Blutdruck, Myosin, energiereiche Phosphate und Elektro- lyte im Herzmuskel. Cardiologia (Basel) 41, 325–348 (1962).CrossRefGoogle Scholar

Pathogenese der malignen Hypertonie

  1. Bali, T., and H Goldblatt: On the pathogenesis of the vascular lesions of malignant hypertension in the rat. The role of elevated blood pressure and renal function. Exp. Med. Surg. 12, 460–479 (1954).PubMedGoogle Scholar
  2. Fishberg, A.M.: Hypertension and nephritis. Philadelphia: Lea & Febiger 1954.Google Scholar
  3. Fleming, H. A.: Factors involved in production of acute arterial lesions in rabbits with experimental renal hypertension. J. Path. Bact. 65, 441 (1953).PubMedCrossRefGoogle Scholar
  4. Gomori, P.: Zur Pathogenese und Therapie der malignen Hypertonie. Ther. hung. 3, 3–9 (1955).Google Scholar
  5. Hoobler, S.W.: Hypertensive disease. Diagnosis and treatment. New York: Hoeber- Harper 1959.Google Scholar
  6. Kincaid-Smith, P., J. McMichael, and E. A. Murphy: The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Quart. J. Med. 27, 117 (1958).Google Scholar
  7. Laragh, J. H., P. J. Cannon, C. J. Bentzel, A. M. Sicinski, and J. I. Meitzer: Angiotensin II, norepinephrine, and renal transport of electrolytes and water in normal man and in cirrhosis with ascites. J. din. Invest. 42,1179–1192 (1963).Google Scholar
  8. Laragh, J. H., S. Ulick, V. Jannszewicz, W. G. Kelly, and S. Lieberman: Electrolyte metabolism and aldosterone secretion in benign and malignant hypertension. Amer. intern. Med. 53, 259 (1960).CrossRefGoogle Scholar
  9. Muirhead, E. E., L.-G. Turner, and A. Grollman: Hypertensive cardiovascular disease; vascular lesions of dogs maintained for extended periods following bilateral nephrectomy or ureteral ligation. Arch. Path. 51, 575 (1951).Google Scholar
  10. Perera, G. A.: Development of hypertensive manifestations after the disappearance of hypertension. Circulation 10, 28 (1954).PubMedCrossRefGoogle Scholar
  11. Perera, G. A.: Primary hypertension. The Lewis A. Conner memorial lecture. Circulation 13, 321–328 (1956).PubMedCrossRefGoogle Scholar
  12. Perera, G. A The accelerated form of hypertension, a unique entity. Trans. Ass. Amer. Phycns 71, 62–68 (1958).Google Scholar
  13. Perera, G. A., and G. Adler: ABO blood groups in the accelerated form of hypertension. Ann. Intern. Med. 53, 84 (1960).PubMedCrossRefGoogle Scholar
  14. Perera, G. A., and A. Damon: Heigt, weight and their ratio in the accelerated form of primary hypertension. Arch, intern. Med. 100, 263 (1957).CrossRefGoogle Scholar
  15. Pickering, G. W.: High blood pressure. New York: Grune & Stratton 1955.Google Scholar
  16. Pickering, G. W., A. D. Wright, and R. H. Heptinstall: Reversibility of malignant hypertension. Lancet 1952 II, 952.CrossRefGoogle Scholar

Pathophysiologie

  1. Bello, C. T., R. W. Seuy, E. A. Ohler, C. A. Papacostas, and R. M. Bücher: Renal hemodynamic responses to stress in normotensive subjects. Circulation 22, 573 (1960).CrossRefGoogle Scholar
  2. Bock, K. D., H. Dengler, H. J. Krecke u. G. Reichel: Untersuchungen über die Wirkung von synthetischem Hypertensin II auf Elektrolythaushalt, Nierenfunktion und Kreislauf beim Menschen. Klin. Wschr. 36, 808 (1958).CrossRefGoogle Scholar
  3. Brod, J.: Essential hypertension. Hemodynamic observations with a bearing on its pathogenesis. Lancet 1960 II, 773–778.CrossRefGoogle Scholar
  4. Brod, J., V. Fence, Z. Heje, and J. Jirka: Hemodjniamics in essential hypertension. Nature (Lond.) 184, Suppl. 21, 1643–1644 (1959).CrossRefGoogle Scholar
  5. Brod, J., V. Fend, Z. Hejl, J. Jirka, and M. Ulrych: General and regional haemodynamic pattern underlying essential hypertension. Clin. Sei. 23, 339–349 (1962).Google Scholar
  6. Brown, J. J., and W S. Peart: The effect of angiotensin on urine flow and electrolyte excretion in hypertensive patients. Clin. Sei. 22, 1–17 (1962).Google Scholar
  7. Chiesura, P., e F. Oobbato: Profilo emodinamico e funzionale del vene nell 27;ipertensione essentiale. Minerva med. 2, 805–812 (1953).Google Scholar
  8. Cottier, P. T.: Renale Haemodynamik, Wasser- und Elektrolytausscheidung bei Hypertonie. Helv. med. Acta, Suppl. 39 ad. vol. 27, fasc. 4Google Scholar
  9. Cottier P.T., J. Gingold, C. Vorburger, H. M. Keller, and F. Reum: Renale Wirkung eines neuen Vasodilatators Ciba 31531-Ba. Helv. med. Acta 32,420–426 (1965).Google Scholar
  10. Crepet, M., e G. Scansetti: Compromissione renale da ipertensione essentiale. Minerva nefrol. 3, 45 (1956).PubMedGoogle Scholar
  11. Crosley jr. A. P., C. Castillo, and G. G. Kowe: The relationship of renal oxygen consumption to renal function and weight in individuals with normal and diseased kidneys. J. din. Invest. 40, 836–842 (1961).Google Scholar
  12. De Leon jr. A. C., L. S. Dreifus, and S. Bellet: Urinary osmolar concentration; a means of evaluating early renal function changes in essential hypertension. Amer. J. med. Sei. 239, 144–147 (1960).CrossRefGoogle Scholar
  13. Del Greco, F.: Effects of valine-5 angiotensin II on excretion of water and salt in primary and secondary hypertension. Proc. Soc. exp. Biol. (N.Y.) 107, 943–946Google Scholar
  14. Doering, P., R. Koch, H. Sancken u. M. Schwab: Die intrarenale Haemodynamik bei essentieller Hypertonie. Klin. Wschr. 1954, 71–76.Google Scholar
  15. Effat, S., M. A. H. Mahdi, and N. Elebrashy: Changes in renal functional pattern in essential hypertension. J. Egypt, med. Ass. 43, 596–608 (1960).Google Scholar
  16. Esch, I., u. J. Krammer: Zur Wirkung von synthetischem Hypertensin II auf die Nierenfunktion beim Hypertoniker. Dtsch. Arch. klin. Med. 208, 586–592 (1963).Google Scholar
  17. Falzoy, M., M. Gelati e G. Gunella: Contributo alio studio delP ipertensione essentiale. Nota I. La funzionalitä renale nella fase stabilizzata dell’ ipertensione essentiale. G. Clin, med. 34, 1381–1406 (1953).Google Scholar
  18. Gargano, M., M. Anichini, G. Leonettl et C. Bartorelli: Les modifications de la tension arterielle, de l’excretion de l’eau et des electrolytes au cours des changements de position chez les hypertendus. Presse med. 72, 321–324 (1964).Google Scholar
  19. Goldring, W., and H. Chasis: Hypertension and hypertensive vascular disease. New York: Commonwealth Fund 1944.Google Scholar
  20. Goldring, W., H. Chassis, H. A. Ranges, and H. W. Smith: Effective renal blood flow in subjects with essential hypertension. J. din. Invest. 20, 637 (1941).Google Scholar
  21. Gomez, D. M.: Evaluation of renal resistances, with special reference to changes in essential hypertension. J. din. Invest. 30, 1142 (1951).Google Scholar
  22. Heidland, A., K. Kliitsch, K. W. Schneider u. L. Pippig: Nierenhaemodynamik bei kompensierter und plusdekompensierter essentieller Hypertonie. Klin. Wschr. 40, 1003–1006Google Scholar
  23. Kodier, J.: Die urämische Azidose des Menschen. Bern: H. Huber 1966.Google Scholar
  24. Hulet, W. H., J. R. Richardson jr., and C. W. Hagedorn: Renal hemodjniamics, tubular excretion, and urine-concentrating capacity in the separate kidneys of subjects with essential hypertension. J. Lab. din. Med. 62, 787–803 (1963).Google Scholar
  25. Imhof, P., H. M. Keller, B. Notter, P. Spirig, J. Paris u. F. Reubi: Wirkung eines unspezifischen Reizstoffes (Sä 1083/IV) auf Blutdruck, Herzminutenvolumen und Nierenfunktion beim Hypertoniker. Helv. med. Acta 23, 515–522 (1956).PubMedGoogle Scholar
  26. Judson, W. E., W. Hollander, and R. W. Wilkins: The effect of exercise in the supine position on cardiovascular and renal function in hypertensive patients before and during chronic oral hydralazine therapy. J. Lab. din. Med. 49, 672–683 (1957).Google Scholar
  27. Kipfer, K.: Persönliche Mitteilung in P. Cottier. Helv. Med. Acta, Suppl. ad vol. 27 (1960).Google Scholar
  28. Meriel, P., F. Galinier, M. Desandre, S. Ribaut et M. Sue: L’hemodynamique renale chez les hypertendus arteriels. Arch. Mai. Cceur 47, 990–1000 (1954).Google Scholar
  29. Moeller, J.: Die Nierenfunktion beim essentiellen Hochdruck. Med. Welt 1960, 609–614.Google Scholar
  30. Moyer, J. H., Ch. Heider, K. Pevey, and R. V. Ford: The vascular status of a heterogenous group of patients with hypertension with particular emphases of renal function. Amer. J. Med. 24, 164–176 (1958).PubMedCrossRefGoogle Scholar
  31. Moyer, J. H., L. C. Mills, R. V. Ford, C. Spurr, C. P. Smith, and G. M. Weiler: The effect of a head-up tilted position and ambulation on renal hemodynamics and water and elektrolyte- excretion in patients with hypertension, with and without renal damage. J. Lab. din. Med. 45, 179–190 (1955).Google Scholar
  32. Nieth, H., u. W. Kaufmann: Renale Haemodynamik und Ausscheidungsfunktion der Niere bei essentieller und renaler Hypertonie in Wärme. Verh. dtsch. Ges. Kreisl.-Forsch. 28, 251–255 (1962).Google Scholar
  33. Peart, W. S., and J. J. Brown: Effect of angiotensin on urine flow and electrolyte excretion in hypertensive patients. Lancet 1961 1, 28–29.PubMedCrossRefGoogle Scholar
  34. Reubi, F.: Le flux sanguin renal. Helv. med. Acta 17, Suppl. 26, Fasc. 2 (1950).Google Scholar
  35. Bern: H. Huber 1960. Clearance tests in clinical medicine. Springfield (111.): Ch. C. Thomas 1963. Die Beteiligung der Niere bei der essentiellen Hypertonie. Verh. dtsch. Ges. KreisL-Forsch. 1963, 120–127.Google Scholar
  36. Schmid, A., R. Sauter u. F. Reubi: Der Zusammenhang zwischen Blutdruckperiodik und Nierendurchblutung. Schweiz, med. Wschr. 28, 760–772 (1954).Google Scholar
  37. Schwab, M., H. Kuhlmann u. Th, Dissmann: Seitengetrennte Nierenfunktionsstudien bei essentieller Hypertonie. In: Hochdruckforsch. II. Symp. Freiburg 1964 (ed. L. Heilmeyer u. H. J. Holtmeier), S. 61–67. Stuttgart: Georg Thieme 1965.Google Scholar
  38. Schwalb, H., u. W. Schimmler: Arterielle Kreislaufdynamik, Nierendurchblutung und Glomerulusfiltrat bei verschiedenen Hochdruckformen. Ärztl. Forsch. 7 (I), 409–413 (1953).Google Scholar
  39. Smith, H. W.: The kidney: stricture and function in health and disease. New York: Oxford University Press 1951.Google Scholar
  40. Szczeklik, E., Z. Wiktor, and S. Kotlarek-Haus: Renal failure in essential hypertension. Pol. Arch. Med. wewnet. 26, 513–522 (1956).PubMedGoogle Scholar
  41. Vagnucci, A. I., D. P. Lanier, R. B. Hickler, and G. W. Thorn: Acute infusion of synthetic angiotensin II in patients with essential hypertension. Its effect on renal hemodynamics and on electrolyte and water excretion. Circulation 29, 523–532 (1964).PubMedCrossRefGoogle Scholar
  42. Vagnncci, A. L, and L. G. Wesson jr.: Diurnal cycle of renal hemodynamics and excretion of chloride and potassium in hypertensive subjects. J. din. Invest. 43, 522–531 (1964).Google Scholar
  43. Vander, A. J.: Inhibition of distal tubular sodium reabsorption by angiotensin II. Amer. J. Physiol. 205, 133–138 (1963).PubMedGoogle Scholar
  44. Veyrat, R.: Le retentissement renal de I’hypertension arterielle. Schweiz, med. Wschr. 92, 1036–1041 (1962).Google Scholar
  45. Wiktor, Z., K. Jacyszyn, and L, Dec: Renal vascular resistance in hypertension. Pol. Arch. Med. wewnet. 32, 989–997 (1962).CrossRefGoogle Scholar

Hypernatriurese

  1. Baldwin, D. S., A. W. Biggs, W. Goldring, H. W. Kniet, and H. Chasis: Exaggerated natriuresis in essential hypertension. Amer. J. Med. 24, 893–902 (1958).PubMedCrossRefGoogle Scholar
  2. Baldwin, D.S., W. H. Kniet, A. W. Biggs, E. A. Gombos, and K. Chasis: II. Hemodynamics and excretion of solute and water in essential hypertension. J. din. Invest. 39, 395–404 (1960).Google Scholar
  3. Birchall, R., S. W. Tnthill, W. S. Jacobs, W. J. Trantman, and T. Findlay: Renal excretion of water, sodium and CI; comparison of the response of hypertensive patients with those of normal subjects; patients with specific adrenal or pituitary defects and a normal subject primed with various hormones. Circulation 7, 258 (1953).PubMedCrossRefGoogle Scholar
  4. Birkenhäger, W. K., L. W. van Eps, and L. A. de Vries: Reversal of rhythmic water and sodium excretion patterns during ganglionic or adrenergic block. Acta med. scand. 172, 105–115 (1962).PubMedCrossRefGoogle Scholar
  5. Brodsky, W. A., and K.N. Granbarth: Excretion of water and electrolytes in patients with essential hypertension. J. Lab. din. Med. 41, 43–55 (1953).Google Scholar
  6. Cottier, P. T.: Die Pathogenese der Hypernatriurese bei essentieller Hypertonie. Cardio- logia (Basel) 35, 410–423 (1959).CrossRefGoogle Scholar
  7. Cottier, P. T.: Renale Haemodynamik, Wasser- und Elektrolytausscheidung bei Hypertonie. Helv. med. Acta, Suppl. ad vol. 27 (1960) (Suppl. 39).Google Scholar
  8. Cottier, P. T.: Renale Haemodynamik, Wasser- und Elektrolytausscheidung bei essentieller Hypertonie. Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier). Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  9. Cottier, P. T., S. W. Koobler, and J. M. Weller: Effcct of a NaCl load on renal hemodynamics and electrolyte excretion in essential hypertension. J. din. Invest. 35, 698 (1956).Google Scholar
  10. Cottier, P. T., A. F. Mnller u. A. Schmid: Natriurese und Aldosteronausschei- dung bei essentieller Hypertonie. Schweiz, med. Wschr. 89, 376–379 (1959).Google Scholar
  11. Cottier, P. T., J. M. Weller, and S. W. Hoobler: Sodium excretion in essential hypertension. Univ. Mich, med. Bull. 23, 245 (1957).Google Scholar
  12. Cottier, P. T., J. M. Weller, and S. W. Hoobler Besonderheiten der renalen Wasser- und Elektrolytausscheidung bei essentieller Hypertonie. Cardiologia (Basel) 31, 278–289 (1957).CrossRefGoogle Scholar
  13. Cottier, P. T., J. M. Weller, and S. W. Hoobler Effect of an intra-venous sodium chloride load on renal hemodynamics and electrolyte excretion in essential hypertension. Circulation 17, 750–760 (1958).PubMedCrossRefGoogle Scholar
  14. Cottier, P. T., J. M. Weller, and S. W. Hoobler Sodium chloride excretion following salt loading in hypertensive subjects. Circulation 18, 196–205 (1958).PubMedCrossRefGoogle Scholar
  15. Ek, J., H. Bncht, and L. Werkö: The influence of a rapid infusion of glucose on renal dynamics and sodium excretion in patients with arterial hypertension. Amer. Heart J. 48, 102 (1954).PubMedCrossRefGoogle Scholar
  16. Farnsworth, E. B.: Renal reabsorption of chloride and phosphate in normal subjects and in patients with essential arterial hypertension. J. din. Invest. 25, 897 (1946).Google Scholar
  17. Farnsworth, E. B., and M. H. Barker: Tubular reabsorption of chloride in hypertensive and in normal individuals. Proc. Soc. exp. Biol. (N.Y.) 52, 74 (1943).CrossRefGoogle Scholar
  18. Farnsworth, E. B., and M. H. Barker: Tubular reabsorption of chloride in essential arterial hypertension: intensive study of one case. Proc. Soc. exp. Biol. (N.Y.) 53, 160 (1943).CrossRefGoogle Scholar
  19. Fieschi, A., S. Lamperi, G. Famagalli, F. di Pietranton jr. e G. C. Bruno: Regolazione della escrezione renale del sodio nel sogetto ipertoso con normale ad alterata funzione renale. Arch. E. Maragliano Pat. Clin. 17, 205–223 (1961).Google Scholar
  20. Gessler, U.: Intra- und extrazelluläre Elektrolytveränderungen und ihre Beeinflussung. Verh. dtsch. Ges. Kreisl.-Forsch. 1963, 229–231.Google Scholar
  21. Green, D. M., A. D. Johnson, W. C. Bridges, and J. H. Lehmann: Stages of salt exchange in essential hypertension. Circulation 9, 416 424 (1954).Google Scholar
  22. Hanenson, L. B., N. Polasky, H. H. Taussky, and B. F. Miller: Studies on the renal excretion of sodium in arterial hypertension. J. Lab. din. Med. 52, 817–818 (1958).Google Scholar
  23. Hanenson, I. B., E. Ricanati, and N. Polasky: Studies on the mechanism of the abnormal sodium excretion in arterial hypertension. Circulation 28, 867–876 (1963).PubMedCrossRefGoogle Scholar
  24. Hanenson, L B., H. H. Taussky, N. Polasky, W. Ransohoff, and B. F. Miller: Renal excretion of sodium in arterial hypertension. Circulation 20, 498–510 (1959).PubMedCrossRefGoogle Scholar
  25. Hollander, W.: Effects of intravenous hydration and pitressin on renal function in subjects with essential hypertension. Circulation 19, 691–696 (1959).PubMedCrossRefGoogle Scholar
  26. Hollander, W., A. V. Chobamian, B. A. Burrows, and T. Bikerman: Body fluid and electrolyte composition in arterial hypertension. I. Studies in essential, renal and malignant hypertension. J. din. Invest. 40, 408–415 (1961).Google Scholar
  27. Hollander, W., and W. E. Judson: Electrolyte and HgO metabolism in essential, renal and steroid induced hypertension. Circulation 16, 893 (1957).CrossRefGoogle Scholar
  28. Hollander, W., and W. E. Judson: Electrolyte and water excretion in arterial hypertension: I. Studies in non medically treated subjects with essential hypertension. J. din. Invest. 36, 1460–1469 (1957).Google Scholar
  29. Hollander, W., and W. E. Judson:Electrolyte and HgO excretion in arterial hypertension. II. Studies in subjects with essential hypertension after antihypertensive drug treatment. Circulation 17, 576 (1958).PubMedCrossRefGoogle Scholar
  30. Hulet, W. H., and J. R. Richardson jr.: Postural natriuresis and renal concentrating capacity in essential hypertension. Amer. J. Med. 33, 27–38 (1962).PubMedCrossRefGoogle Scholar
  31. Eirkendall, W. M., R. D. Peterson, and M. L. Armstrong: Salt loading and exchangeable electrolytes in patients without and with mild hypertension. J. Lab. din. Med. 54, 915 (1959).Google Scholar
  32. Ledingham, J. M.: Disturbances in water and electrolvte metabolism in experimental hypertension. Brit. med. Bull. 13, 33–38 (1957).PubMedGoogle Scholar
  33. Levin, N. W., and B. Goldberg: Studies in hypertension. I. Extracellular fluid volume (inuline space) in hypertension. S. Afr. J. med. Sei. 25, 1–8 (1960).Google Scholar
  34. Levinsky, N. G., and R. C. Lalone: The mechanism of sodium diuresis after saline infusion in the dog. J. din. Invest. 42, 1261–1276 (1963).Google Scholar
  35. Losse, H., H. Wehmeyer, and H. Zumkley: The behaviour of the intracellular electrolytes in arterial hypertension, investigations on erythrocytes. Electrolytes and cardiovascular diseases (ed. E. Bajusz), p. 174–197. Basel and New York: S. Karger 1966.Google Scholar
  36. Losse, H., H. Zumkley u. H. Wehmeyer: Untersuchungen über den Elektrolyt- und Wassergehalt von Erythrocyten bei arterieller Hypertonie. Z. Kreisl.-Forsch. 51, 43–51 (1962).Google Scholar
  37. Mertz, D. P.: Der Mechanismus der renalen Natriumausscheidung bei exzessiver Belastung mit hypertonischer NaCl-Lösung. I. Funktionelles Verhalten von Glomerulusfiltrat, Reabsorption von Natrium im proximalen Tubulus und Harnkonzentrierungsmechanismus. Klin. Wschr. 39, 903–909 (1961).PubMedCrossRefGoogle Scholar
  38. Mertz, D. P.:Der Mechanismus der renalen Natriumausscheidung bei exzessiver Belastung mit hypertonischer NaCl-Lösung. II. Funktionelles Verhalten von effektiver Nierendurchblutung, renaler Elektrolytausscheidung und extracellulärer Flüssigkeitsphasen. Klin. Wschr. 39, 942–948 (1961).PubMedCrossRefGoogle Scholar
  39. Mertz, D. P.: Über das Verhalten physiologisch aktiver extrazellulärer Volumenphasen bei essentieller Hypertonie und den Mechanismus der antihypertensiven Wirkung einer Natriumrestitution. Klin. Wschr. 39, 1123–1130 (1961).PubMedCrossRefGoogle Scholar
  40. Mertz, D. P.: Über die Abhängigkeit der renalen Hämodynamik von den Bedingungen im Wasser- und Salzhaushalt. Z. klin. Med. 157, 1–13 (1961).PubMedGoogle Scholar
  41. Der Mineralhaushalt bei essentieller Hypertonie. Med. Welt 1962, 1973–1976Google Scholar
  42. Mertz, D. P.: Die Nierenhaemodynamik als natriumbewahrendes Prinzip. Z. ges. exp. Med. 136, 11–41 (1962).PubMedCrossRefGoogle Scholar
  43. Mertz, D. P.: Wasser- und Mineralhaushalt als pathogenetische Faktoren bei der essentiellen Hypertonie. Verh. dtsch. Ges. Kreisl.-Forsch. 1963, 42–59.Google Scholar
  44. Papper, S., J. L. Belsky, and K. H. Bleifer: The response to the administration of an isotonic sodium chloride lactate solution in patients with essential hypertension. J. din. Invest. 39, 876–884 (1960).Google Scholar
  45. Ross, E. I.: Total exchangeable Na in hypertensive patients. Clin.Sei. 15, 81–91 (1956).Google Scholar
  46. Sapirstein, L. A.: Conference on electrolyte and adrenal factors in human and experimental renal hypertension. Circulation 17, 779 (1958).Google Scholar
  47. Sasamori, Ch.: Effect of salt loading on renal hemodynamics and electrolyte excretion in essential hypertension and in chronic glomerulonephritis. Tohoku J. exp. Med. 71, 311–329 (1960).Google Scholar
  48. Sporn, I. N., R. G. Lancestremere, C. A. Vaamonde, and S. Papper: Acute renal conservation of sodium in hypertension. Arch, intern. Med. I, 439–442 (1963).CrossRefGoogle Scholar
  49. Steinmetz, P. R., R. P. Eisinger, E. A. Gombos, H. Chasis, and D. S. Baldwin: Excretion of free water and solute during maximal water diuresis in normal and hypertensive subjects. J. Lab. din. Med. 64, 238–256 (1964).Google Scholar
  50. Taquini, A. C., S. A. Plesch, T. A. Capris, and B. N. Badano: Some observations on water and electrolyte metabolism in essential hypertension. Acta cardiol. (Brüx.) 11, 109 (1956).Google Scholar
  51. Thompson, J. E., T. F. Silva, D. Kinsey, and R. H. Smithwick: The effect of acute salt loads on the urinary sodium output of normotensive and hypertensive patients before and after surgery. Circulation 6, 912 (1954).CrossRefGoogle Scholar
  52. Thurau, K., u. P. Deetjen: Die Diurese bei arteriellen Drucksteigerungen. Bedeutung der Haemodynamik des Nierenmarkes für die Hamkonzen- trierung. Mit einem theoretischen Beitrag von H. Günzler: Gegenstromsysteme mit Stoff- 35 Handbuch der inneren Medizin, Bd. VIII/2, 5. Aufl. zufuhr durch die Außenwände. Pflügers Arch. ges. Physiol. 274, 567–580 (1962).Google Scholar
  53. Thurau, K., P. Deetjen u. K. Kramer: Haemodynamik des Nierenmarkes. II. Wechselbeziehung zwischen vaskulärem und tubulärem Gegenstromsystem bei arteriellen Drucksteigerungen, Wasserdiurese und osmotische Diurese. Pflügers Arch. ges. Physiol. 270, 270–285 (1960).CrossRefGoogle Scholar
  54. Tobian, L.: Sodium, renal arterial distension and the juxtaglomerular apparatus. Canad. med. Ass. J. 90, 160–162 (1964).PubMedGoogle Scholar
  55. Tobian, L., K. Coffee, D. Ferreira, and J. Meuli: The effect of renal perfusion pressure on the transport of sodium out of distal tubular urine as studied with the stop-flow technique. J. din. Invest. 43, 118–128 (1964).Google Scholar
  56. Ullmann, T D., S. H. Blondheim, S. Dickstein, and D. Ben-Ishay: Water and salt excretion after intravenous salt load in hypertensive subjects. Circulation 19, 729–734 (1959).PubMedCrossRefGoogle Scholar

Aldosteron und Hypertonie

  1. Albeaux-Fernet, M., et J. D, Romani: L’excretion urinaire de l’aldosterone au cours de l’hypertension arterielle. Ann. Endoer. (Paris) 22, 516–523 (1961).Google Scholar
  2. Albeaux-Fernet, M., et J. D. Romani: Etude de l’excretion basale de l’aldosterone dans 19 cas d’hypertension arterielle. Bull. Acad. nat. Med. (Paris), Ser. III, 145, 128–133 (1961).Google Scholar
  3. Barraclough, M, A,: Sodium and water depletion with acute malignant hypertension. Amer. J. Med. 40, 265–272 (1966).CrossRefGoogle Scholar
  4. Conn, J. W.: Adrenal factors in hypertension. Circulation 17, 743 (1958).Google Scholar
  5. Conn, J. W. Aldosteronism and hypertension. Primary aldosteronism versus hypertensive disease with secondary aldosteronism. Arch, intern. Med. 107, 813–828 (1961).CrossRefGoogle Scholar
  6. Conn, J. W., E. L. Cohen, D. R. Rooner, M. Reed, and R. M. Nesbit: Normokalemic primary aldosteronism a detectable cause of curable "essential" hypertension. J. Amer. med. Ass. 193, 200–206 (1965).CrossRefGoogle Scholar
  7. Conn, J. W., D. R Rooner, E L Cohen, and R. M. Nesbit: Normokalemic primary aldosteronism, its masquerade as „essential"hypertension. J. Amer. med. Ass. 195, 21–24 (1966).CrossRefGoogle Scholar
  8. Davis, J. O.: A critical evaluation of the role of receptors in the control of aldosterone secretion and sodium excretion. Progr. cardio vase. Dis. 4, 27–46 (1961).CrossRefGoogle Scholar
  9. Genest, J.: Angiotensin, aldosterone in human arterial hypertension. Canad. med. Ass. J. 84, 403–419 (1961).PubMedGoogle Scholar
  10. Georgopulos, A. J., H. Dustan, and L. H. Page: Spironolactone in hypertensive patients. Arch, intern. Med. 108, 389 (1961).CrossRefGoogle Scholar
  11. Gill jr. J. R., J. M. George, A. Salomon, F. C. Bartter, and D. McBirney: Hyperaldosteronism and renal sodium loss reversed by drug treatment for malignant hypertension. New Engl. J. Med. 270,1088–1092 (1964).PubMedCrossRefGoogle Scholar
  12. Izahara, K., D. Musha, K. Ito, T. Tominaga, S. Fokuchi, T. Jimbo, T. Sato, and H. Yaoita: Studies on total body water. VIII. Total exchangeable sodium and potassium, and aldosterone excretion in hypertension. Abstr. of papers 56th sei. Sess. Jap. Soc. intern. Med. 1959, p. 86–87.Google Scholar
  13. Johnson, O. D., and R. V. Ford: Adrenocortical function in hypertensive and non hypertensive patients. Amer. Heart J. 64, 321 (1962).PubMedCrossRefGoogle Scholar
  14. Jones, N. F., W. F. Clapham, M. A. Barraclough, and L. H Mills: Blood volume, total body water and aldosterone excretion in essential hypertension. Clin. Sei. 26, 307–313 (1964).Google Scholar
  15. Josephson, B., J. Bergström, H. Bucht, and E. Hultman: On the influence of body water volume and potassium supply on the aldosterone excretion in arterial hypertension. Scand. J. din. Lab. Invest. 14, 47–58 (1962).Google Scholar
  16. Laragh, J. H., P. J. Cannon, and R. P. Ames: Aldosterone secretion and various forms of hypertensive vascular disease. Ann. intern. Med. 59, 117–120 (1963).PubMedCrossRefGoogle Scholar
  17. Laragh, J. H., P. J. Cannon, and R. P. Interaction between aldosterone secretion, sodium and potassium balance, and angiotensin activity in man: Studies in hypertension and cirrhosis. Canad. med. Ass. J. 90, 248–256 (1964).Google Scholar
  18. Mach, R. S.: Le role des surrenales dans I’hjrpertension arterielle. Schweiz, med. Wschr. 92, 1027–1034 (1962).Google Scholar
  19. Muller, A. F., G. Greder et E. L. Manning: Insuffisance renale et eh- mination urinaire de l’aldosterone. Helv. med. Acta 30, 570–574 (1963).PubMedGoogle Scholar
  20. Sambhi, M. P., J. C. Beck, and E. H. Venning: Malignant hypertension and aldosterone secretion. Influence of reversal and progression of the syndrome in two cases. Amer. J. Med. 35, 251–256 (1963).PubMedCrossRefGoogle Scholar
  21. Tronchetti, F., e R. Romanelli: L’intervento dell’aldosterone e degli elettroliti nella pato- genesi della ipertensione essenziale. Foha endocr. (Pisa) 15, 141–162 (1962).Google Scholar
  22. Travis, R.H., J. B. Garst, and R. Jeiliffe: Urinary aldosterone and hypertension. Circulation 24, 592–598 (1961).PubMedCrossRefGoogle Scholar
  23. Venning E, L. Dyrenfurth, J. B. Dossetor, and J. C. Beck: Effect of chlorothiazide upon aldosterone excretion and sodium and potassium balance in essential hypertension. J. Lab. din. Med. 60, 79–85 (1962).Google Scholar
  24. Wärter, J., J. Schwartz et R Bloch: L’hyperaldosteronisme secondaire au cours de I’hjrpertension arterielle. Presse med. 68, 5–6 (1960).PubMedGoogle Scholar
  25. Wärter, J., J. Schwartz et R Bloch Aldosterone et hypertension arterielle. Symposium. Path, et Biol. 9, 1523–1528 (1961).Google Scholar

Klinik der Hypertonieniere bzw. Nephrosklerose

  1. Arnold, O. H,, u. E. Messmer: Untersuchungen zum Problem der Beziehung Hochdruck- Niere. Dtsch. med. Wschr. 1952, 1565–1571.Google Scholar
  2. Bechgaard, P.: Der Spontanverlauf der benignen Hypertonie. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier), S. 217–233. BerUn-Göttingen-Heidelberg: Springer 1960.Google Scholar
  3. Bechgaard, P.: Essentielle Hypertonie. Internat. Symp. Ciba (ed. K. D. Bock u. P. T. Cottier). Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  4. Betz, E,, u. H. Breitinger: Rückwirkungen der arteriellen Hypertonie auf Herz, Gefäß-System und Niere mit mehrjährigen Verlaufsbeobachtungen. Medizinische 1959, 707–712.Google Scholar
  5. Betz E, u. H. Breitinger Hypertension, recent advances. The second Hahnemann Symp. in hypertensive disease (ed. A. N. Brest, and J. H. Moyer). Philadelphia: Lea & Febiger 1961.Google Scholar
  6. Corcoran, A. C., H. P. Dustan, R. D. Taylor, and H. J. Page: Amer. J. Med. 17, 383 (1954).PubMedCrossRefGoogle Scholar
  7. Corcoran, A. C., I. H. Page, H. P. Dustan, and L. A. Lewis: Cleveland Clin. Quart. 23, 115 (1956).PubMedCrossRefGoogle Scholar
  8. Cottier, P. T.: Renale Haemodynamik, Wasser- und Elektrolytausscheidung bei Hypertonie. Helv. med. Acta, Suppl. 39, 27 (4), 1–180 (1960).Google Scholar
  9. Danowski, T. S., M. Kren, F. M. Mateer, A. J. Puntereri, and E. R. Fisher: Laboratory and clinical differenziation of chronic glomerulonephritis and nephrosclerosis. Amer. J. med. Sei. 236, 551–566 (1958).Google Scholar
  10. Edwards, J. C.: Management of hypertensive diseases. St. Louis: C. V. Mosby Co. 1960.Google Scholar
  11. Griep, A. P., G. R. Barry, W. C. Hall, and S. W. Hoobler: The prognosis in arterial hypertension. Report on 117 patients under 53 years of age, followed 8–10 years. Amer. J. med. Sei. 221, 239 (1951).CrossRefGoogle Scholar
  12. Hamburger, J., Cr. Riebet, J. Crosnier, J. L. Fnnck-Brentano, B. Antoine, H. Ducrot, J. P. Mery, H. de Montera et P. Royer: Nephrologie (ed. Pasteur Vallery-Radot et J. Hamburger). Paris: Editions Medicales Flammarion 1966.Google Scholar
  13. Hamburger, J., Cr. Riebet, J. Crosnier, J. L. Fnnck-Brentano, B. Antoine, H. Ducrot, J. P. Mery, H. de Montera et P. Royer: Hochdruckforschung (ed. L. Heilmeyer u. H. J. Holtmeier). Stuttgart: Georg Thieme 1965.Google Scholar
  14. Hamburger, J., Cr. Riebet, J. Crosnier, J. L. Fnnck-Brentano, B. Antoine, H. Ducrot, J. P. Mery, H. de Montera et P. Royer: Antihypertensive therapy. Principles and practice. Internat. Symp. (Ciba) Siena 1965 (ed. F. Gross). Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  15. Hoobler, S. W.: Hypertensive disease. New York:Hoeber- Harper 1959.Google Scholar
  16. Jvanyi, J., u. J. Lippai: Beobachtungen an 1152 Hypertoniekranken. Ärztl. Forsch. 14, 583–590 (1960).Google Scholar
  17. Leman jr., J.: Diagnostic value of urin analysis in patients with hypertension. Amer. J. Surg. 107, 38–42 (1964).CrossRefGoogle Scholar
  18. Lockhart, G., G. von Noorden, H. P. Dustan, A. C. Corcoran, and I. H. Page: The course of retinopathy in treated malignant hypertension. Arch, intern. Med. 106, 205–212 (1960).CrossRefGoogle Scholar
  19. Milliez, P., P. Tcherdakoff, P. Samarcq, and L. P. Rey: Der Spontanverlauf der malignen Hvpertonie. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier), S.233–251. Berlin-Göttingen-Heidelberg: Springer 1960).Google Scholar
  20. Moyer, H.: Hypertension. The first Hahnemann Symposium on hypertensive disease (ed. J. H. Moyer). Philadelphia and London: W. B. Saunders Co. 1959.Google Scholar
  21. Pickering, G. W.: High blood pressure. London: Churchill 1955.Google Scholar
  22. Piette Y., and A. C. Corcoran: Proteinuria and malignant hypertension. Canad. med. Ass. J. 71, 542–546 (1954).PubMedGoogle Scholar
  23. Reubi, F.: Nierenkrankheiten. Bern: Hans Huber 1960.Google Scholar
  24. Reubi F., G. Nowak et R. Witmer: Existe-t-il une correlation entre le flux sanguin renal, la tension arterielle et les lesions retiniennes chez les nephritiques et les hypertendus essentiels ? Helv. med. Acta 22, 1–15 (1955).PubMedGoogle Scholar
  25. Scbroeder, H. A.: Hypertensive disease. Philadelphia: Lea & Febiger 1953.Google Scholar
  26. Schwalb, H.: Clearance-Untersuchung bei Nierenkrankheiten und Hochdruck. Münch, med. Wschr. 1953, 1001–1004.Google Scholar
  27. Smirk, F. H.: High arterial pressure. Springfield (111.): Ch. C. Thomas 1957.Google Scholar
  28. Wollheim, E.: Praktische und klinische Klassifizierung der Hypertonieformen. Regens- bürg Jb. ärztl. Fortbild. 10, 373–381 (1962).Google Scholar
  29. Wollheim, E.: Differentialdiagnose und Therapie der Hypertonie. Wien. med. Wschr. 112, 831–836 (1962).Google Scholar
  30. Wollheim, E., u. J. Moeller: Hypertonie. In: Mohr-Staehelin-Bermann, Frey Schwiegk, Handbuch der inneren Medizin, 4. Aufl., Bd. IX. Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar

Therapie

  1. Bock, K. D.: ABC für Hochdruckkranke. Stuttgart: Georg Thieme 1966.Google Scholar
  2. Brest A. N., and J. H. Moyer: Current drug therapy in hypertension. Angiology 14, 64–68 (1963).PubMedCrossRefGoogle Scholar
  3. Cottier, P. T.: Renale Haemodynamik, Wasser- und Elektrolytausscheidung bei Hypertonie. Helv. med. Acta, Suppl. 39, 27, 1–180 (1960).Google Scholar
  4. Cottier, P. T., u. A. Zimmerli: Vergleichende Untersuchung über die Wirkung verschiedener Hypertensiva auf Blutdruck und Nierenfunktion nach längerer Behandlung. Helv. med. Acta 26, 648–654 (1959).PubMedGoogle Scholar
  5. Hoobler, S.W.: Hypertensive disease, diagnosis and treatment, p. 1–353. New York: Paul B. Hoeber 1959.Google Scholar
  6. Kroneberg, H.: Pharmakologie der blutdrucksenkenden Arzneimittel. Verh. dtsch. Ges. Kreisl.-Forsch. 1963, 172–184.Google Scholar
  7. Moeller, J., u. A. Wedl: Blutdrucksenkung und Nierenfunktion. Klin. Wschr. 1955, 10–14.Google Scholar
  8. Moyer, J. H.: Drug therapy of hypertension. IV. The indications and contraindications for antihypertensive drugs. Arch, intern. Med. 98, 427–443 (1956).CrossRefGoogle Scholar
  9. Moyer, J. H., and A. Brest: Untreated and treated patients with hypertension. Dis. Chest 36, 297–314 (1959).PubMedCrossRefGoogle Scholar
  10. Moyer, J. H., E. W. Dennis, R. Ford, R. G. McConn, W. M. Hughes, and H. L. Beazley: Medical management of hypertension. 11. Drugs blocking the symp, nervous system. Med. Ree. (Houston) 49, 303 (1955).Google Scholar
  11. Moyer, J. H., Ch. Heider, K. Pevey, and R. V. Ford: The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function. Amer. J. Med. 24, 177–192 (1958).PubMedCrossRefGoogle Scholar
  12. Odashima, H.: The effect of hypotensive agents on renal hemodynamics in hypertensive patients. Tohoku J. exp. Med. 63, 171–184 (1956).Google Scholar
  13. Page, I. H.: The effect on renal efficiency of lowering arterial blood pressure in cases of essential hypertension and nephritis. J. din. Invest. 13, 909 (1934).Google Scholar
  14. Page, I. H.: Drug treatment of hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 602–614. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  15. Perry jr. H.M., and H.A. Schroeder: Studies on the control of hypertension. VI. Some evidence for reversal of the process during hexa- methonium and hyialazine therapy. Circulation 13, 528–536 (1956).PubMedCrossRefGoogle Scholar
  16. Perry jr., H.M., and H.A. Schroeder:Studies on the control of hypertension. VII. Effects of ganglionic blockade combined with hydralazine on the malignant stage complicated by renal azotemia. Circulation 14, 105–114 (1956).PubMedCrossRefGoogle Scholar
  17. Reubi, F.: Le flux sanguin renal. Helv. med. Acta Suppl. 26, 1–108 (1950).Google Scholar
  18. Reubi, F.: Therapeutische Probleme bei Nierenarteriosklerose und Hochdruck. Therapiewoche 7, 245–262 (1957). Nierenkrankheiten. Bern: Hans Huber 1960.Google Scholar
  19. Schroeder, H. A., J. D. Morrow, and H. M. Perry jr.: Studies on the control of hypertension by hyphex. V. Effects on the course of the malignant stage. Circulation 10, 321–330 (1954).PubMedCrossRefGoogle Scholar
  20. Schwartz, H., G. A. Eadie, R. D. Remington, and S. W. Hoobler: Effect of a simple therapeutic regimen on blood pressure and its variability in mild hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 242–253. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  21. Takagi, H.: Hypertension and renal functions. VI. Clinical studies. Neurogenic hypertension. Jap. Circulat. J. 22, 414–426 (1958).Google Scholar
  22. Taylor, R. M.: Renal aspects of certain antihypertensive agents. Angiology 14, 79–83 (1963).PubMedCrossRefGoogle Scholar
  23. Whitelaw, G. P., D. Kinsey, and R. H. Smithwick: Factors influencing the choice of treatment in essential hypertension. Surgical, medical or a combination of both. Symposium. Amer. J. Surg. 107, 220–231 (1964).CrossRefGoogle Scholar

Reserpin

  1. Andreae, E., and F. E. Smith jr.: The effect of oral reserpine on renal plasma flow in hypertension. Amer. J. med. Sei. 230, 45–48 (1955).CrossRefGoogle Scholar
  2. Drovanti, S., e C. Cei: Sul trattamento dell 27;ipertensione nefrogena ed essentiale con alcaloidi totali di Rauwolfia somministrali per via parenterale. Minerva med. 2, 607–612 (1955).Google Scholar
  3. Földi, M., A. O. B. Kovach u. E. Koltay: Die Wirkung des intravenös injizierten Rauwopur auf die allgemeine und renale Haemodynamik. Z. ges. inn. Med. 16, 256 (1961).PubMedGoogle Scholar
  4. Hübner, K., G. Schettler u. E. Stein: Klinische Untersuchungen zur Hochdruckbehandlung mit Reserpin. Dtsch. med. Wschr. 80, 47 (1955).PubMedCrossRefGoogle Scholar
  5. Krogsgaard, A. R.: The effect of intravenously injected reserpine on blood pressure, renal function and sodium excretion. Acta med. scand. 154, 41–51 (1956).PubMedCrossRefGoogle Scholar
  6. Meier, R., C. Briini et J. Tripod: Differenciation pharmacodynamiques de I’apresoline, du serpasil et de la chlorpromazine lors de leur action sur la retention du rat. Arch. int. Pharmaco- dyn. 104, 137–145 (1955).Google Scholar
  7. Michtschenko, P. I.: The influence of Rauwolfia alkaloids on the kidney in hypertension. Kardiologija (Mosk.) 2, (4), 80–82 (1962) Russisch.Google Scholar
  8. Moyer, J. H.: Drug therapy (Rauwolfia) of hypertension. I. Pharmacodynamics of Rauwolfia. Arch, intern. Med. 96, 518–529 (1955).CrossRefGoogle Scholar
  9. Moyer, J. H., W. Hughes, and R. Huggins: The cardiovascular and renal hemodynamic response to the administration of reserpine (serpasil). Amer. J. med. Sei. 227, 640–648 (1954).CrossRefGoogle Scholar
  10. Reubi, F., P. Müller et P. Stueki: Effects circulatoires de la reserpine (Serpasil). Helv. med. Acta 21, 493–497 (1954).PubMedGoogle Scholar
  11. Reusch, C. S.: The cardiorenal hemodynamic effects of antihypertensive therapy with reserpine. Amer. Heart J. 64, 643–649 (1962).PubMedCrossRefGoogle Scholar
  12. Schwab, M.: Der Einfluß von Reserpin auf die renale Wasser- und Elektrolytausscheidung und die Plasmaelektrolyte bei Hypertonikern und Normotonikern. Verh. dtsch. Ges. inn. Med. 1959, 630–635.Google Scholar
  13. Szabo, Z., u. Z. Nagy: Wirkung des Rawopurs auf die renale Haemodynamik und die Diurese im Tierversuch und bei Hypertonikern. Z. Kreisl.-Forsch. 49, 789–796 (1960).Google Scholar
  14. Vercillo, L., e A. Oiraldi: Azione del pentolinio e della sua associazione con diidrossi- propilteofillina e con reserpina suH’emodinamica renale in pazienti affetti da ipertensione arteriosa. Gazz. int. Med. Chir. 65, 1757–1766 (1961).Google Scholar

Hydergin

  1. Deutsch, E., u. Th. Markoff: Mitteilungen zur Nierenclearance. VI. Die Beeinflussung der Nierenleistung durch Hydergin. Klin. Med. (Wien) 8, 105–115 (1953).Google Scholar

Hydralazin

  1. Ablad, B.: A study of the mechanism of the hemodynamic effects of hydralazine in man, p. 53. Copenhagen: Munksgaard 1963.Google Scholar
  2. Bendersky, G., and C. Ramirez: Hydralazine prisoning. Review of the literature and autopsy study of person with massive intestinal bleeding. J. Amer. med. Ass. 173, 1789–1794 (1960).CrossRefGoogle Scholar
  3. Comens, P., and H. A. Schroeder: The LE cell as a manifestation of delayed hydralazine intoxication. J. Amer. med. Ass. 160, 1134–1136 (1956).CrossRefGoogle Scholar
  4. Corcoran, A.C., H. P. Dustan, R. D. Taylor, and I. H. Page: Management of hypertensive disease (Apresolin). Amer. J. Med. 17, 383 (1954).PubMedCrossRefGoogle Scholar
  5. Crosley, A. P., G. Rowe, R. McKenna, and C. W. Crumpton: Hemodynamic response of the human hypertensive kidney to Apresoline. J. din. Invest. 32, 561 (1953).Google Scholar
  6. Doering, P., R. Koch, K. Kiihns u. M. Schwab: Der Einfluß von Hydrazinophthalesin auf die intrarenale Haemodynamik bei essentieller Hypertonie. Dtsch. Arch. klin. Med. 201, 44–56 (1954).PubMedGoogle Scholar
  7. Freis, E. D., J. C. Rose, T. F. Higgins, F. A. Finnerty jr., R. T. Kelley, and E. A. Partenope: The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine. Circulation 8, 199–204 (1953).CrossRefGoogle Scholar
  8. Gjörup, S., and T. Hilden: The effect of hydralazine (Apresoline) on kidney function and sodium excretion. Scand. J. din. Lab. Invest. 8, 273–277 (1956).CrossRefGoogle Scholar
  9. Herbenval, R., O. Cuny, R. Guidat et J. Linck: Action du chlorhydrate de la 1-hydrazin- ophthalazine chez 60 hypertendus. Presse med. 1953, 1459–1460.Google Scholar
  10. Hildreth E. A., C. E. Biro, and T. A. McCreary: Persistance of the "hydralazine-syndrome". A followup study of 11 cases. J. Amer. med. Ass. 173, 657–660 (1960).CrossRefGoogle Scholar
  11. Judson, W. E., and W. Hollander: Comparative effects of intravenous and chronic oral 1-hydrazinoophthalazine on the cardiorenal hemodynamics and the excretion of sodium in hypertensive patients with and without congestive heart failure. Clin. Res. Proc. 2, 70 (1954).Google Scholar
  12. Judson, W. E., W. Hollander, and R. W. Wilkins: The effects of i.v. Apresoline on cardiovascular and renal function in patients with and without congestive heart failure. Circulation 13, 664–674 (1956).PubMedCrossRefGoogle Scholar
  13. Lattanzi, A., e S. Panichi: L’azione delle idrazinoftalazine sul circolo renale nell ipertensione arteriosa. Progr. med. (Napoli) 11, 72–78 (1955).Google Scholar
  14. Mader, I. J., and L. T. Iseri: The effect of oral 1-hydrazinophthalazine therapy on renal function in essential vascular hjrpertension. Amer. Heart J. 50, 556–566 (1955).PubMedCrossRefGoogle Scholar
  15. Pigeon, Gr., and J. Genest: Prolonged hydralazine hydrochloride administration in 132 hypertensive patients; study of toxicity. Canad. med. Ass. J. 83, 743–746 (1960).PubMedGoogle Scholar
  16. Reinhardt, D. J., and J. M. Waldron: Lupus erythematosus-like syndrome complicating hydralazine therapy. J. Amer. med. Ass. 155, 1491–1492 (1954).CrossRefGoogle Scholar
  17. Reubi, F. C.: Renal hyperemia induced in man by a new phthalazine derivative. Proc. Soc. exp. Biol. (N.Y.) 73, 102 (1950).CrossRefGoogle Scholar
  18. Schmid, A., u. F. Reubi: Helv. med. Acta 17, 543 (1950).PubMedGoogle Scholar
  19. Schroeder, H. A.: The effect of 1-hydrazinophthalazine in hypertension. Circulation 5, 28–37 (1952).PubMedCrossRefGoogle Scholar
  20. Schwab, M., P. Doering u. K. Kiihns: Die intrarenale Haemodynamik bei essentieller Hypertonie und ihre Beeinflussung durch Dihydrazinophthalazin. Verh. Dtsch. Ges. inn. Med. 1953, 437–441.Google Scholar
  21. Werko, L., J. Ek, H. Eliasch, E. Varnauskas, A. Holmgren, and H. Bucht: Inverkan av apresoline pa circulationen vid hypertension och mitralisstenos. Nord. Med. 49, 397 (1953).PubMedGoogle Scholar
  22. Wilkinson, E. L., H. Backman, and H. H. Hecht: Cardiovascular and renal adjustments to a hypotensive agent (1-hydrazinophthalazine: Ciba Ba-5968: Apresonline). J. din. Invest. 31, 872–879 (1952).Google Scholar

Saluretica

  1. Bartorelli, C.: Die Wirkung saluretischer Substanzen bei der Behandlung der arteriellen Hypertonie. In; Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. T. Cottier), S. 306–319. Berlin-Göttingen-Heidelberg: Springer 1960.CrossRefGoogle Scholar
  2. Bartorelli, C., N. Gargano, and O. Leonetti: Potassium loss and potassium replacement during longterm diuretic treatment in hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 422–435. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  3. Braun, P., u. F. Schaub: Nierenfunktion unter Salidiuretica. Schweiz, med. Wschr. 91, 39–45 (1961).Google Scholar
  4. Bryant, J. M., T. F. Yü, L. Berger, N. Sehvartz, S. Torosdag, L. Fletcher jr., H. Fertig, M. S. Schwartz, and R. B. F. Quan: Hyperuricemia induced by the administration of chlorthalidone and other sulfonamide diuretics. Amer. J. Med. 33, 408–420 (1962).PubMedCrossRefGoogle Scholar
  5. Conway, J., and P. Lauwers: Hemodynamic and hypertensive effects of longterm therapy with chlorothiazide. Circulation 21, 21–27 (1960).PubMedCrossRefGoogle Scholar
  6. Conway, J., and P. Lauwers Mode of action of chlorothiazide in the reduction of blood pressure in hypertension. Amer. J. Cardiol. 8, 884–886 (1961).PubMedCrossRefGoogle Scholar
  7. Corcoran, A. C., C. Macleod, H. P. Dustan, and I. H. Page: Effects of chlorothiazide on specific renal function in hypertension. Circulation 19, 355–359 (1959).PubMedCrossRefGoogle Scholar
  8. Cottier, P. T.: Die Wirkung langdauemder Chlorothiazidbehandlung auf die Nierenfunktion bei essentieller Hypertonie. Ther. Umsch. 16 (1), 1–20 (1959).Google Scholar
  9. Cottier, P. T., R. Gloor u. L. Pugatsch: Die Wirkung einer langdauernden Hygroton-Behandlung auf die Hypertonie. Schweiz, med. Wschr. 90, 540–546 (1960).Google Scholar
  10. Dollery, C. T.: Hypotensive effects of diuretics. Acta cardiol. (Brüx.) 17, 672–683 (1962).Google Scholar
  11. Dollery, C. T., E. H. O. Parry, and D. S. Young: Diuretic and hypotensive properties of ethacrynic acid: a comparison with hydrochlorothiazide. Lancet 1964 1, 947–952.PubMedCrossRefGoogle Scholar
  12. Dontas, A. S., N. T. Papanicolau, and C. S. Cottas: Comparison of longterm effects of saluretics and of anabolic steroids on renal functions. Antihypertensive therapy. Principles and practice. Internat. Symp. (ed. F. Gross), p. 448–462. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  13. Dreifus, L. S., C. Duarte, R. Kodama, and J. H. Moyer: The effect of thiazide diuretics on the abnormal kidney. Ann. intern. Med. 53, 1170–1179 (1960).PubMedCrossRefGoogle Scholar
  14. Frank H, H. Dentler, F. Eberlein u. E. Schmid: Untersuchungen über ein blutdrucksenkendes Diureticum mit langer Wirkungsdauer. Arzneimittel-Forsch. 10, 343–440 (1960).Google Scholar
  15. Freeman, R. B., and G. G. Duncan: Chlorothiazide-induced hyperuremica. Report of 2 cases. Metabolism 9, 1107–1110 (1960).PubMedGoogle Scholar
  16. Freis, E. D.: Mechanismus der blutdrucksenkenden Wirkung der Saluretica. Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier). Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  17. Freis, E. D.: Mechanism of the antihypertensive effects of diuretics. Possible role of salt in hypertension. Clin. Pharmacol. Ther. 1, 337–344 (1960).PubMedGoogle Scholar
  18. Gifford jr. R. W., V. R. Mattox, A. L. Orvis, D. A. Sones, and J. W. Rosevear: Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation 24, 1197–1205 (1961).PubMedCrossRefGoogle Scholar
  19. Harington, M., and P. Kincaid-Smith: Effect of chlorothiazide on the hypotensive action of recamylamine and on its urinary excretion. Lancet 1958 I, 403.CrossRefGoogle Scholar
  20. Hartmann, F., and V. Heimsoth: Disturbances in carbohydrate and uric acid metabolism during diuretic treatment. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 436–447. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  21. Heider C., E. Dennis, and J. H. Moyer: Chlorothiazide potentiation of ganglionic blockade in patients with hypertension. Ann. N.Y. Acad. Sei. 71, 456 (1958).CrossRefGoogle Scholar
  22. Johnson O. D., H. Ruchelman, V. Ford, and J. Bush: Diuretics and hypertension. Effect of sodium balance. New Engl. J. Med. 267, 336–338 (1962).PubMedCrossRefGoogle Scholar
  23. Joy, R. J. L, and W. R. Beisel: An exploration of the antihypertensive action of chlorothiazide. Amer. J. med. Sei. 239, 601–608 (1960).CrossRefGoogle Scholar
  24. Macleod, C., H. P. Dustan, and I. H. Page: Sequential changes evoked by chlorothiazide in hypertensive patients. Arch, intern. Med. 106, 316 (1960).CrossRefGoogle Scholar
  25. Masoni, A., A M. Tomasi e F. Rossi: Studio clinico funzionalita renale in ipertesi trattati con idroclorotiazide. Boll. Soc. ital. Cardiol. 5, 601–611 (1960).Google Scholar
  26. Reubi, F., and P. T Cottier: Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation 23, 200 (1961).PubMedCrossRefGoogle Scholar
  27. Reutter, F., u. F. Schaub: Erfahrungen in der Hypertoniebehandlung mit Chlorthalidon. Praxis 51, 918–921 (1962).PubMedGoogle Scholar
  28. Reutter, F., F. Schaub u. A. üehlinger: Untersuchungen zur haemodynamischen Wirkung der Saluretica. Cardiologia (Basel) 38, 190–196 (1961).CrossRefGoogle Scholar
  29. Senft, G.: Die Bedeutung des Elektrolytstoffwechsels für die Pathogenese und Therapie der essentiellen Hjrpertonie. Berl. Med. 12, 143–146 (1961).Google Scholar
  30. Varnauskas, E., G, Cramer, R. Malmcrona, and L. Werkö: Effect of chlorothiazide on blood pressure and blood flow at rest and on exercise in patients with arterial hypertension. Clin. Sei. 20, 407–416 (1961).Google Scholar
  31. Vorburger, C., u. F. Reubi: Chlorothiazid und Harnsäureausscheidung. Helv. med. Acta 30, 593–602 (1963).PubMedGoogle Scholar

Veratrumalhaloide

  1. Barath, E., u. P. Tarjan: Klinische Untersuchungen über die Wirkung von Veratrum- Alkaloiden bei Hypertonie. Schweiz, med. Wschr. 1956,100–104Google Scholar
  2. Gfoldman, R., H. R. Frierson, and Gr. B. Duncan: Effect of veriloid upon renal function when administered in hypotensive doses to patients with arterial hypertension. Amer. J. Med. 14, 168–174 (1953).CrossRefGoogle Scholar
  3. Hoobler, S. W., T. G. Kabza, and R. W. Corley: The effect of protoveratrine on the cardiac output and some regional circulations in man. J. din. Invest. 34, 559 (1955).Google Scholar
  4. Meilmann, E.: Clinical studies on veratrum alkaloids. III. The effect of protoveratrine on renal function in man. J. din. Invest. 32, 80–89 (1953).Google Scholar
  5. Ramsay, A. G., J. B. Derrick, J. A. Lewis, and J. A. F. Stevenson: The effect of intravenous veratrum viride alkaloid (veniloid) on blood pressure and renal function. Canad. med. Ass. J. 72, 356–362 (1955).PubMedGoogle Scholar

Guanethidin

  1. Bartorelli, C., N. Gargano, D. Regoli u. A. Zanchetti: Die Wirkung langdauernder Guanethidin-Verabreichung auf die Nierenfunktion von Hochdruckkranken. Dtsch. med. Wschr. 85, 1271–1275 (1960).PubMedCrossRefGoogle Scholar
  2. Bonomini, V., P. Zucchelli e G. Dalmaski: Modificazioni dell’emodinamica della funzione renale in normotesi ed ipertesi dopo somministratione unica di guanetidina. Minerva med. 51, 4183–4189 (1960).Google Scholar
  3. Bordoni, C., A. Carbonara et G. Miglian: Le influenze della guanetidina sull’ipertensione e sulla funzionalita renale. Clin, ter. 20, 392–405 (1961).Google Scholar
  4. Cottier, P. T., F. Reubi u. E. Dupasquier: Die Wirkung von Guanethidin auf den Hochdruck und die Nierenfunktion bei klinischer und ambulanter Behandlung. Dtsch. med. Wschr. 85, 1263–1271 (1960).PubMedCrossRefGoogle Scholar
  5. Dollery, C. T., D. Emslie-Smith, and J. P. Schillingford: Hemodynamic effects of guane- thidine. Lancet 1961 II, 331–334.CrossRefGoogle Scholar
  6. Fry, L., and K. A, Barlow: Serum uric acid levels in hypertensive patients treated with guanethidine. Brit. med. J. 1962 I, 920–921.CrossRefGoogle Scholar
  7. Richardson, D. W., u. M. P. Stephenson: Über die Wirkung von Guanethidin auf den Blutdruck, das Herzzeitvolumen und die Nierenfunktion. Dtsch. med. Wschr. 85, 1258–1263 (1960).CrossRefGoogle Scholar
  8. Sasamoto, H., H. Okino, T. Okazaki, K. Fnjisaku, T. Yokoyama, D. Sakaguchi, Y. Takagy, Y. Nakamura, T. Date, and K. Amemiya: Experimental and clinical observations with guanethidine. Cardiologia (Basel) 39, 65–80 (1961).CrossRefGoogle Scholar
  9. Vercillo, L., e A. Giraldi: Influenze sull’emodinamica renale di un nuovo ipotensivo: il 2-(octaidro-l-azocinil)-etil-guanadina solfato o guanetidina. Minerva med. 51, 4190–4193 (1960).PubMedGoogle Scholar

Envacar

  1. Pauli, H. O., W. Sommer u. Ch. Vorburger: Guanoxan, ein neues Antihypertensivum der Guanidingruppe. Im Druck. - Peart, W. S., and M. T, MacMahon: Clinical trial of 2-guani- dinomethyl(I,4)benzodioxan (compound 1003). Brit. med. J. 1964 1, 398–402.Google Scholar

Diazoxid

  1. Lockwood, C. H., D. M. Nicholls, V. L. Troop, and J. A. Lewis: Diazoxide therapy in hypertension. Amer. J. Sei. 246, 312–317 (1963).CrossRefGoogle Scholar
  2. Okun, R., R. P. Russell, and W. R. Wilson: Use of diazoxide with trichlormethiazide for hypertension. Arch, intern. Med. 112, 882–888 (1963).Google Scholar

Methyldopa

  1. Dollery, C. T., and M, Harington: Methyldopa in hypertension: clinical and pharmacological studies. Lancet 1962 I, 759–763.CrossRefGoogle Scholar
  2. Dollery, C. T., M. Harington, and J. V. Hodge: Haemodynamic studies with methyldopa: Effect on cardiac output and response to pressor amines. Brit. Heart J. 670–676 (1963).Google Scholar
  3. Grillespie jr, L., J. A. Oares, J. R. Crout, and A. Sjoerdsma: Clinical and chemical studies with a-methyldopa in patients with hypertension. Circulation 25, 281–291 (1962).CrossRefGoogle Scholar
  4. Goldberg, B., N. W. Levin, A. Rubinstein, and L. Cohen: Alpha-methyldopa in hypertension. S.Afr. med. J. 37, 755–760 (1963).PubMedGoogle Scholar
  5. Hamilton, M., and H, Kopelman: Treatment of severe hypertension with methyldopa. Brit. med. J. 1963 I, 151–155.CrossRefGoogle Scholar
  6. Morin, Y., L. Turmel, and J. Fortier: Methyldopa: clinical studies in arterial hypertension. Amer. J. med. Sei. 248, 633–639 (1964).CrossRefGoogle Scholar
  7. Onesti, G., A. N. Brest, G. Nowack, H. Kasparian, and J. H. Moyer: Pharmacodynamic effects of alpha-methyl dopa in hypertensive subjects. Amer. Heart J. 67, 32–38 (1964).PubMedCrossRefGoogle Scholar
  8. Sannerstedt, R., G. Bojs, E. Yarnauskas, and L. Werkö: Alphamethyldopa in arterial hypertension. Clinical, renal and hemodynamic studies. Acta med. scand. 174, 53–76 (1963).PubMedCrossRefGoogle Scholar
  9. Schaub, F., F. Nager, H. Schaer, W. Ziegler u. P, Lichten: a-Methyl-Dopa. Therapeutische Erfahrungen bei Hypertonie und biochemische Untersuchungen zu seiner Wirkungsweise. Schweiz, med. Wschr. 92, 620–628 (1962).Google Scholar
  10. Sjordsma, A.: Relationships between alterations in anuric metabolism and blood pressure. Circulat. Res. 9, 734–745 (1961).CrossRefGoogle Scholar
  11. Weil, M. H., B. H. Barbour, and R. B. Chesne: Alpha-methyl dopa for the treatment of hypertension. Circulation 28, 165–174 (1963).PubMedCrossRefGoogle Scholar

Ganglienblocker

  1. Allanby, K. D., and J. R. Trounce: Excretion of mecamylamine after intravenous and oral administration. Brit. med. J. 1957II, No 5055, 1219–1221.Google Scholar
  2. Berthoud, E., et T. Yaybulak: Le traitement de Fhypertension arterielle par I’hexa- methonium. Helv. med. Acta 21, 141–167 (1954).Google Scholar
  3. Campbell, A. J. M., J. G. Graham, and R. D. H. Maxwell: Treatment of hypertension by oral methonium compounds. Brit. med. J. 1952 I, No 4752, 251–254.CrossRefGoogle Scholar
  4. Comes, B., J. R. K. Preedy, H. O. Wheeler, R. M. Hays, and S. E. Bradley: The hemodynamic effects of hexa- methonium bromide in the dog with special reference to splanchnic pooling. J. din. Invest. 36, 860 (1957).Google Scholar
  5. Conway, J., P. Lauwers, and S. W. Hoobler: A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension. J. Lab. din. Med. 57, 199–205 (1961).Google Scholar
  6. Corcoran, A. C., and I. H. Page: The kidney in hypertension. Symposium on diseases of the kidney. Med. Clin. N. Amer. 39, 1027–1034 (1955).Google Scholar
  7. Corcoran, A C., W. E. Wagner, and I. H. Page: Renal response to noradrenaline after hexamethonium. J. din. Invest. 8, 868 (1956).Google Scholar
  8. Cottier, P. T., J. M. Weiler, and S. W. Hoobler: Evaluation of mecamylamine in the treatment of hypertension. J. Lab. din. Med. 50, 199–208 (1957).Google Scholar
  9. Crosley jr. A. P., J. P. Brown, H. Tuchmann, C.W. Crumpton, J. H. Huston, and G. G. Rowe: The acute hemodynamic and metabolic response of hypertensive patients to pentolinium tartrate. Circulation 14, 584–592 (1956).PubMedCrossRefGoogle Scholar
  10. Doyle, A. E., J. R. E. Fraser, and P. K. Smith: Effects of bretylium tosylate on blood pressure, cardiac output, and renal function in hypertension. Brit. med. J. 1960 II, 422–425.CrossRefGoogle Scholar
  11. Falzoi, M., M. Gelati e G. Gunella: Contributo alio studio dell’ipertensione essentiale. Nota II. Modificazioni acute della funzione renale da bitartrato di esametonio. G. Clin. med. 35, 81–96 (1954).Google Scholar
  12. Ford, R. V.: Pharmacology and clinical use of ganglionic blocking agents in the treatment of hypertension. Symposium. Amer. J. Cardiol. 9, 860–862 (1962).PubMedCrossRefGoogle Scholar
  13. Ford, R. v., J. H. Moyer, S. Kinard, G. V. Weiler, and B. J. Estes: Pharmacology of mecamylamine. Amer. J. med. Sd. 232, 129–143 (1956).CrossRefGoogle Scholar
  14. Ford, R. V., J. H. Moyer, C. L. Spurr, C. P. Smith, and G. Weiler: Hexamethonium in the chronic treatment of hypertension. Its effect on renal hemodynamics and on the excretion of water and electrolytes. J. din. Invest. 32, 1133–1139 (1953).Google Scholar
  15. Freis, E. D., J. C. Rose, E. A. Partenope, T. F. Higgins, R. T. Kelley, H. W. Schnaper, and R. L. Johnson: The hemodjmamic effects of hypotensive drugs in man. III. Hexamethonium. j. din. Invest. 32, 1285–1298 (1953).Google Scholar
  16. Goldberg, B.: Renal hemodjniamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine. Lancet 1957 I, 74–77.CrossRefGoogle Scholar
  17. Hangen, H. N., and E. M. Biegen: The renal response to hexamethonium. Scand. J. din. Lab. Invest. 5, 58–62 (1953).CrossRefGoogle Scholar
  18. Kaulman, J. W., and M. Sokolow: Thirty-month followup on the treatment of malignant hypertension with hexamethonium. Clin. Res. Proc. 4, 59 (1956).Google Scholar
  19. Mackinnon, J., and J. D. S. Hammond: Effect of prolonged treatment with hypotensive drugs on renal function in hypertension. Brit. med. J. 1960 II, 987–990.CrossRefGoogle Scholar
  20. McDonald, L., and B. Goldberg: Renal haemodynamic effects of hypotensive drugs. II. Effects of oral maintenance therapy with pentapyrrolidium bitartrate and reserpine. Lancet 1957 1,77–78.CrossRefGoogle Scholar
  21. McQueen, E. G., and E. Trewin: Hexamethonium bromide and kidney function. Med. J. Aust. 1, 769–771 (1952).PubMedGoogle Scholar
  22. Mills, L. C., and J. H. Moyer: The acute effects of hexamethonium on renal hemodjniamics in normotensive human subjects. Amer. J. med. Sei. 226, 1–15 (1953).CrossRefGoogle Scholar
  23. Moeller, J.: Behandlung des Hochdrucks mit 3-Methyl-Pentapyrrolidin. Med. Klin. 1956, 1466–1471.Google Scholar
  24. Moyer, J.H., R. McCohn, R.A. Seibert, C. P. Smith, and A. Milnor: The effect of blood-pressure reduction with arfonad on renal hemodynamics and the excretion of water and electrolytes in patients with hypertension. Amer. Heart J. 49, 360–366 (1955).PubMedCrossRefGoogle Scholar
  25. Moyer, J. H., R. Ford, E. Dennis, and C. A. Handley: Laboratory and clinical observations on mecamylamine as a hypotensive agent. Proc. Soc. exp. biol. (N.Y.) 90, 402–408 (1955).CrossRefGoogle Scholar
  26. Moyer, J. H., L. C.Mills, and C. P. Smith: Hexamethonium - its effect on G.F.R. maximal tubular function and renal excretion of electrolytes. J. din. Invest. 32, 172–184 (1953).Google Scholar
  27. Notter, B., F. Wiithrich, A. Schmid, P. Spring u. F. Reubi: Haemodynamische und renale Untersuchungen mit einem neuen Ganglienblocker (Ecolid Ciba) am Menschen. Helv. med. Acta 23, 509 (1956).PubMedGoogle Scholar
  28. Perry jr., H. M., and H. A. Schroeder: Neurological manifestations after antihypertensive therapy with mecamylamine. J. Amer. med. Ass. 164, 1455–1458 (1957).CrossRefGoogle Scholar
  29. Reubi, F.: Le traitement medical de I’hypertension arterielle. Acta cardiol. (Brüx.), Suppl. 6, 54–91 (1956).Google Scholar
  30. Ripka, O., F. Malis, V. Teichmann, and K. Drab: The clinical pharmacology of dimecamine, a new oral ganglionic blocking agent. Dimecamin (3-Dimethyl- aminoisocamphan). Cor et vasa (Prague) 2, 130–144 (1960).Google Scholar
  31. Ronnov-Jessen, V.: Penta- pyrrolidinium and kidney function. Scand. J. din. Lab. Invest. 7, 160 (1955).CrossRefGoogle Scholar
  32. Ronnov-Jessen, V.: Blood- volume during treatment of hypertension with guanethidine. Acta med. scand. 174, 307–310Google Scholar
  33. Rosenfeld, J. B., J. Straughn, and J. H. Moyer: Pharmacologic effects of (2-(2,6- dimethyl-phenoxy)propyl) Dimethyl ammonium chloride hydrate in hypertensive patients. Clin. Pharmacol. Ther. 1, 39–57 (1960).Google Scholar
  34. Schimmler, W., u. H. Schwalb: Über die Beziehungen zwischen arteriellem Kreislauf und Nierenfunktion unter der Wirkung von Hexamethoniumbromid. Naunjm-Schmiedebergs Arch. exp. Path. Pharmacol. 221, 177–186 (1954).Google Scholar
  35. Schmid, A., P. T. Cottier, J. M. Weller u. S. W. Hoobler: Mevasin in der Behandlung der essentiellen Hypertonie. Helv. med. Acta 24, 334–341 (1957).Google Scholar
  36. Smith, J. R., and S. W Hoobler: Acute and chronic cardiovascular effects of pentolinium in hypertensive patients. Circulation 14, 1061–1068 (1956).PubMedCrossRefGoogle Scholar
  37. Stein, D. H., and H. H. Hecht: Cardiovascular and renal response to the combination of hexamethonium and 1-hydrazinophthalazine (Apresoline) in hypertensive subjects. J. din. Invest. 34, 867–874 (1955).Google Scholar
  38. Vercillo, L., G. Moreo e V. Castiglioni: Corportamento dell’emodinamica renale in pazienti ipertesi trattati con clorisondamina e con I’associazione clorisondamina +1,4 diidrazino- ftalazina (Ecolid). Gazz. int. Med. Chir. 65, 1847–1857 (1960).Google Scholar
  39. Wiithrich, P., B. Notter, P. Imhof, A. Schmid u. E. Blaser: Klinische Erfahrungen beim Hypertoniker mit dem neuen Ganglienblocker Ecolid Ciba. Helv. med. Acta, Ser. A23, 500–508 (1956).Google Scholar

MAO-Hemmer

  1. Brest, A. N., and J. H. Moyer: Enzyme inhibitions in the treatment of hypertension. Amer. J. med. Sei. 242, 729–735 (1961).CrossRefGoogle Scholar
  2. Brest, A. N., G. Onesti, C. Heider, R. H. Seller, and J. H. Moyer: Comparative effectiveness of pargyline as an antihypertensive agent. Amer. Heart J. 68, 621–626 (1964).CrossRefGoogle Scholar
  3. Dupasquier, E., et P. Reubi: Les repercussions de I’iproniazide (Marsilid) sur la tension arterielle et Fhemodynamique renale. Cardiologia (Basel) 35, 256–269 (1959).CrossRefGoogle Scholar
  4. Moser, M., B. Brodoff, A. Miller, and A. G. Goldman: Pargyline treatment of hypertension. Experience with a nonhydrazine amino oxydase inhibitor. J. Amer. med. Ass. 187, 192–195Google Scholar
  5. Onesti, G., P. Novack, O. Ramirez, A N, Brest, and J. H. Moyer: Hemodynamic effects of pargyline in hypertensive patients. Circulation 30, 830–835 (1964).PubMedCrossRefGoogle Scholar
  6. Teuscher, A., u. H. Luginbühl: Die antihypertensiven Eigenschaften eines Monoaminoxydasehemmers (DL-Serin-N2-Isopropylhydrazid: Ro 4–1038). Klinische Ergebnisse und Wirkung auf die Nierenfunktion. Cardiologia (Basel) 45, 1, 1–20 (1964).CrossRefGoogle Scholar

Sympathektomie

  1. Jelsma, L.: Thoraco-lumbar sympathectomy and malignant hypertension: review of twenty cases. Bull. Johns Hopk. Hosp. 113, 13–19 (1963).Google Scholar
  2. Sarre, H.: Spätresultate der chirurgischen Therapie (Sympathectomie und Adrenalectomie) in essentieller Hypertonie. Internat. Symp. Bern 1960 (ed. K. D. Bock u. P. Cottier). Berlin- Göttingen-Heidelberg: Springer 1960.Google Scholar
  3. Smithwick, R. H.: Symposium on hypertension. Amer. J. Surg. 107, 1–4 (1964).CrossRefGoogle Scholar
  4. Smithwick, R. H., G. P. Whitelaw, and D. Kinsey: Surgical approach to the treatment of essential hypertension. Results of therapy (medical and surgical). Symposium. Amer. J. Cardiol. 9, 893–899 (1962).PubMedCrossRefGoogle Scholar
  5. Therapie und Prognose der malignen HypertonieGoogle Scholar

Therapie und Prognose der malignen Hypertonie

  1. Björk, S., R. Sannerstedt, G. Angervall, and B. Hood: Treatment and prognosis in malignant hypertension. Clinical follow-up study of 93 patients on modern medical treatment. Acta med. scand. 166, 175–187 (1960).PubMedCrossRefGoogle Scholar
  2. Björk, S., R. Sannerstedt, T. Falkheden, and B. Hood: The effect of active drug treatment in severe hypertension disease. An analysis of survival rates in 381 cases on combined treatment with various hypotensive agents. Acta med. scand. 169, 673–689 (1961).CrossRefGoogle Scholar
  3. Dustan, H. P., R. E. Schneckloth, A. C. Corcoran, and L. H. Page: The effectiveness of longterm treatment of malignant hypertension. Circulation 18, 644–651 (1958).PubMedCrossRefGoogle Scholar
  4. Hany, A., P. Schanb u. P. Nager: Die Prognose der behandelten malignen Hypertonie. Dtsch. med. Wschr. 90, 18, 21–26 (1965).Google Scholar
  5. Harington, M., P. Kincaid-Smith, and J. McMichael: Results of treatment in malignant hypertension. Brit. med. J. 1959 II, 969–980.CrossRefGoogle Scholar
  6. Hood B., S. Björk, R. Sannerstedt, and G. Angervall: Analysis of mortality and survival in actively treated hypertensive disease. Acta med. scand. 174, 393–406 (1963).PubMedCrossRefGoogle Scholar
  7. Kinsey, D., G. P. Whitelaw, R. J. Walther, C. A. Theophilis, and R. H. Smithwick: The long-term follow-up of malignant hypertension. J. Amer. med. Ass. 181, 571–576 (1962).CrossRefGoogle Scholar
  8. Lichtlen, P., u. P. Schanb: Zur langfristigen Therapie und Prognose der malignen Hypertonie. Schweiz, med. Wschr. 90, 405–413 (1960).Google Scholar
  9. McCormack, L. J., J. E. Beland, R. E. Schneckloth, and A. C. Corcoran: Effects of antihypertensive treatment on evolution of renal lesions in malignant nephrosclerosis. Amer. J. Path. 34, 1011–1022 (1958).Google Scholar
  10. McMichael, J.: Malignant hypertension. Jornadas Cardiol. Lisboa 1, 59–73 (1955).Google Scholar
  11. McMichael, J., and E A. Murphy: Methonium treatment of severe and malignant hypertension. J. chron. Dis. 1, 527–535 (1955).PubMedCrossRefGoogle Scholar
  12. Meriel, P., F. Galinier, J. M. Sue, J. P. Bounhoure, P. F. Combes, T. T. Hung et Muriel Pierre: Le Mtroprussiate de sonde dans le traitement des encephalopathies hypertensives survenant au cours de Tinsuffi- sance renale. J. Urol. Nephrol. 68, 148–151 (1962).Google Scholar
  13. Möhler jr. E. R., and E. D. Freis: Five year survival of patients with malignant hypertension treated with antihypertensive agents. Amer. Heart J. 60, 329–335 (1960).PubMedCrossRefGoogle Scholar
  14. Moyer, J. H., and C. Heider: Some observations on morbidity and prognosis as affected by antihjertensive therapy with essential hypertension. Symposium. Amer. J. Cardiol. 9, 920–923 (1962).CrossRefGoogle Scholar
  15. Muri, J. W.: Medical therapy of malignant hypertension. Acta med. scand. 158, 173–180 (1957).PubMedCrossRefGoogle Scholar
  16. Page, I. H.: Medikamentöse Behandlung des Hochdrucks. Vortrag gehalten anläßlich der Verleihung der Würde eines Doctor honoris causa der Med. Fakultät Siena 3. 7. 1965. Ed. Ciba, Basel.Google Scholar
  17. Pap, I. H., A. C. Corcoran, H. P. Dustan, and T. Eoppanyi: Cardiovascular actions of sodium nitro prusside in animals and hypertensive patients. Circulation 11,188–198 (1955).CrossRefGoogle Scholar
  18. Perera, G. A.: Methimazole in "malignant" hypertension: report of patient’s progress after two years. Amer. J. med. Sei. 247, 175–176 (1964).CrossRefGoogle Scholar
  19. Perry jr., H. M., A. Caloyeropoulos, and D, Moore Jones: Therapy of severe hypertension complicated by renal failure. Symposium. Amer. J. Cardiol. 9, 908–915 (1962).PubMedCrossRefGoogle Scholar
  20. Scribner, B. H., R. Buri, J. E. Z. Caner, R. Hegstrom, and J. M. Burnell: The treatment of chronic uremia by means of intermittent hemodialysis; a preliminary report. Trans. Amer. Soc. int. org. 6, 114 (1960).Google Scholar
  21. Simpson, F. O., and F. H. Smirk: The treatment of malignant hypertension. Symposium. Amer. J. Cardiol. 9, 868–873 (1962).CrossRefGoogle Scholar
  22. Sokolow, M., and D. Perloff: Five year survival of consecutive patients with malignant hjrpertension treated with antihypertensive agents. Amer. J. Cardiol. 6, 858–863 (1960).CrossRefGoogle Scholar
  23. Wilson, C., and D. G. Abrahams: The treatment of hypertension in primary renal disease. Brit. med. Bull. 13, 39–42 (1957).PubMedGoogle Scholar

Nephrosklerose und Gravidität

  1. Sarre, H.: Die Indikation zur Schwangerschaftsunterbrechung bei Nierenkrankheiten. Münch, med. Wschr. 102, 136 (1960).Google Scholar

Literatur: Einleitung

  1. Baker jr. G. P., L. B. Page, and G.W. Leadbetter: Hypertension and renovascular disease. A follow-up study of 23 patients, with an analysis of factors influencing the results of surgery. New Engl. J. Med. 267, 1325–1334 (1962).PubMedCrossRefGoogle Scholar
  2. Berthaux, B., H. Beck, D. Polet, J. P. Bouchon et J. Vignalou: Les stenoses des arteres renales chez le vieillard. Sem. Hop. Paris 38, 3451–3454 (1962).Google Scholar
  3. Brest, A. N., C. Heider, and J. H. Moyer: Renal vascular disease as a cause of hypertension. Symposium. Amer. J. Cardiol. 9, 748–755 (1962).CrossRefGoogle Scholar
  4. Brest, A. N., and J. H. Moyer: Renal hypertension. Med. Clin. N. Amer. 47,1057–1068 (1963).PubMedGoogle Scholar
  5. Brough, A. J., and W. W. Zuelzer: Renal vascular disease. Symposium. Pediat. Clin. N. Amer. 11, 533–547 (1964).PubMedGoogle Scholar
  6. Dustan, H. P., I. H. Page, and E. F. Poutasse: Renal hypertension. New Engl. J. Med. 261, 647–653 (1959).PubMedCrossRefGoogle Scholar
  7. Eigler, F. W., K. F. Albrecht u. G. Heberer: Das "Frühurogramm" und der „Rapoport- Test"zur Erkennung von Hochdruckkranken mit Nierenarterienstenosen. Vorh. dtsch. Ges. inn. Med. 69, 685–688 (1963).Google Scholar
  8. Giroud, M,: L’hypertension arterielle par ischemie renale, syndrome de Goldblatt, chez l’homme. These med. Lyon, No. 292, 1–244, Bosc Freres, Lyon (1955).Google Scholar
  9. Goldblatt, H.: Renovascular hypertension due to renal ischemia (Editorial). Circulation 32, 1–3 (1965).PubMedCrossRefGoogle Scholar
  10. Goldblatt, H., J. Lynch, R. F. Hanzal, and W. W. Sommerville: Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. exp. Med. 59, 347–379 (1934).PubMedCrossRefGoogle Scholar
  11. Hafemeister, G., u. G. Kuhlgatz: Arterielle renale Durchblutungsstörungen und Hypertonie. Dtsch. Gesundh.-Wes. 17, 2246–2252 (1962).Google Scholar
  12. Harder, S. L., u. Gifford jr., R. W.: Hypertonie als Folge stenosierender Nierengefäßerkrankungen. Praxis 52, 1194–1198Google Scholar
  13. Howard, J. E.: Hypertension as related to renal ischemia. The George E. Brown memorial lecture. Circulation 29, 657–665 (1964).CrossRefGoogle Scholar
  14. Howard, J. E., M. Berthrong, D. M. Gould, and E. R. Yendt: Hypertension resulting from unilateral renal vascular disease and its relief by nephrectomy. Bull. Johns Hopk. Hop. 94, 51–85 (1954).Google Scholar
  15. Howard, J. E., M. Berthrong, R. D. Sloan, and E. R. Yendt: Relief of malignant hypertension by nephrectomy in four patients with unilateral renal vascular disease. Trans. Ass. Amer. Phys. 66, 164–169 (1953).Google Scholar
  16. Kaufman, J. J., and M. H. Maxwell: Surgery for renovascular hypertension. Analysis of 67 cases. J. Amer. med. Ass. 190 (8), 709–714 (1964).CrossRefGoogle Scholar
  17. Masland jr. R. P., F. P. Heald, W. T. Goodale, and J. R. Gallagher: Hypertensive vascular disease in adolescence. New Engl. J. Med. 255, 894–897 (1956).PubMedCrossRefGoogle Scholar
  18. Maxwell, M. H., and G. B. Prozan: Definition of renovascular hypertension: Hypertension caused by occlusive disease of the renal arterial vasculature which is potentially curable by either reconstructive vascular surgery or by nephrectomy. Progr. cardiovasc. Dis. 5, 81 (1962).CrossRefGoogle Scholar
  19. McGlazier, C., and L. J. Lombardo jr.: Diseases of renal artery. J. Urol. (Baltimore) 81, 27–34 (1959).Google Scholar
  20. Merrill, J. P.: Diagnosis and treatment of renal hypertension of humoral origin. Anesthesiology 24, 479–486 (1963).PubMedCrossRefGoogle Scholar
  21. Milliez, P., G. Lagrue, Ph. Tscherdakoff et Ph. Meyer: L’hyper- tension arterielle par lesion renale unilaterale: aspect particulier de I’hypertension arterielle d’origine renale et chirurgicalement curable. J. Urol. Nephrol. 68, 491–524 (1962).Google Scholar
  22. Page, I. H., H. P. Dustan, and E. P. Poutasse: Mechanisms, diagnosis and treatment of hypertension of renal vascular origin. Ann. intern. Med. 51, 196–211 (1959).PubMedCrossRefGoogle Scholar
  23. Perloff, D., M. Sokolow, E. J. Wyle, D. R. Smith, and A. J. Palubiskas: Hypertension secondary to renal artery occlusive disease. Circulation 24, 1286–1304 (1961).PubMedCrossRefGoogle Scholar
  24. Poutasse, E. F.: Occlusion of a renal artery as a cause of hypertension. Circulation 13, 37–48 (1956).PubMedCrossRefGoogle Scholar
  25. Poutasse, E. F.: Diagnosis and treatment of occlusive renal artery disease and hypertension. J. Amer. med. Ass. 178, 1078–1083 (1961).CrossRefGoogle Scholar
  26. Proesmans, J., S. Ringoir, E. van de Velde et J. Verstraeten: L’hyper- tension renovasculaire. Acta din. belg. 17, 353–371 (1962).Google Scholar
  27. Sarre, H.: Renaler Hochdruck durch ein- und doppelseitige Nierenerkrankungen. Med. Klin. 59, 888–892 (1964).PubMedGoogle Scholar
  28. Smithwick, R. H., R. C. Newton, D. H. Grocker, and J. H. Harrison: Symposium on hypertension and its treatment. Med. Clin. N. Amer. 45, 233–500Google Scholar
  29. Smithwick, R. H., R. C. Newton, D. H. Grocker, and J. H. Harrison: Surgical management of renal hypertension. Combined experiences at the Massachusetts memorial and the Peter Bent Brigham Hospitals. Amer. J. Surg. 107, 104–120Google Scholar
  30. Trippel, O. H, and V. J. O’Conor jr.: Renovascular hypertension. Symposium. Surg. Clin. N. Amer. 42, 109–130 (1962).PubMedGoogle Scholar
  31. Verniory, A.: Relation d’un cas d’hypertension avec atrophic renale unilaterale. Guerison par nephrectomie. Bull. Acad. roy. Med. Belg, livre jubil. Paul Govaerts: 194–202 (1955).Google Scholar

Zur pathologischen Anatomie der Nierenarterienstenose

  1. Abrahams, D G., and E. H. O. Parry: Hypertension due to renal artery stenosis caused by abdominal aortic aneurysm. Successful treatment by nephrectomy. Circulation 26, 104–107Google Scholar
  2. Barrie, H. J, A. I. Macrae, and S. M Shea: Relation of hypertension to unilateral renal atrophy. A study of necropsy records. Lancet 1961 1, 193–195.PubMedCrossRefGoogle Scholar
  3. Batzenschlager, A., E, Blum et A. Porte: Le petit rein dans I’obliteration ancienne totale de I’artère renale. (Etude anatomo-pathologique et anatomo-clinique.) J. Urol. Nephrol. 68, 15–40 (1962).Google Scholar
  4. Batzenschlager, A., E. Blum et M. Weill-Bousson: Le petit rein unilateral. Etude anatomo-clinique. I. Le petit rein unilateral acquis. Ann. Anat. path., N.S. 7, 427–469 (1962).Google Scholar
  5. Bauer, H., and G. L. Forbes: Amer. Heart J. 44, 634 -952).Google Scholar
  6. Blum, E., et A. Batzenschlager: Le petit rein unilateral dans I’hypertension arterielle. Strasbourg med., N.S. 10, 264–268 (1959).Google Scholar
  7. Bohle, A.: Kritischer Beitrag zur Morphologie einer endokrinen Nierenfunktion und deren Bedeutung für den Hochdruck. Arch. Kreisl.-Forsch. 20, 193–246 (1954).CrossRefGoogle Scholar
  8. Bohle, A.: IV. Symp. Ges. für Nephrologie 23.-25. 9. 1965 Saarbrücken. Persönliche Mitteilung.Google Scholar
  9. Bohle, A., M. Kohler u. H. Burow: Experimentelle Untersuchungen zur "Endokrinen Niere" (Selye). Virchows Arch. path. Anat. 323, 1–23 (1953).Google Scholar
  10. Boijisen, E.: Angiographie studies of the anatomy of single and multiple renal arteries. Acta radiol. (Stockh.), Suppl. 183, 5–135 (1959).Google Scholar
  11. Boughton, R. M., and S. C. Sommers: A new concept of renal hypertension. J. Urol. (Baltimore) 89, 133–136 (1963).Google Scholar
  12. Braunsteiner H., u. A. Schimatzek: Juvenile Hypertonie bei Verengerung einer Nierenarterie. Wien. Z. inn. Med. 41, 360–364 (1960).Google Scholar
  13. Brust, A. A., J. M. Howard, M. R Bryant, and J. T. Godwin: Coarctation of the abdominal aorta with stenosis of the renal arteries and hypertension. Amer. J. Med. 27, 793–802 (1959).CrossRefGoogle Scholar
  14. Castillo, P. A., and F. Barrera: Human hypertension due to thrombolic occlusion of both renal arteries. Report of a case cured by surgical removal of the thrombus. Amer. Heart J. 56, 769–775 (1958).PubMedCrossRefGoogle Scholar
  15. Cordonnier, J. J.: Unilateral renal artery disease with hypertension. J. Urol. (Baltimore) 82, 1–9 (1959).Google Scholar
  16. Cottier, P.: Maligne Hypertonie bei Mesaortitis luetica mit partiellem Verschluß der Nierenarterien und akzessorischer Äste. Nicht publizierte Beobachtung 1963.Google Scholar
  17. Cottier, P., E. Wildbolz u. H. Cottier: Hypertonie als Unfallfolge. Z. Urol. 51, 441–456 (1958).PubMedGoogle Scholar
  18. Crocker, D. W.: AppHcations of frozen section technic to study of primary renal ischemia. Amer. J. Surg. 107, 121–122 (1964).PubMedCrossRefGoogle Scholar
  19. Crocker, D. W., R. A. Neon, E. M. Mahoney, and J H. Harrison: Hypertension due to primary renal ischemia. A correlation of juxta-glomerular cell counts with clinicopathological findings in twenty-five cases. New Engl. J. Med. 267, 794–800 (1962).PubMedCrossRefGoogle Scholar
  20. D’Abreu, F, and B. Strickland: Developmental renal-artery stenosis. Lancet 1962 II, 517–521.CrossRefGoogle Scholar
  21. Danarj, T. J., H. O. Wong, and M. A. Thomas: Primary arteriitis of aorta causing renal artery stenosis and hypertension. Brit. Heart J. 25, 153 (1963).CrossRefGoogle Scholar
  22. De Camp, P. T., and R. Birchall: Recognition and treatment of renal arterial stenosis associated with hypertension. Surgery 43, 134 (1958).Google Scholar
  23. Derrick, J. R., and E. Hanna: Abnormal renal mobility and hypertension. Amer. J. Surg. 106, 673–677 (1963).CrossRefGoogle Scholar
  24. Derrick, J. R., and R. T. Tyson: The association of aberrant renal arteries and systemic hypertension. Surgery 48, 907–912 (1960).PubMedGoogle Scholar
  25. Derrick, J. R., and R. T. Tyson: The surgical significance of aberrant renal arteries in relation to systemic hypertension. Circulation 24, 1192–1196 (1961).PubMedCrossRefGoogle Scholar
  26. Fisher, E. R., and A. C Corcoran: Congenital coarctation of the abdominal aorta with resultant renal hypertension. Arch, intern. Med. 89, 943–950 (1952).CrossRefGoogle Scholar
  27. Gellman, D. D.: Reversible hypertension and unilateral renal artery disease. Quart. J. Med. N.S. 27, 103–115 (1958).Google Scholar
  28. Genest, J.: The activity of the renin-angiotensin system in hypertensive and hydropic disease. IV. Symp. Ges. für Nephrologie 23.-25. 9. 1965 Saarbrücken (im Druck).Google Scholar
  29. Genest, J., P. Biron, E. Koiw, W. Novaczynski, R. Boucher, and M, Chretien: Studies of the pathogenesis of human hypertension. The adrenal cortex and renal pressor mechanism. Ann. intern. Med. 55, 12–28 (1961).PubMedCrossRefGoogle Scholar
  30. Genest, J., R. Boucher, J. Champlain, R. Veyrat, M. Chretien, P. Biron, G. Tramblay, P. Roy, and P. Cartier: Studies on the renin-angiotensin system in hypertensive patients. Canad. med. Ass. J. 90, 263–268 (1964).PubMedGoogle Scholar
  31. Goodman, H. L.: Malignant hypertension with unilateral renal artery occlusion. New Engl. J. Med. 246, 8 (1952).PubMedCrossRefGoogle Scholar
  32. Györi, E.: Arteriosklerotische Stenosen in Nierenarterien besonders bei Arterienverdoppelung und ihre Beziehung zur Hypertonie. Beitr. path. Anat. 112 187–204 (1952).Google Scholar
  33. Hartroft, P.M.: Juxtaglomerular cells. Circulat. Res. 12, 525–538 (1963).CrossRefGoogle Scholar
  34. Juxta- glomerular cells as the source of renin. IV. Symp. Ges. für Nephrologie 23.-25. 9. 1965 Saarbrücken (im Druck).Google Scholar
  35. Hartroft, P. M., and W. S. Hartroft: Studies on renal juxtaglomerular cells. 1. Variations produced by NaCl and DOCA. J. exp. Med. 97, 415 (1953).PubMedCrossRefGoogle Scholar
  36. Hartroft, P. M., and W. S. Hartroft: Studies on renal juxtaglomerular cells. II. Correlation of the degree of granulation of juxtaglomerular cells with width of the zona glomerulosa of the adrenal cortex. J. exp. Med. 102, 205 (1955).PubMedCrossRefGoogle Scholar
  37. Hatt, O. P. Y.: L’appareil juxta-glomerulaire dans I’hypertension arterielle experimentale. Rev. frang. fitud. din. biol. 8, 358–365 (1963).Google Scholar
  38. Hatt, P. Y., M. Dvojakovic, P. Cornet et J. Grossetete: Contribution de la microscopie electronique a I’etude du mecanisme de I’hypertension arterielle experimentale d’origine renale. II. L’ischemie renale chez le lapin. Path, et Biol. 10, 23–40 (1962).Google Scholar
  39. Holley, K. E., J. C. Hunt, A. L. Brown jr. O. W. Kincaid, and S. G. Sheps: Renal artery atherosclerosis in normotensive and hypertensive subjects studied at necropsy. Circulation 26, 731 (1962).Google Scholar
  40. Holley, K. E., J. C. Hunt, A. L. Brown jr. O. W. Kincaid, and S. G. Sheps Renal artery stenosis. A clinical pathologic study in normotensive and hypertensive patients. Amer. J. Med. 37, 14–22 (1964).PubMedCrossRefGoogle Scholar
  41. Huber, J,: Experimentelle Untersuchungen zur Frage der kontralateralen renalen Fixierung bei einseitigem Nierendrosselungshochdruck. Z. ges. exp. Med. 133, 285–298 (1960).PubMedCrossRefGoogle Scholar
  42. Hunt, J. C., E. G. Harrison jr., O. W. Kincaid, P. E. Bernatz, and G. D. Davis: Idiopathic fibrous and fibromuscular stenoses of the renal arteries associated with hypertension. Proc. Mayo Clin. 37, 181–216 (1962).Google Scholar
  43. Isaacson, C., D. M. Klaschko, and S. Wayburne: Aortitis in children. Lancet 1959 II, 542.CrossRefGoogle Scholar
  44. Katz, Y. J., P. R Patek, and S. Bernick: Effect of angiotensin on juxtaglomerular cells and vessels of the kidney. Circulat. Res. 11, 955–960 (1962).PubMedCrossRefGoogle Scholar
  45. Kaufmann, J. J., W. Hanafee, and M. H. Maxwell: Upright renal arteriography in the study of renal hypertension. J. Amer. med. Ass. 187, 977–980 (1964).CrossRefGoogle Scholar
  46. Kincaid-Smith, P.: Vascular obstruction in chronic pyelo- nephritic kidneys and its relation to hypertension. Lancet 1955 II, 1263–1269.CrossRefGoogle Scholar
  47. MacDonald, J. S., and J. A. McMillan: Fibromuscular hyperplasia of the renal arteries. A case report with radiological and histological findings. Clin. Radiol. (Edinb.) 14, 392–396 (1963).CrossRefGoogle Scholar
  48. Mathe, C. P., and L. de la Pena Sanchez: Orthostatic renal hypertension resulting from torsion and ptosis of the kidney. J. int. Coll. Surg. 27, 36–45 (1957).PubMedGoogle Scholar
  49. McCor- mack, L. J.: Vascular changes in hypertension. Med. Clin. N. Amer. 45, 247 (1961).Google Scholar
  50. McCormack, L. J., J. B. Hazard, and E. F. Poutasse: Obstructive lesions of the renal artery associated with remediable hypertension. Amer. J. Path. 34, 582 (1958).Google Scholar
  51. McCormack, L. J., T. J. Notojr., E. F. Poutasse, and H. P. Dustan: A radiologic-pathologic correlation of occlusive renal arterial disease. Clin. Res. 12, 363 (1964).Google Scholar
  52. McCormack, L. J., E. F. Poutasse, T. F. Meaney, T. J. Noto jr., and H. P. Dustan: A pathologic-arteriographic correlation of renal arterial disease. Im Druck.Google Scholar
  53. Meine, J. L.: Die einseitigen Schrumpfnieren. Häufigkeit, Nosologie und Beziehungen zur Hypertonie. Schweiz, med. Wschr. 24, 799–805 (1965).Google Scholar
  54. O’Morchoe, C. C. C.: Collateral blood supply to the rabbit kidney after ligation of the renal artery. Brit. J. Urol. 33, 278–283 (1961).PubMedCrossRefGoogle Scholar
  55. Owen, G. D., and P. N. Coleman: Dissecting aneurysm of the aorta associated with Goldblatt kidney. Brit. Heart J. 21, 570–572 (1959).PubMedCrossRefGoogle Scholar
  56. Palubinskas, A. J., D. Perloff, and E. J. Wylie: Curable hypertension due to renal artery lesions. Radiol, din. (Basel) 33, 207–216 (1964).Google Scholar
  57. Palubinskas, A. J., and H. R. Ripley: Fibromuscular hyperplasia in extrarenal arteries. Radiology 82, 451 (1964).PubMedGoogle Scholar
  58. Parker, R. A.: The microdissection and staining of the juxtaglomerular apparatus in the rabbit kidney. J. Physiol. (Lond.) 171, 31P-32P (1964).Google Scholar
  59. Pitcock, J. A., P. M. Hartroft, and L. N. Newmark: Increased renal pressor activity (renin) in sodium deficient rats and correlation with juxta-glomerular cell granulation. Proc. Soc. exp. Biol. (N.Y.) 100, 868–869 (1959).CrossRefGoogle Scholar
  60. Sykes, D.: The arterial supply of the human kidney with special reference to accessory renal arteries. Brit. J. Surg. 50, 368–374 (1963).Google Scholar
  61. Targeon, C., and S. C. Sommers: Juxtaglomerular cell counts and human hypertension. Amer. J. Path. 38, 227–241 (1961).Google Scholar
  62. Tcherdakoff, Ph., D. Fritel et P. Milliez: Maladie fibro- musculaire de I’artere renale, cause possible d’hypertension arterielle. Bull. Soc. med. Hop. Paris, Ser. IV, 77, 1077–1086 (1961).Google Scholar
  63. Wellington, J. S.: Fibromuscular hyperplasia of renal arteries in hypertension. Amer. J. Path. 43, 955–967 (1963).PubMedGoogle Scholar
  64. Wood, C., and F. J. Borges: Perimuscular fibrosis of renal arteries with hypertension. Arch, intern. Med. 112, 79–91 (1963).Google Scholar
  65. Wylie, E. J., D. Perloff, and J. S. Wellington: Fibromuscular hyperplasia of the renal arteries. Ann. Surg. 156, 592–609 (1962).PubMedCrossRefGoogle Scholar
  66. Wylie, E. J., and J. S. Wellington: Hypertension caused by fibromuscular hyperplasia of the renal arteries. Amer. J. Surg. 100, 183–193 (1960).CrossRefGoogle Scholar

Diagnose der Nierenarterienstenose: Anamnese — Symptome

  1. Cottier, P.: Diagnose und Therapie der Nierenarterienstenose. Schweiz, med. Wschr. (im Druck).Google Scholar
  2. Deming, Q. B.: Association of polyuria and albuminuria with hypertension of unilateral renal origin. Arch, intern. Med. 93, 197–204 (1954).CrossRefGoogle Scholar
  3. Ducrot, H., J. Hamburger, P. Milliez, P. Souli et J. Vaysse: Comment reconnaitre et traiter les hypertensions par anomalie de I’artere renale. Presse med. 70, 467–468 (1962).PubMedGoogle Scholar
  4. Dustan, H. P., and I. H. Page: Renal hypertensive suspect. Clinical characteristics. Amer. J. Surg. 107, 35–37 (1964).PubMedCrossRefGoogle Scholar
  5. Fiorani, P., W. Coppola, U. Mercati e P.P. Fazzini: Aspetti clinici deU’ipertensione arteriosa di origine renale in corso di arteriopatie periferiche. Recenti Progr. Med. 32, 502–511 (1962).Google Scholar
  6. Eark, R. M.: Office and bedside examination of patients suspected of having a renal disorder. Med. Clin. N. Amer. 46, 785–794 (1962).Google Scholar
  7. Maxwell, M. H.: Reversible renal hypertension. Clinical characteristics and predictive tests. Amer. J. Cardiol. 9, 126–133 (1962).CrossRefGoogle Scholar
  8. McDonald, D. F.: The diagnosis of renal hypertension. Geriatrics 18, 589–601 (1963).PubMedGoogle Scholar
  9. Morris, G. C., P. G. Kirchhoff u. K. G. v. Buch: Diagnostik und chirurgische Behandlung der renovaskulären Hypertonie. Med. Klin. 59, 291–297 (1964).PubMedGoogle Scholar
  10. Moser jr K. J., and J. ßCaldwell: Abdominal murmurs, an aid in the diagnosis of renal artery disease in hypertension. Ann. intern. Med. 56, 741–483 (1962).CrossRefGoogle Scholar
  11. Poutasse, E. F., and H. P. Dustan: Cleveland Clin. Quart. 23, 3 (1956).PubMedCrossRefGoogle Scholar
  12. Poutasse, E. F., and H. P. Dustan: Arteriosclerosis and renal hypertension. Indications for arteriography in hypertensive patients and results of surgical treatment of obstructive lesions of renal artery. J. Amer. med. Ass. 165,1521–1525 (1957); 178, 1078–1083 (1961).CrossRefGoogle Scholar
  13. Schönthal, H.: Das Phonogramm bei Nierenarterienstenose. Klin. Wschr. 41, 1207–1208Google Scholar
  14. Stewart, B. H., M. S. Deweese, J. Conway, and R. J. Correa jr.: Renal hypertension. An appraisal of diagnostic studies and of direct operative treatment. Arch. Surg. 85, 617–636 (1962).PubMedCrossRefGoogle Scholar

Intravenöses Pyelogramm

  1. Bookstein, J. J., and H. L. Abrams: Surgically correctable renal hypertension. A review and presentation of four cases. Radiology 75, 207–214 (1960).PubMedGoogle Scholar
  2. Brannan, W., R Birchall, H. M. Batson, and W. E. Kittredge: Dehydrated-hydrated excretory urography in the diagnosis of renal arterial hypertension. J. Urol. (Baltimore) 91, 26–32 (1964).Google Scholar
  3. Correa jr. R. J., B. H. Stewart, and D. E. Boblitt: Intravenous pyelography as a screening test in renal hypertension. Amer. J. Roentgenol. 88, 1135–1141 (1962).PubMedGoogle Scholar
  4. Don, C.: Unilateral manifestations of bilateral renal artery disease. Canad. med. Ass. J. 85, 1188–1192 (1961).PubMedGoogle Scholar
  5. Evans, J. A.: Nephrotomography in the investigation of renal masses. Radiology 684–689 (1957).Google Scholar
  6. Frencken, V. A. M.: Ureterimpression bei Nierenarterienstenose. Fortschr. Röntgenstr. 100, 741–745 (1964).CrossRefGoogle Scholar
  7. Halpern, M., and J. A. Evans: Coarctation of the renal artery with „notching" of the ureter. A roentgenologic sign of unilateral renal disease as a cause of hypertension. Amer, J. Roentgenol. 88, 159–164 (1962).Google Scholar
  8. Kaufman, J. J., A. F. Schanche, and M. H. Maxwell: Excretory urography in the diagnosis of renovascular hypertension: methods of enhancing its value. J. Urol. (Baltimore) 489–505 (1963).Google Scholar
  9. Maxwell, M. H., H. C. Gonick, R. Wiita, and J. J. Kaufman: Use of the rapid-sequence intravenous pyelogram in the diagnosis of renovascular hypertension. New Engl. J. Med. 270. 213–220 (1964).PubMedCrossRefGoogle Scholar
  10. Poutasse, E. F.: Postgrad. Med. 33, 488 (1963).PubMedGoogle Scholar
  11. Siggers, R. L.: Early physiologic nephro-urography as a test of kidney function. Radio logy 77, 452- 457 (1961).Google Scholar
  12. Veyrat, R.: L’hypertension arterielle renovasculaire chez I’homme. Rev. Med. (Paris) 84 360–368 (1964).Google Scholar
  13. Wale, C. A., and T. J. Whalen: Criteria for screening the hypertensive patient with renal artery occlusion. J. Amer. med. Ass. 192, 1125–1129 (1965).CrossRefGoogle Scholar

Renogramm (Szintigramm)

  1. Boyd, J. D., and H. R. Murdock jr.: The radiorenogram as a measure of renal function. Arch, intern. Med. 109, 654–659 (1962).CrossRefGoogle Scholar
  2. Burbank, M. K., J. C. Hunt, W. N. Tauxe, and F. T. Maher: Radioisotopic renography. Diagnosis of renal arterial disease in hypertensive patients. Circulation 27, 328–338 (1963).PubMedCrossRefGoogle Scholar
  3. Doig, A., J. R. Lawrence, T. Philip, P. Tothill, and K. W. Donald: iil. "Hippuran" renography in detection of unilateral renal disease in patients with hypertension. Brit. med. J. 1963 I, 500–504.CrossRefGoogle Scholar
  4. Farmelant, M. H., and B. A. Burrows: Urine flow response to mannitol loading in unilateral renal disease. J. din. Invest. 40, 1037 (1961).Google Scholar
  5. Farmelant, M. H., C. A. Lipietz, V. Bickerman, and B. A. Burrows: Radioisotopic renal function. Studies and surgical findings in 102 hypertensive patients. Amer. J. Surg. 107, 50–57 (1964).PubMedCrossRefGoogle Scholar
  6. Feine V., u. K. M. Bauer: Zur Technik, Deutung und Indikation des Radioisotopennephrogrammes mit Jod-131- markiertem Urografin: Fortschr. Röntgenstr. 94, 623–633 (1961).CrossRefGoogle Scholar
  7. Gasser, G., u. F. Hawliczek: Das Isotopennephrogramm. Med. Klin. 59, 1297–1301.Google Scholar
  8. Hunt, J. C., W. N. Tauxe, F. T. Maher, L. F. Greene, R. W. Giffordjr., and Ph. E. Bernatz: Clinical evaluation of hypertensive patients. Indications for and utilization of the isotope renogram, separated renal function study and aorticorenal arteriogram. Amer. J. Cardiol. 9, 134–140 (1962).PubMedCrossRefGoogle Scholar
  9. Kaufman J. J, and M. H. Maxwell: Surgery for renovascular hypertension. J. Amer. med. Ass. 190, 709 (1964.CrossRefGoogle Scholar
  10. Kennedy, A. C., R. G. Luke, J. D. Briggs, and W. B. Stirling: Detection of renovascular hypertension. Lancet 1965 II, No 7420, 963–968.CrossRefGoogle Scholar
  11. Klapproth, H. J., A. Hirakawa, and A. C. Corcoran: Functional significance of the radioisotope renogram. An experimental study. J. Urol. (Baltimore) 87, 77–84 (1962).Google Scholar
  12. Koplowitz, J. M., J. F. Mitchell, and W. H. Blahd: The radioisotope renogram. A comparison of qualitative and quantitative interpretation. J. Amer. med. Ass. 192, 1932–1034 (1965).CrossRefGoogle Scholar
  13. Lambie, R. W., S. Rubin, M. B. Ozar, and H. Statland: Single scintillation counter and recording device. Its use as asscreening test for unilateral renal hypertension. J. Amer. med. Ass. 181, 582–586 (1962).CrossRefGoogle Scholar
  14. Milliez, P., Ph. Tcherdakoff, and L. P Rey: Les investigations isotopiques des reins. Ann. Radiol. 5, 201–210 (1962).PubMedGoogle Scholar
  15. Oeff, K., W. Lorenz u. A. Scholz: Indikationen und Wert der Radioisotopen-Renographie. Verh. dtsch. Ges. inn. Med. 69, 749–753 (1963).Google Scholar
  16. Roth, H. W., H. Movarrekhi et P. Wenger: Le nephrogramme isotopique. Methode, analyse quantitative et utilite clinique. Schweiz, med. Wschr. 90, 286–292 (1960).Google Scholar
  17. Scholz, A., A. Hange u. K. Oeff: Die Bedeutung der Isotopenrenographie für die Diagnostik des renalen Hypertonus, insbesondere der operablen Formen. Dtsch. med. Wschr. 21, 1011–1017 (1964).CrossRefGoogle Scholar
  18. Sitia, L., F. Pillirone, F. Pontiggia, G. B. Cerutti e S. Lamperi: La nefro- grafia con radioisotopi nella diagnosi delle uropatie ostruttive. Minerva urol. 16,65–70(1964).PubMedGoogle Scholar
  19. Taplin, G. V., O. M. Meredith, H. Kade, and C. C. Winter: The radioisotope renogram. An external test for individual kidney function and upper urinary tract patency. J. Lab. din. Med. 48, 886–901 (1956).Google Scholar
  20. Tauxe, W. N.: The radioisotope renogram in renal artery disease (Symposium). Proc. Mayo Clin. 36, 684–689 (1961).Google Scholar
  21. Wedeen, R. P., E. Littman, M. F. Levitt, and M. H. Goldstein: The use of the J 131- hippuran renogram in the detection of disperate kidney function in hypertensive patients. Circulation 32, 5–12 (1965).PubMedCrossRefGoogle Scholar
  22. Whitley, J., R. L. Witcofski, J. L. Quinn, and L Meschan: The radiologic diagnosis of renovascular hypertension. Radiology 78, 414–424 (1962).PubMedGoogle Scholar
  23. Winter, C C.: A clinical study of a new renal function test: the radioactive diodrast renogram. J. Urol. (Baltimore) 76, 182–196 (1957).Google Scholar
  24. Winter, C C.: Unilateral renal disease and hypertension: use of the radioactive diodrast renogram as a screening test. J. of Urol. 78, 107–116 (1957).Google Scholar
  25. Winter, C C.: Radioisotope renography. Baltimore: William & Wilkins Co. 1963.Google Scholar
  26. Winter, C C.Renogram and other radioisotope tests in the diagnosis of renal hypertension (Symposium). Amer. J. Surg. 107, 439 (1964).Google Scholar
  27. Winter, C. C. A., M. H. Maxwell, R. E. Rockney, C. R. Kleeman, C.R. Schmitt, and N. Johnson: Results of the radioisotope renogram and comparison with other kidney tests among hypertensive persons. J. Urol. (Baltimore) 82, 674–680 (1959).Google Scholar
  28. Woodruff, M. W., R. S. Kibler, M. A. Bender, and M. Blau: Hg 203 neohydrin kidney photo- scan: an adjuvant to diagnosis of renal disease. J. Urol. (Baltimore) 89, 746–752 (1963).Google Scholar
  29. Zum Winkel, K.: Nierendiagnostik mit Radioisotopen: Funktionelle und morphologische Ergebnisse in Experiment und Klinik. Stuttgart: Georg Thieme 1964.Google Scholar
  30. Zum Winkel, K., u. K. E. Scheer: Grundlagen der Nieren-Szintigraphie mit Hg 203 Salyrgan. Nuc. Med. (Stuttg.) 2, 71–79 (1961).Google Scholar
  31. Zum Winkel, K., G. Schütterle u. K. E. Scheer: Die Isotopen- Nephrographie in der Diagnostik der Nierenkrankheiten. Dtsch. med. Wschr. 86, 1751–1754, 1757 (1961).Google Scholar

Renale Angiographie

  1. Ansay, J., J. Buisseret et F. Mahieu: L’arteriographie renale dans l’hypertension. J. beige. Radiol. 45, 13–30 (1962).Google Scholar
  2. Crane, Ch.: Renal arteriography lumbar approach. Amer. J. Surg. 107, 74–77 (1964).PubMedCrossRefGoogle Scholar
  3. Descotes, J., et A. Levy: L’angiographie renale. La valeur semeiologique de stenoses des arteres renales dans les hypertensions arterielles d’origine renale. J. Radiol, filectrol. 43, 211–214 (1962).Google Scholar
  4. Düx, A., u. P. Thum: Zur Methodik der Nierenarteriographie. Fortschr. Röntgenstr. 98, 659–674 (1963).CrossRefGoogle Scholar
  5. Fiorani, P., U. Mercati e N. Zicari: Indicazioni e tecniche dell’angiografia delle arterie renah in pazienti ipertesi. Chir. gen. (Perugia) 11, 102–113 (1962).Google Scholar
  6. Fuchs, W. A.: Zur Technik der Nierenangiographie. Radiol, clin. (Basel) 32, 121–141 (1963).Google Scholar
  7. Fuchs, W. A.: Die Interpretation der Nierenangiographie. Schweiz, med. Wschr. 93, 1783–1786 (1963).Google Scholar
  8. Halpern, M., N. Finby, and J. A. Evans: Percutaneous transfemoral renal arteriography in hypertension. Radiology 77, 25–34 (1961).PubMedGoogle Scholar
  9. Kong, T. Q., T. F. Meaney, H. P. Dustan, and F. M. Sones: Safety of selective renal arteriography. Amer. J. med. Sei. 246, 527–531 (1963).CrossRefGoogle Scholar
  10. Kong, Y., W. F. Barryjr., R. E. Whalen, V. A. Politano, and D. Mcintosh: Visualization of the renal artery. A comparison of translumbar and percutaneous retrograde catheter approaches, single-film and seriographie technics. Circulation 28, 843–852 (1963).PubMedCrossRefGoogle Scholar
  11. Lang, E. K.: A survey of the complications of percutaneous retrograde arteriography: Seldinger technic. Radiology 81, 257–263 (1963).PubMedGoogle Scholar
  12. Lefebure, J, C. Faure, J. Bennet et M. Savary: L’arteriographie renale dans I’hypertension arterielle. Ann. Radiol. 3, 753–771Google Scholar
  13. Lelek, I.: Erfahrungen auf dem Gebiete der Nierenangiographie. Radiol, austriaca 13, 253–261 (1962).Google Scholar
  14. Lindgren, P.: Renal circulatory insufficiency after renal angiography. An experimental study. Acta radiol. (Stockh.) 56, 423–432 (1961).CrossRefGoogle Scholar
  15. Luttwak, E. M., G. E. Reed, and E. S. Breed: Effect of aortography on renal function. Ann. Surg. 154, 190–209.Google Scholar
  16. Maluf, N. S. R.: Internal diameter of renal artery and renal function. Surg. Gynec. Obstet. 107, 415–428 (1958).Google Scholar
  17. Marshall, T. R., and J. T. Ling: Percutaneous noncatheter left brachial renal arteriography. Amer. J. Roentgenol. 92, 315–320 (1964).Google Scholar
  18. Meaney, T. F., and H. P. Dustan: Selective renal arteriography in the diagnosis of renal hypertension. Circulation 28, 1035–1041 (1963).PubMedCrossRefGoogle Scholar
  19. Morino, F., S. Olivero e A. Tarquini: Indicazioni e limiti dell’arteriografia renale selettiva. Minerva med. 1957 I, 825–841.Google Scholar
  20. Morris, G, C., and M. E. DeBakey: Diagnosis of renal vascular disease. Symposium. Amer. J. Cardiol. 9, 756–759.Google Scholar
  21. Olsson, O.: Die diagnostische Bedeutung der Angiographie der Nierengefäße. Verh. dtsch. Ges. inn. Med. 69, 363–369 (1963).Google Scholar
  22. Porstmann, W.: Die Bedeutung der Renovasographie beim renalen Drosselungshochdruck. Radiol. diagn. (Berl.) 2, 511–520(1961).Google Scholar
  23. Porstmann, W.: Etude radiologique des lesions de Fartere renale, facteurs d’hypertension. Presse med. 72, Suppl. au no. 8 (Atlas de Radiologie clinique) (1964).Google Scholar
  24. Robertson, C. W.: Retrograde aortography in the study of renal arterial lesions. Amer. J. Surg. 107, 78–83 (1964).PubMedCrossRefGoogle Scholar
  25. Schneider, H. J., u. W. Heibig: Zur Frage der Nierenschädigung nach Ausscheidungsuro- graphie. Z. Urol. 55, 529–535 (1962).PubMedGoogle Scholar
  26. Seldinger, S. L: Catheter replacement of needle in percutaneous arteriography. Acta radiol. (Stockh.) 39, 368–376 (1953).CrossRefGoogle Scholar
  27. Smith, P., T. W. Rush, and A. T. Evans: The technique of translumbar arteriography. J. Amer. med. Ass. 148, 255–258 (1952).CrossRefGoogle Scholar
  28. Thum, P., W. Fritz, A. Dilx u. A. Heymer: Die Bedeutung der Nierenarteriographie für Diagnostik und Therapie der renalen Hypertonie. Dtsch. med. Wschr. 87, 838–834, 849–850, 891–892 (1962).CrossRefGoogle Scholar
  29. Travis, L. B., C. W. Daeschnerjr., W. F. Dodge, and H. C. Kopps: Effect of aortographic contrast media on renal histology. J. Pediat. 59, 304–305 (1961).PubMedCrossRefGoogle Scholar
  30. Tcherdakoff, Ph.: Indications et resultats de l’arteriographie renale au cours de I’hypertension arterielle. Cour Med. interne 1, 433–437 (1962).Google Scholar
  31. Tcherdakoff, Ph., et P. Milliez: L’arterio-graphie renale retrograde au cours de I’hypertension arterielle. Etude de nos 100 premieres observations. Sem. Hop. Paris 37, 762–770 (1961).Google Scholar
  32. Vogler, E.: Angiographie der Nieren. Indikation und Ergebnisse. 9. Congr. Radiol. 1, 342–347 (1961).Google Scholar

Komplikationen der Aortographie d.h. der renalen Angiographie

  1. Albores-Saavedra, J., J. P. Abbott, and R. M. Nunnally: Unilateral malignant nephrosclerosis with superimposed unilateral cortical necrosis, following aortogram. Amer. J. din. Path. 35, 147–154 (1961).Google Scholar
  2. Baudisch, E., u. W. Baumann: Kontrastmittelschäden der Nieren nach angiographischen Untersuchungen. Z. Urol. 57, 251–268 (1964).PubMedGoogle Scholar
  3. Beall jr, A. C., G. C. Morrisjr., E. S. Crawford, D. A. Colley, and M. E. DeBakey: Translumbar aortography: re-evaluation. Surgery 49, 772 (1961).Google Scholar
  4. Bell, J. W.: Treatment of post catheterization arterial injuries. Ann. Surg. 155, 591 (1962).PubMedCrossRefGoogle Scholar
  5. Bunnell, I. L., and D. G. Greene: Rewards and hazards of selective renal arteriography. J. Amer. med. Ass. 194, 1177–1180 (1965).CrossRefGoogle Scholar
  6. Dormandy, K. M., A. M. Jockes, and D. Sutton: Renal failure following renal angiography. Lancet 18, 6984 (1957).Google Scholar
  7. Edling, N. P. G., and C. G. Helander: The renal damage due to aortography and its prevention by renal tests. With reports of five cases of severe renal damage. Acta radiol. (Stockh.) 47, 473–480 (1957).CrossRefGoogle Scholar
  8. Edling, N. P. G., and C. O. Ovenfors: Risks in selective renal catheterization and arteriography. An experimental study in dogs. Acta radiol. (Stockh.), N.S. 2, 241–249 (1964).Google Scholar
  9. Ferrand, J., et U. Elbaz: Les complications de Faortographie et de I 7;arterographie. Minerva cardioangiol. 7, 224–234 (1959).Google Scholar
  10. Foex, P., H. Lambert et C. Mentha: Les comph- cations medullaires graves de I’aortographie abdominale. Arch. Mai. Coeur 57,142–157 (1964).Google Scholar
  11. Gjudberg, O. E., and J. Christensen: Dissection of the aortic wall in retrograde lumbar aortography. Acta radiol. (Stockh.) 55, 364 (1961).CrossRefGoogle Scholar
  12. Lambeth, C. B., J. R. Derrick, and A. E. Hansen: Stenosis of a branch of the renal artery causing hypertension in a child. Including a complication of translumbar renal arteriography. Pediatrics 26, 822–827 (1960).PubMedGoogle Scholar
  13. Lead better. G. W., and C. Markland: Evaluation of technics and complications of renal angiography. New Engl. J. Med. 266, 10–13 (1962).CrossRefGoogle Scholar
  14. Handbuch der inneren Medizin, Bd. VIII/2, 5. Aufl.Google Scholar
  15. Luke, J. C., and J. Y. McGraw: Complications following catheter angiography. Arch. Surg. 86, 414–418 (1963).PubMedCrossRefGoogle Scholar
  16. McAfee, J. G., and J K, Willson: A review of the complications of translumbar aortography. Amer. J. Roentgenol. 75, 956 (1956).PubMedGoogle Scholar
  17. McCallister, B. D., J. C. Hunt, and W. Kincaid: Unilateral renal atrophy subsequent to renal arteriography. Proc. Mayo Clin. 37, 323–338 (1962).Google Scholar
  18. Palubinskas, A. J., and E. J. Wylie: Roentgen diagnosis of fibromuscular hyperplasia of the renal arteries. Radiology 76, 634–639 (1961).PubMedGoogle Scholar
  19. Pigeon, G., R. Lefebure, G. E. Cartier, and J. Genest: Unilateral renal damage after translumbar aortography. Canad. med. Ass. J. 83, 69–72 (1960).PubMedGoogle Scholar

Getrennte Clearance-Untersuchungen

  1. Baldwin, D. S.: Function of the separate kidneys in hypertension of unilateral renal origin. Progr. Cardiovasc. Dis. 4, 134–147 (1961).CrossRefGoogle Scholar
  2. Berthoud, E.: Le test de Howard. Schweiz, med. Wschr. 93, 1763–1766 (1963).Google Scholar
  3. Birchall, R., H. M. Batson, and C. B. Moore: Hypertension due to unilateral renal arterial obstruction. Preliminary observations on the contribution of differential renal clearance studies. Amer. Heart J. 56, 616–628 (1958).PubMedCrossRefGoogle Scholar
  4. Birchall, R., H. M. Batson Jr., and E. G. Anderson: Diagnosis of hypertension due to renal arterial stenosis. Circulation 29, 6–13 (1964).PubMedCrossRefGoogle Scholar
  5. Birchall, R., H. M. Batson Jr., and W. Brannan: Contribution of differential renal studies to the diagnosis of renal arterial hypertension with emphasis on the value of Usodium/Ucreatinine. Amer. J. Med. 32, 164–170 (1962).PubMedCrossRefGoogle Scholar
  6. Blake, W. D., R. Wegria, H. P. Ward, and C. W. Frank: Effect of renal arterial constriction on excretion of Na and H2O. Amer. J. Physiol. 163, 422 (1950).PubMedGoogle Scholar
  7. Brown, J. J., K. Owen, W. S. Peart, J. T. S. Robertson, and D. Sutton: The diagnosis and treatment of renal artery stenosis. Brit. med. J. 1960 II, 327–338.CrossRefGoogle Scholar
  8. Connor, T. B., M. Berthrong, W. C. Thomas Jr., and J. E. Howard: Hypertension due to unilateral renal disease with a report on a functional test helpful in diagnosis. Bull. Johns Hopk. Hosp. 100, 241–276 (1957).Google Scholar
  9. Connor, T. B., W. C. Thomas Jr., L. Haddock, and J. E. Howard: Unilateral renal disease as cause of hypertension: its detection by ureteral catheterization studies. Ann. intern. Med. 52, 544–559 (1960).PubMedCrossRefGoogle Scholar
  10. Cottier, P. T., J. Gingold, C. Vorburger, H. M. Keller u. F. Reubi: Rénale Wirkung eines neuen Vasodilatators Ciba 31531-Ba. Helv. med. Acta 32, 420–426 (1965).Google Scholar
  11. Cottier, P. T., u. A. Montandon: Zur Diagnose der renovaskulären Hypertonie. Eibl, gastroent. (Basel) 8, 185–194 (1965).Google Scholar
  12. Cottier, P. T., J. M. Weller u. S. W. Hoobler: Besonderheiten der rénalen Wasser- und Elektrolytausscheidung bei essentieller Hypertonie. Cardiologia (Basel) 31, 278–289 (1957).CrossRefGoogle Scholar
  13. Cottier, P. T., J. M. Weller u. S. W. Hoobler: Effect of an intravenous sodium chloride load on renal hemodynamics and electrolyte excretion in essential hypertension. Circulation 17, 750–760 (1958).PubMedCrossRefGoogle Scholar
  14. Davidson, D. G., N. G. Levinsky, and R. W. Berliner: Maintenace of potassium excretion despite reduction of glomerular filtration during sodium diuresis. J. din. Invest. 37, 548–555 (1958).Google Scholar
  15. Dustan, H. P., E. F. Poutasse, A. C. Corcoran, and H. Page: Separated renal function in patients with renal arterial disease, pyelonephritis, and essential hypertension. Circulation 23, 34–41 (1961).PubMedCrossRefGoogle Scholar
  16. Eigler, F. W., K. F. Albrecht u. G. Heberer: Scitengetrennte Nierenfunktionsprüfung bei Hochdruckkranken mit Nierenarterienstenosen. Verh. dtsch. Ges. Kreisl.-Forsch. 1963, 272–276.Google Scholar
  17. Graber, J. G., and R. Shackman: Divided renal function studies in hypertension. Brit, med. J. 1956 I, No 4979, 1321–1326.CrossRefGoogle Scholar
  18. Howard, J. E., M. Berthrong, D. M. Gould, and E. R. Yendt: Hypertension resulting from unilateral renal vascular disease and its relief by nephrectomy. Bull. Johns Hopk. Hosp. 94, 51 (1954).Google Scholar
  19. Howard, J. E., and T. B. Connor: Hypertension produced by unilateral renal disease. Arch, intern. Med. 109, 8–17 (1962).CrossRefGoogle Scholar
  20. Howard, J. E., and T. B. Connor: Use of differential renal function studies in the diagnosis of renovascular hypertension. Amer. J. Surg. 107, 58–66 (1964).PubMedCrossRefGoogle Scholar
  21. Howard, J. E., T. B. Connor, and W. C. Thomas Jr.: Functional test for detection of hypertension produced by the kidney. Preliminary studies. Trans. Ass. Amer. Phycns 69, 291–298 (1956).Google Scholar
  22. Kjellbo, H., P. Vikgren, S. Oman, and B. Hood: The functional pattern of renal artery stenosis. Acta med. scand. 172, 485–495 (1962).PubMedCrossRefGoogle Scholar
  23. Lanier, D. P., and J. H. Harrison: Ureteral catheterization measurements in renal hypertension. Amer. J. Surg. 107, 67–73 (1964).CrossRefGoogle Scholar
  24. Lawrence, J. R., A. Doig, J. C. S. Knight Google Scholar
  25. F. Maclaren, and K. W. Donald: Renal artery stenosis without renal ischemia. Lancet 1964 I, 62–65.Google Scholar
  26. Levinsky, N., D.G. Davidson, and R. Berliner: Effects of reduced glomerular filtration on urine concentration in the presence of antidiuretic hormone. J. din. Invest. 38, 730–740 (1959).Google Scholar
  27. Madeloff, M. S., F. D. Schwartz, F. J. Borges, G. Enwisle, S. T. R. Revell Jr., and J. D. Young: Differential renal clearance patterns in the evaluation of hypertension. J. Urol. (Baltimore) 87, 258–272 (1962).Google Scholar
  28. McGrigor, R. B.: Experiences with differential renal function studies in the investigation of hypertension of renal origin. Brit. J. Surg. 49, 70–77 (1961).CrossRefGoogle Scholar
  29. Mueller, C. B., A. Sortshin, M. R. Carlin, and H. L. White: Glomerular and tubular influences on sodium and water excretion. Amer. J. Physiol. 165, 411–422 (1951).PubMedGoogle Scholar
  30. Nishiura, T., and S. Yokoyame: Hypertension of unilateral renal origin. Urol. int. (Basel) 12, 191 (1961).CrossRefGoogle Scholar
  31. Ocker Jr., J. M., T. H. Lehmann, R. J. Moore, and C. V. Hodges: Experiences with differential function studies in renal vascular hypertension. J. Urol. (Baltimore) 91, 639–645 (1964).Google Scholar
  32. Osius, T. G., and D. R. Smith: Phenolsulfonphthalein-test in the surgical prognosis of unilateral renovascular hypertension. New Engl. J. Med. 269, 122–125 (1963).PubMedCrossRefGoogle Scholar
  33. Rapoport, A.: Modification of the "Howard-Test" for the detection of renal-artery obstruction. New Engl. J. Med. 263, 1159 (1960).PubMedCrossRefGoogle Scholar
  34. Revell Jr., S. T. R., F. J. Borges, G. Entwisle, and J. D. Young Jr.: An appraisal of certain tests for the detection of hypertension of unilateral renal origin. Ann. intern. Med. 53, 970–991 (1960).PubMedCrossRefGoogle Scholar
  35. Scheitlin, W.: Die Abklärung der Hypertonie bei einScitigen Nierenleiden. Helv. chir. Acta 29, 440–445 (1962).PubMedGoogle Scholar
  36. Schlegel, J. U., E. D. Savlov, and F. Gabor: Some studies in renal hypertension. J. Urol. (Baltimore) 81, 581–595 (1959).Google Scholar
  37. Scikurt, E. E., P. W. Hall, and M. P. Spencer: Influence of graded arterial pressure. Decrement on renal clearance of creatinine P-AH and Na. Amer. J. Physiol. 159, 369 (1949).Google Scholar
  38. Smith, H. W.: Unilateral nephrectomy in hypertensive disease. J. Urol. (Baltimore) 76, 685–701 (1956).Google Scholar
  39. Spencer, A. G.: Clearance studies in unilateral renal disease. In: M. D. Milne (ed.). Recent advances in renal disease, p. 208. London: Pitman Medial Publ. Co. 1960.Google Scholar
  40. Spencer, F. C., T. A. Stamey, H. T. Bahnson, and A. Cohen: Diagnosis and treatment of hypertension due to occlusive disease of the renal artery. Ann. Surg. 154, 674 (1961).PubMedCrossRefGoogle Scholar
  41. Stamey, T. A.: Functional characteristics of renovascular hypertension with emphasis on the relationship of renal blood flow to hypertension. Proc. Council High Blood Press 10, 209 (1961).Google Scholar
  42. Stamey, T. A.: Functional characteristics of renovascular hypertension with emphasis on the relationship of renal blood flow to hypertension. Circulat. Res. 11, 209–219 (1962).PubMedCrossRefGoogle Scholar
  43. Stamey, T. A.: Renovascular hypertension, p. 1–232. Baltimore: Williams & Wilkins Co. 1963.Google Scholar
  44. Stamey, T. A.: Surgical treatment of renovascular lypertension: the importance of peroperative functional asessment. Antihypertensive therapy principles and practice. Internat. Symp. Siena (ed. F. Gross). Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  45. Stamey, T. A., I. J. Nudelman, P. H. Good, F. N. Schwentker, and F. Herdricks: Functional characteristics of renovascular hypertension. Medicine (Baltimore) 40, 347–394 (1961).CrossRefGoogle Scholar
  46. Stewart, D. H., and T. P. Haynie: Critical appraisal of renogram in renal vascular disease. J. Amer. med. Ass. 180, 454–459 (1962).CrossRefGoogle Scholar
  47. Stone, P. W., J. B. McNally, J. W. Lord Jr., and J. W. Hinton: Successful treatment by nephrectomy of hypertension resulting from aorticorenal embolus. New Engl. J. Med. 256, 1076–1079 (1957).PubMedCrossRefGoogle Scholar
  48. Vertes, V., S. Genuth, D. E. Leb, and J. B. Galvin: Unilateral renal plasma flow in the assessment of correctable renovascular hypertension. New Engl. J. Med. 273, 855–857 (1965).PubMedCrossRefGoogle Scholar
  49. White, H. L.: The excretion of sodium in relation to glomerular filtration in renal function. Transactions of the Second Conference (ed. S. E. Bradley), p. 127. New York: Josiah Macy Jr. Foundation 1950.Google Scholar
  50. Williams, T. F.: Renal cortical necrosis, renal infarction and hypertension due to renal vascular disease. In: Diseases of the kidney (ed. M. B. Strauss, and L. G. Welt), p. 526–574. Boston: Little, Brown & Co. 1963.Google Scholar
  51. Wilson, L., H. P. Dustan, I. H. Page, and E. F. Poutasse: Diagnosis of renal arterial lesions. Arch, intern. Med. 112, 270–277 (1963).CrossRefGoogle Scholar
  52. Yendt, E. R., W. K. Kerr, D. W. Wilson, and Z. F. Jaworski: The diagnosis and treatment on renal hypertension: with special reference to a case of hypertension due to stenosis of both renal arteries. Amer. J. Med. 28, 169–187 (1960).PubMedCrossRefGoogle Scholar

Hypertensintest

  1. Breckenridge, A.: Angiotensin-infusion test. Lancet 1965 II, 209–211.CrossRefGoogle Scholar
  2. Brown, J. J., D. L. Davies, A. F. Lever, and J. I. S. Robertson: Variations in plasma renin concentration in several physiological and pathological states. Canad. med. Ass. J. 90, 201–206 (1964).PubMedGoogle Scholar
  3. Conway, J.: Vascular reactivity in experimental hypertension measured after hexa-methonium. Circulation 17, 807 (1958).PubMedCrossRefGoogle Scholar
  4. Cottier, P., J. Gingold, C. Vorburger, H. M. Keller u. F. Reubi: Rénale Wirkung eines neuen Vasodilatators Ciba 31531-Ba. Helv. med. Acta (im Druck) (1965).Google Scholar
  5. Cottier, P., R. Wettstein, R. Veyrat u. F. Reubi: Die Bedeutung des intravenösen Hypertensintestes nach Kaplan für die Diagnose der renovaskulären Hypertonie (ed. H. P. Wolff). IV. Symp. Ges. für Néphrol., Saarbrücken 1965. Berlin-Heidelberg-New York: Springer (im Druck).Google Scholar
  6. Dérot, M., J. Guedon et J. Trad: Ren Scignements foumis par le test a l’angiotensine de Kaplan dans l’exploration des hypertensions d’origine rénale. J. Urol. Néphrol. 70, 723 (1964).Google Scholar
  7. Oaskell, J. R., R. K. Jones, and A. P. Shapiro: Hyperresponsiveness of renal hypertensive rats to intravenous angiotensin. II. Proc. Soc. exp. Biol. (N.Y.) 115, 179–182 (1964).CrossRefGoogle Scholar
  8. Hocken, A. G., R. M. Kark, and M. Passovoy: The angiotensin-infusion-test. Lancet 1966 I, No 7427, 4–11.Google Scholar
  9. Johnston, C. I., and A. D. Jose: Eeduced vascular response to angiotensin II in secondary hyperaldosteronism. J. cHn. Invest. 42, 1411–1420 (1963).CrossRefGoogle Scholar
  10. Kaplan, N. M., and J. G. Silah: Effect of angiotensin II on blood pressure in humans with hypertensive disease. J. din. Invest. 43, 659–669 (1964).Google Scholar
  11. Kaplan, N. M., and J. G. Silah: The angiotensin-infusion test. A new approach to the differential diagnosis of renovascular hypertension. New Engl. J. Med. 271, 536–541 (1964).PubMedCrossRefGoogle Scholar
  12. Khairallah, P. A., I. H. Page, F. M. Bumpus, and R. R. Smeby: Angiotensin II: Its metabolic fate. Science 138, 523–525 (1962).PubMedCrossRefGoogle Scholar
  13. Laragh, J. H.: Interrelationship between angiotensin, norepinephrine, epinephrine, aldosterone secretion, and electrolyte metabolism in man. Circulation 25, 203–211 (1962).PubMedCrossRefGoogle Scholar
  14. Laragh, J. H., P. Milliez u. Ph. Teherdakoff: Mitteilung.Google Scholar
  15. McCubbin, J. W., J. H. Green, and I. H. Page: Baroceptor function in chronic renal hypertension. Circulation Res. 4, 205–210 (1956).PubMedCrossRefGoogle Scholar
  16. McCubbin, J. W., and I. H. Page: Influence of carotid sinus and aortic buffer reflexes and tetraaethyl-ammoniumchloride on vascular reactivity to angiotonin and renin. Amer. J. Physiol. 170, 309–320 (1952).PubMedGoogle Scholar
  17. McCubbin, J. W., and I. H. Page: Renal pressor system and neurogenic control of blood pressure. Circulation 12, 553 (1963).CrossRefGoogle Scholar
  18. McCubbin, J. W., and I. H. Page: Neurogenic component of chronic renal hypertension. Science 139, 210–215 (1963).PubMedCrossRefGoogle Scholar
  19. McCubbin, J. W., and I. H. Page: Renal pressor system and neurogenic control of arterial pressure. Circulat. Res. 12, 553–561 (1963).Google Scholar
  20. Meudlowitz, M., R. L. Wolf, S. E. Gitlow, and N. E. Naftchi: Angiotensin II studies in hypertension. Circulation 25, 231–236 (1962).CrossRefGoogle Scholar
  21. Tobian Jr., L., and J. T. Binion: Tissue cations and water in arterial hypertension. Circulation 5, 754 (1952).PubMedCrossRefGoogle Scholar
  22. Veyrat, R.: Persönliche Mitteilung.Google Scholar
  23. Veyrat, R., H. R. Brunner, E. L. Manning et A. F. Muller: Confrontation de Taction pressive de l’angiotensin, du taux de la rénine plasmatique et de l’aldosteronurie chez I’homme. Helv. med. Acta 32 (4/5), 412–417 (1965).Google Scholar
  24. Wolf, R. L., M. Medlowitz, J. Pick, S. E. Gitlow, and N. Naftchi: Metabohsm and distribution of J 131-labeled angiotensin II. J. Lab. din. Med. 60, 150–159 (1962).Google Scholar

Renin, Angiotensin, Aldosteron und Granulationsindex des juxtaglomerulären Apparates

  1. Barraclough, M. A., B. Bacchus, J. J. Brown, D. L. Davies, A. F. Lever, and J. I. S. Robertson: Plasma-renin and aldosterone secretion in hypertensive patients with renal or renal artery lesions. Lancet 1965 II/3, No 7426, 1310–1312.CrossRefGoogle Scholar
  2. Bock, K. D.: Angiotensin, Pharmakologie und klinische Anwendung. Heidelberg: A. Hüthig 1966.Google Scholar
  3. Bohie: Diskussionsbeitrag IV. Symp. Ges. für Néphrol., Saarbrücken 1965.Google Scholar
  4. Boucher, R., R. Veyrat, J. de Champlain, and J. Genest: New procedures for measurement of human plasma angiotensin and renin activity levels. Canad. med. Ass. J. 90, 194 (1964).PubMedGoogle Scholar
  5. Brown, J. J., D. L. Davies, A. F. Lever, W. S. Peart, and J. L S. Robertson: Brit. med. J. 1965, 1636.Google Scholar
  6. Brown, J. J., D. L. Davies, A. F. Lever, and J. I. S. Robertson: In: Boerhave Course Hypertension (ed. J. de Graeff), p. 44. Leyden 1963.Google Scholar
  7. Brown, J. J., D. L. Davies, A. F. Lever, and J. I. S. Robertson: The assay of renin in single rabbit glomeruli. J. Physiol. (Lond.) 117, 32P-33P (1964).Google Scholar
  8. Brown, J. J., D. L. Davies, A. F. Lever, and J. I. S. Robertson: Plasma renin concentration in human hypertension. Brit, med. J. 1965 II, 144–148.CrossRefGoogle Scholar
  9. Davis, J. O., P. M. Hartroft, E. O. Titus, C. C. J. Carpenter, C. R. Ayers, and H. E. Spiegel: The role of the renin-angiotensin system in the control of aldosterone secretion. J. din. Invest. 41, 378–389 (1962).Google Scholar
  10. Genest, J., G. Y. Trembley, R. Boucher, J. de Champlain, J. M. Rojo Ortega, R. Lefebure, P. Roy, and P. Cartier: Diagnostic significance of humoral factors in renovascular hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 518–540. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  11. Genest, J., W. Novaczynski, E. Koiw, T. Sandor u. P.Biron: Nebennierenfunktion bei essentieller Hypertonie. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier). Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  12. Goldberg, M., and D. K. McCurdy: Hyperaldosteronism and hypergranularity of the juxtaglomerular cells in renal hypertension. Metabolic studies. Ann. intern. Med. 59, 24–36 (1963).PubMedCrossRefGoogle Scholar
  13. Grollmann, A.: Antihypertensive and pressor agents of renal origin. Canad. med. Ass. J. 90, 299–302 (1964).Google Scholar
  14. Gross, F.: Nebennierenfunktion und rénale Pressor-mechanismen bei experimenteller Hypertension. In: Essentielle Hypertonie. Internat. Symp. (ed. K. D. Bock u. P. Cottier). Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  15. Hartroft, Ph.: Histological and functional aspects of juxtaglomerular cells. Angiotensin systems and experimental renal diseases. Proc. 14th Annual Conference on the kidney (ed. J. Metcoff), p. 5–14. Boston: Little, Brown & Co. 1963.Google Scholar
  16. Hartroft, Ph.: Juxtaglomerular cells as the source of renin. IV. Symp. Ges. für Néphrol., Saarbrücken 1965. Berlin-Göttingen-Heidelberg: Springer 1966.Google Scholar
  17. Helmer, O. M.: Presence of renin in plasma of patients with arterial hypertension. Symposium. Circulation 25, 169–173 (1962).PubMedCrossRefGoogle Scholar
  18. Helmer, O. M.: Renin activity in blood from patients with hypertension. Canad. med. Ass. J. 90, 221–225 (1964).PubMedGoogle Scholar
  19. Helmer, O. M., and W. E. Judson: The quantitative Détermination of renin in the plasma of patients with arterial hypertension. Circulation 27, 1050–1060 (1963).PubMedCrossRefGoogle Scholar
  20. Helmer, O. M., and R. E. Shipley: Recovery of a pressor principle from the blood plasma of cats given kidney extracts. Amer. J. Physiol. 150, 353–357 (1947).PubMedGoogle Scholar
  21. Hickler, R. B., D. P. Lauler, and G. W. Thorn: Plasma angiotensinase activity in patients with hypertension and edema. J. din. Invest. 42, 635–648 (1963).Google Scholar
  22. Higgins Jr., J. T., J. O. Davis, J. Urquhart, and M. J. Olichney: Increased plasma level of renin in experimental secondary hyperaldosteronism. Amer. J. Physiol. 207, 814–820 (1964).PubMedGoogle Scholar
  23. Judson, W. E.: Pressor activity of dialyzed plasma of patients with primary and secondary (renal) hypertension. Symposium. Amer. J. Cardiol. 9, 710–716 (1962).PubMedCrossRefGoogle Scholar
  24. Lever, A. F., and W. S. Peart: Renin and angiotensin-like activity in renal lymph. J. Physiol. (Lond.) 160, 548–563 (1962).Google Scholar
  25. Lever, A. F., and J. L S. Robertson: Renin in the plasma of normal and hypertensive rabbits. J. Physiol. (Lond.) 170, 212–218 (1964).Google Scholar
  26. Mach, R. S.: Le role des surrénales dans I’hypertension arterielle. Schweiz, med. Wschr. 34, 1027–1034 (1962).Google Scholar
  27. Margolin, E. P., J. P. Merrill, and J. H. Harrison: New Engl. J. Med. 256, 581 (1957).PubMedCrossRefGoogle Scholar
  28. McPhaul, J. J., D. A. Mcintosh, L. R. Williams, E. J. Grifti, W. G. Malette, and A. Grollman: Remediable hypertension due to unilateral renal disease. Arch, intern. Med. 115, 644–651 (1965).CrossRefGoogle Scholar
  29. Morris, R. E., P. R. Robinson, and G. A. Scheele: The relationship of angiotensin to renal hypertension. Canad. med. Ass. J. 90, 272–276 (1964).PubMedGoogle Scholar
  30. Morris Jr., R. E., and P. R. Robinson: Method for Détermination of angiotensin II in human blood. Bull. Johns Hopk. Hosp. 114, 127–145 (1964).Google Scholar
  31. Mulrow, P. J.: The role of the renin-angiotensin system in the hypertension associated with renal vascular disease. Canad. med. Ass. J. 90, 277 (1964).PubMedGoogle Scholar
  32. Page, L H., and F. M. Rumpus: Angiotensin. Physiol. Rev. 41, 331–390 (1961).PubMedGoogle Scholar
  33. Peart, W. S.: Diagnosis of renal artery stenosis. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 468–484. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  34. Reubi, F., A. Cerutti u. J. Veyrat: Hypokaliämie bei bioptisch nachgewiesener Hyperplasie des juxtaglomerulären Apparates. IV. Symp. Ges. für Néphrol., Saarbrücken u. Homburg/Saar 1965. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  35. Schröder, R., Th. Dissmann u. W. Dissmann: Sekundärer Aldosteronismus unter dem Bild des Conn-Syndromes bei einScitiger Nierenarterienstenose. Dtsch. med. Wschr. 17, 759–766 (1965).CrossRefGoogle Scholar
  36. Schwab, M., R. Schröder, C. Schattenfroh u. R. M. Schütz: Dtsch. med. Wschr. 88, 814 (1963).PubMedCrossRefGoogle Scholar
  37. Tobian, L.: Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol. Rev. 40, 280–312 (1960).PubMedGoogle Scholar
  38. Tobian, L.: Physiology of the juxtaglomerular cells. Ann. intern. Med. 52, 395 (1960).PubMedCrossRefGoogle Scholar
  39. Tobian, L.: Relationship of juxtaglomerular apparatus to renin and angiotensin. Symposium. Circulation 25, 189–192 (1962).PubMedCrossRefGoogle Scholar
  40. Tobian, L., J. Janecek, and A. Tomboulian: The effect of a high sodium intake on the developement of permanent nephrosclerotic hypertension. Effect of nephrosclerotic hypertension on the granularity of the juxtaglomerular cells. J. Lab. din. Med. 53, 842–848 (1959).Google Scholar
  41. Tobian, L., S. Schonning, and C. Seefeldt: The influence of arterial pressure on the antihypertensive action of a normal kidney, a biological servomechanism. Ann. intern. Med. 60, 378–383 (1964).PubMedCrossRefGoogle Scholar
  42. Tobian, L. J. Thompson, R. Twedt, and J. Janecek: Granulation of juxtaglomerular cells in hypertension. J. din. Invest. 37, 660 (1958).Google Scholar
  43. Tobian, L., A. Tomboulian, and J. Janecek: The effect of high perfusion pressures on the granulation of juxtaglomerular cells in an isolated kidney. J. din. Invest. 38, 605–610 (1959).Google Scholar
  44. Tobian Jr., L.: Effect of salt on the kidney and the juxta-glomerular apparatus. Amer. J. Cardiol. 8, 684–687 (1961).PubMedCrossRefGoogle Scholar
  45. Tremblay, G. Y., R. Veyrat, J. de Champlain, R. Boucher, R. Lefebure, P. Roy, P. Cartier, and J. Genest: Criteria for success of surgery in renovascular hypertension. Trans. Ass. Amer. Phycns. 77, 201–209 (1964).Google Scholar
  46. Turgeon, C., and S. C. Sommers: Juxtaglomerular cell counts and human hypertension. Amer. J. Path. 38, 227–241 (1964).Google Scholar
  47. Veyrat, R.: Détermination du rôle du systéme rénine-angiotensine dans l’hypertension arterielle renovasculaire chez I’homme. Bibl. gastroent. (Basel) 8, 232–237 (1965).Google Scholar
  48. Veyrat, R., H. R. Brunner, E. L. Manning et A. F. Müller: Confrontation de Faction pressive de I’angiotensine, du taux de la rénine plasmatique et de I’aldosteronurie chez I’homme. Helv. med. Acta 32 (4/5), 412–417 (1965).Google Scholar
  49. Veyrat, R., J. de Champlain, R. Boucher, and J. Genest: Measurement of human arterial renin activity in some physiological and pathological states. Canad. med. Ass. J. 90, 215–220 (1964).PubMedGoogle Scholar

Nierenbiopsie

  1. Kincaid-Smith, P.: The diagnostic value of renal biopsy in renovascular and other forms of renal hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 485–498. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  2. Morgan, J. M., T. J. Ferrell, C. Lyons, and H. V. Murdaugh Jr.: Diagnosis of renal hypertension. The use of the radiorenogram and the role of kidney biopsy. Amer. J. Cardiol. 9, 760–772 (1962).PubMedCrossRefGoogle Scholar
  3. Vertes, V., and J. A, Grauel: Observations on renal hypertension. The role of renal biopsy. Circulation 28, 536–541 (1963).PubMedCrossRefGoogle Scholar
  4. Vertes, V., J. A. Grauel, and H. Goldblatt: Studies of patients with renal hypertension undergoing vascular surgery. New Engl. J. Med. 272 (4), 186–189 (1965).PubMedCrossRefGoogle Scholar

Verschiedene Teste

  1. Brust, A. A., and E. B. Ferris: The diagnostic approach to hypertension due to unilateral kidney disease. Ann. intern. Med. 47, 1049–1066 (1957).PubMedCrossRefGoogle Scholar
  2. Jones, N. F., and M. A. Barraclough: Angiotensin response of the kidneys in unilateral renal-artery stenosis. Lancet 1962 I, 454–456.CrossRefGoogle Scholar
  3. Smlthwiek, R. H., D. Kinsey, and G. P. Whitelaw: Screening test for renal and adrenal forms of hypertension based upon postural change in blood pressure. Circulation 16, 939 (1957).Google Scholar
  4. Smithwick, R. H., W. J. Porell, and G. P. Whitelaw: Diagnosis of hypertension of adrenal and renal origin. J. Amer. med. Ass. 174, 127–132 (1960).CrossRefGoogle Scholar

Therapie

  1. Bernatz, E. P., J. C. Hunt, and E. G. Harrison Jr.: Idiopathic fibrous and fibromuscular stenoses of the renal artery. A frequent obstacle to revascularization in renal vascular hypertension. Arch. Surg. 85, 608–616 (1962).PubMedCrossRefGoogle Scholar
  2. Chute, R., E. T. O’Hara, R. N. Goldman, J. D. Houghton, and B. L. Toy: The inferior vena cava as a good source of tissue for renal artery patch grafting for renal revascularization for hypertension. J. Urol. (Baltimore) 89, 303–310 (1963).Google Scholar
  3. DeBakey, M. E.: Basic concepts of therapy in arterial disease. J. Amer. med. Ass. 186, 484–498 (1963).CrossRefGoogle Scholar
  4. DeBakey, M. E., G. C. Morris Jr., R. O. Morgen, E. St. Crawford, and D. A. Cooley: Lesions of the renal artery. Surgical technic and results. Amer. J. Surg. 107, 84–96 (1964).PubMedCrossRefGoogle Scholar
  5. DeCamp, P. T.: Current therapy: renal artery hypertension a correctable clinical condition. Dis. Chest 34, 640–643 (1958).PubMedCrossRefGoogle Scholar
  6. DeCamp, P. T.: Renal arterial insufficiency causing hypertension. Surg. Gynec. Obstet. 112, 120–121 (1961).PubMedGoogle Scholar
  7. Détrie, Ph.: Le traitement chi-rurgical de I’hypertension arterielle. J. Chir. (Paris) 85, 95–98 (1963).Google Scholar
  8. Dupas, M.: Stenoses de I’artère rénale consequences hemodynamiques et indications de la revascularisation du rein. Ann. Chir. (Paris) 15, 1591–1603 (1961).Google Scholar
  9. Dustan, H. P., I. H. Page, E. F. Poutasse, and L. Wilson: An evaluation of treatment of hypertension associated with occlusive renal arterial disease. Circulation 27, 1018–1027 (1963).CrossRefGoogle Scholar
  10. Dustan, H. P., T. F. Meaney, and I. H. Page: Conservative treatment of renovascular hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 544–554. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  11. Heberer, G., u. R. Giessler: Probleme der Widerherstellungschirurgie bei Verschlußkrankheiten am Aorta-Iliaca-Abschnitt. Verh. dtsch. Ges. Kreisl.-Forsch. 1963, 133–140.Google Scholar
  12. Kincaid-Smith, P.: The diagnosis and treatment of hypertension due to unilateral renal disease. Med. J. Aust. 48 (I), 641–648 (1961).PubMedGoogle Scholar
  13. Linder, F.: Die operative Behandlung von Nierenarterienstenosen bei Hypertonie. Verh. dtsch. Kreisl.-Forsch. 1963, 209–216.Google Scholar
  14. Michon, J.: L’hypertension arterielle dans les nephropathies chirurgicales unilaterales et dans les maladies de I’artère rénale. J. Urol. Néphrol. 67, 711–756 (1961).Google Scholar
  15. Morris Jr., G. C., and M. E. DeBakey: Treatment of hypertension associated with renal arterial occlusive disease Symposium. Amer. J. Cardiol. 9, 916–919 (1962).PubMedCrossRefGoogle Scholar
  16. Morris Jr., G. C., M.E. DeBakey, A. Cooley, and E. S. Crawford: Surgical treatment of renal hypertension. Ann. Surg. 151, 854 (1960).PubMedCrossRefGoogle Scholar
  17. Morris Jr., G. C., M.E. DeBakey, A. Cooley, and E. S. Crawford: Experience with 200 renal artery reconstructive procedures for hypertension or renal failure. Circulation 27, 346–350 (1963).CrossRefGoogle Scholar
  18. Morris Jr., G. C., M. E. DeBakey, St. Crawford, and D. A. Cooley: Surgical treatment of renovascular hypertension. Arch. Surg. 82, 723–734 (1961).PubMedCrossRefGoogle Scholar
  19. Morris Jr., G. C., M. E. DeBakey, J. W. Overstreet, and R. Scott Jr.: Surgical treatment of hypertension resulting from renal artery stenosis. Amer. Surg. 26, 745–749 (1960).Google Scholar
  20. Morris Jr., G. C., D. A. Cooley, E. S. Crawford, W. B. Berry, and M. E. DeBakey: Renal revascularization for hypertension. Clinical and physiologic studies in 32 cases. Surgery 48, 95–110 (1960).PubMedGoogle Scholar
  21. Page, I. H., H. P. Dustan, and E. F. Poutasse: Mechanisms, diagnosis and treatment of hypertension of renal vascular origin. Ann. intern. Med. 5, 196 (1959).Google Scholar
  22. Poutasse, E. F.: Surgical treatment of renal hypertension: results in patients with occlusive lesions of renal arteries. J. Urol. (Baltimore) 82, 403–411 (1959).Google Scholar
  23. Poutasse, E. F.: Diagnosis and treatment of occlusive renal artery disease and hypertension. J. Amer. med. Ass. 178, 1078 (1961).CrossRefGoogle Scholar
  24. Poutasse, E. F.: Partial nephrectomy: new techniques, approach, operative indications and review of 51 cases. J. Urol. (Baltimore) 88, 153–159 (1962).Google Scholar
  25. Poutasse, E. F.: Surgical treatment of renal hypertension. Amer. J. Surg. 107, 97–103 (1964).PubMedCrossRefGoogle Scholar
  26. Poutasse, E. F., A. W. Homphries, L. J. McCormack, and A. C. Coscoran: Bilateral stenosis of renal arteries and hypertension. Treatment by arterial homografts. J. Amer. med. Ass. 161, 419–423 (1956).CrossRefGoogle Scholar
  27. Pytel, A.: Diagnostik und operative Behandlung der durch Pyelonephritis und okklusierende Erkrankungen der Nieren-arterie bedingten Hypertonie. Urologia (Treviso) 29, 285–296 (1962).Google Scholar
  28. Pytel, A.: Entero-revasculari-zation of the kidney in the treatment of nephrogenous hypertension. Urol. int. (Basel) 17, 1–13 (1964).CrossRefGoogle Scholar
  29. Sheps, S. G., P. J. Osmundson, J. C. Hunt, A. Schirger, and J. F. Fairbairn: Hypertension and renal artery stenosis. Serial observations on 54 patients treated medically. Clin. Pharmacol. Ther. 6, 700–709 (1965).PubMedGoogle Scholar
  30. Spencer, F. C., T. A. Stamey, H. T. Bahnson, and A. Cohen: Diagnosis and treatment of hypertension due to occlusive disease of renal artery. Ann. Surg. 154, 674 (1961).PubMedCrossRefGoogle Scholar
  31. Stamey, P. A.: Some observations on the filtration fraction, on the transport of sodium and water in the ischemic kidney, and on the prognostic importance of R.P.F. to the contralateral kidney in renovascular hypertension. Antihypertensive therapy. Internat. Symp. (ed. F. Gross), p. 555–579. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  32. Vertes, V., J. A. Grauel, and H. Goldblatt: Studies of patients with renal hypertension undergoing vascular surgery. New Engl. J. Med. 272, 186–189 (1965).PubMedCrossRefGoogle Scholar
  33. Williams, T. F.: Renal cortical necrosis, renal infarction, and hypertension due to renal vascular disease. In: Diseases of the kidney, p. 557. Boston: Little, Brown & Cie. 1963.Google Scholar
  34. Yendt, E. R., W. K. Kerr, D. R. Wilson, and Z. F. Jaworski: The diagnosis and treatment of renal hypertension. Amer. J. Med. 28, 169–187 (1960).PubMedCrossRefGoogle Scholar
  1. Cottier, P. T., u. C. Vorburger: Nierenerkrankungen im Alter und ihre Behandlung. Therapiewoche 14, 10, 506–515 (1964).PubMedGoogle Scholar
  2. Davies, D. F., and N. W. Shock: Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J. din. Invest. 29, 496 (1950).Google Scholar
  3. Greenblatt, M.: Primary renal arteriosclerosis. A comparative angiographic study of hypertensive and normotensive individuals. Lab. Invest. 12, 1270–1280 (1963).PubMedGoogle Scholar
  4. Klütsch, K., A. Heidland u. A. Oebek: Altersabhängigkeit der Nierenhaemodjniamik. Klin. Wschr. 40, 1002–1003 (1962).CrossRefGoogle Scholar
  5. Meine, J. L.: Die einScitige Schrumpfniere. Häufigkeit, Nosologie und Beziehung zur Hypertonie. Statistische Untersuchung an 10000 Sektionen. Schweiz, med. Wschr. 95, 799 (1965).Google Scholar
  6. Miller, J. H., and N. W. Shock: Age differences in the renal tubular response to antidiuretic hormone. J. Geront. 8, 446–450 (1953).PubMedCrossRefGoogle Scholar
  7. Moeller, J.: Arteriosklerotischer rénaler Hochdruck. Medizinische 1958, 2036–2039.Google Scholar
  8. Ozoa, A. K., and Seymour Gflagov: Induction of atheroma in renal arteries of rabbits. Arch. Path. 76, 667–676 (1963).PubMedGoogle Scholar
  9. Philippson, Chr.: Morphologische und funktionelle Altersveränderungen der Nieren. I. Z. Altersforsch. 16, 111–128 (1962).Google Scholar
  10. Pickering, S. O.: Arteriosclerosis and atherosclerosis. The need for clear thinking. Amer. J. Med. 34, 7–18 (1963).PubMedCrossRefGoogle Scholar
  11. Sarre, H.: Sklerose der Nierengefäße und Hypertonie. Regensburg. Jb. ärztl. Fortbild. 7, 164–170 (1959).Google Scholar
  12. Schindler, A. M.: Insuffisance rénale par decortication arteriosclerotique des reins. J. Urol. Néphrol. 68, 1–14 (1962).Google Scholar
  13. Shock, N. W.: The role of the kidney in electrolyte and water regulation in the aged. Ciba Found. Colloq. on Aging. Vol. IV. Water and electrolyte metabolism in relation to age and sex. Boston: Little, Brown & Co. 1958.Google Scholar
  14. Tsuji, M.: A cUnicopathological study on renal arteriosclerosis in the aged. Jap. Circulat. J. 23, 256–268 (1959).Google Scholar
  15. Hamburger, J., G. Riebet, J. Crosnier, J. L. Funk-Brentano, B. Antoine, H. Ducrot, J. P. Mery, H. De Montera et P. Royer: Rein goutteux. In: Néphrologie coli, medico-chirurgicale (ed. Pasteur Vallery-Radot; Jean Hamburger). Paris: Med. Flammarion 1966.Google Scholar
  16. Koller, F., u. H. U. Zollinger: Gichtische Glomerulosklerose. Schweiz, med. Wschr. 75, 97 (1945).Google Scholar
  17. Kuzell, W. C., et R. W. Schaffaszik: Simultanéité de la goutte et d’autres maladies chez 520 goutteux. In: 3e conf. int. mal. rhum. Imp. réunies, Chambéry 1956.Google Scholar
  18. Layani, F., J. Sézane, C. Bieth et J. Fracon: Les manifestations abarticulaires de la goutte. In: 3e Conf. int. Maladies Rhum. Imp. Réunies, Chambéry 1956.Google Scholar
  19. Reubi, F., u. C. Vorburger: Die Gichtniere. Münch, med. Wschr. 104, 2152–2155 (1962).Google Scholar
  20. Rotes-Querol, J., S. Casals-Punti e P. Crespi: Estudio clinico de la gota basado en 145 obser-vaciones. In: C.R. Confer, int. Rhumat. Minerva Medica, Roma 1961, vol. II, p. 636.Google Scholar
  21. Rubens-Duval, A., J. Villaumey et A. Bernadon: Les manifestations extra-articulaires et extrarénales de la goutte. In: La Goutte. Rapports du 34e Congr. frangais de la Medicine Paris: Masson & Cie. 1963, I. vol.Google Scholar
  22. Séze, S. de, et A. Ryckewaert: La Goutte. Paris: Ed. Expansions scient. franç 1960.Google Scholar
  23. Talbott, J. H., and K. L. Terplan: The kidney in gout. Medicine (Baltimore) 39, 405 (1960).Google Scholar
  24. Beck, J. S.: Acute radiation nephritis in childhood. Brit. med. J. 1958 II, 489.CrossRefGoogle Scholar
  25. Bennett, L. R., S. M. Chastain, J. S. Flint, R. A. Hansen, and A. E. Lewis: Late effects of roentgen irradiation. I. Studies on rats irradiated under anoxia. Radiology 61, 411 (1953).PubMedGoogle Scholar
  26. Bianchi, L.: Experimentelle Untersuchungen über Gefäßveränderungen der Roentgenniere. Path, et Microbiol. (Basel) 24, 270–275 (1961).Google Scholar
  27. Cottier, H.: Strahlenbedingte Lebensverkürzung. Berlin-Göttingen-Heidelberg: Springer 1961.CrossRefGoogle Scholar
  28. Cottier, H.: I. Histopathologie der Wirkung ionisierender Strahlen auf höhere Organismen (Tier und Mensch). In: Handbuch der medizinischen Radiologie (ed. L. Diethelm, O. Olsson, F. Strnad, H. Vieten, A. Zuppinger), Bd. II, Teil 2, S. 35–272. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  29. Hamburger, J., G. Riebet, J. Crosnier, J. L. Funck-Brentano, B. Antoine, H. Ducrot, J, F. Rery, H. de Montera et F. Royer: Rein radiotherapique. In: Néphrologie Coli. Med. chir. (ed. Pasteur Vallery-Radot et Jean Hamburger). Paris: Medicales Flammarion 1966.Google Scholar
  30. Jammet, H., G. Matbe, B. Fendic, J. F. Duplan, B. Maupin, R. Latarjet, D. Kalic, L. Schwarzenberg, Z. Djukic et J. Vigne: Etude de six cas d’irradiation totale aigue accidentelle. Rev. franç. fitud. clin. biol. 4, 210 (1959).Google Scholar
  31. Kohn, H. L, C. C. Berdjis, and K. B. DeOme: Late effects of whole-body x-irradiation in the mouse. Some gross and histologic aspects of the development of morbidity prior to terminal state with special reference to the gonad, uterus, heart, liver, kidney and sub-mamillary gland. Radiat. Res. 7, 407 (1957).PubMedCrossRefGoogle Scholar
  32. Kunkler, P. B., R. F. Fan, and R. W. Luxton: The limit of renal tolerance to x-rays: an investigation into renal damage occuring following the treatment of tumours of the testis by abdominal baths. Brit. J. Radiol. 25, 190 (1952).CrossRefGoogle Scholar
  33. Lamson, B. G., R. A. Meek, and L. R. Bennett: Late effects of total body roentgen irradiation. Arch. path. 64, 505 (1957).Google Scholar
  34. Levitt, W.M., an S. Oram: Irradiation-induced malignant hypertension: cured by nephrectomy. Brit. med. J. 1956 II, 910.CrossRefGoogle Scholar
  35. Luxton, R. W.: Radiation nephritis: a long-term study of 54 patients. Lancet 1961 II, 1221.CrossRefGoogle Scholar
  36. Redd Jr., B. L.: Radiation nephritis, review, case report and animal study. Amer. J. Roentgenol. 83, 88 (1960).PubMedGoogle Scholar
  37. Sarre, H., u. F. Moser: Bestrahlungsfibrose, Bestrahlungsnephritis und isolierte Hypertonie nach Roentgenbestrahlung der Nieren. Dtsch. med. J. 12, 232–241 (1961).PubMedGoogle Scholar
  38. Wilson, C., J. M. Ledingham, and M. Cohen: Hypertension following x-irradiation of the kidneys. Lancet 1958 I, 9.CrossRefGoogle Scholar

Thrombose und Embolie der Nierenarterien

  1. Amar, A. D., and C. P. Gray: Perirenal hematoma following renal infarction. J. Urol. (Baltimore) 89, 652–655 (1963).Google Scholar
  2. Belliveau, R., and M. E. Marsh: Effects of sodium chloride in rats fed an atherogenic diet. Reference to the incidence of myocardial and renal infarcts. Arch. Path. 71,559–565 (1961).Google Scholar
  3. Bürki, K., M. Ledermann u. H. Cottier: Atheroembolische Gefäßverschlüsse in der Niere. In Bearbeitung.Google Scholar
  4. Duggan, M. L.: Acute renal infarction. J. Urol. (Baltimore) 90, 669–676 (1963).Google Scholar
  5. Eliahou, H. G., H. Boichis, and E. Eden: Traumatic renal infarction in a solitary kidney. J. Urol. (Baltimore) 90, 16–21 (1963).Google Scholar
  6. Fitzgerald, J. S., and P. S. Mullins: Infarcts of the kidney. J. Urol. (Baltimore) 70,352–357 (1953).Google Scholar
  7. Fraenkel, G. J.: Renal infarct as space occupying lesion. Brit. J. Urol. 28, 145–146 (1956).PubMedCrossRefGoogle Scholar
  8. Frahm, C. J., and R. Folse: Serum oxaloacetic transaminase levels following renal infarction. Report of a case and experimental observations following ligation of the renal arteries. J. Amer. med. Ass. 180, 209–211 (1962).CrossRefGoogle Scholar
  9. Fritzsch, W.: Bauchaortenaneurysma mit besonderen Komplikationen. Münch, med. Wschr. 104, 1085–1086 (1962).Google Scholar
  10. Fruchtman, M. Z., and J. R. Caldwell: Hypertension due to renal infarction. Report of a case. New Engl. J. Med. 263, 907–909 (1960).PubMedCrossRefGoogle Scholar
  11. Gayet, R., F. Cabanne et R. Michiels: Hypertension arterielle maligne avec thrombose arterielle rénale unilaterale et tuberculose rénale associee. J. Urol. Néphrol. 67, 401–405 (1961).Google Scholar
  12. Gill, Th. J., and G. J. Dammin: Paradoxical embolism with renal failure caused by occlusion of the renal arteries. Amer. J. Med. 25, 780–787 (1958).PubMedCrossRefGoogle Scholar
  13. Götzen, F. J.: Partieller Niereninfarkt und Hochdruck als Folge der Unterbindung akzessorischer Gefäße. Medizinische 1953, 545–547.Google Scholar
  14. Goodman, H. L.: Malignant hypertension with unilateral renal artery occlusion. New Engl. J. Med. 246, 8–12 (1952).PubMedCrossRefGoogle Scholar
  15. Haller Jr., J. A., L. R. Radigan, and A. G. Morrow: Hypertension due to segmental infarction of the kidney. Amer. J. Med. 22, 303–305 (1957).PubMedCrossRefGoogle Scholar
  16. Handler, F. P.: Clinical and pathological significance of atheromatous embolization with emphasis on etiology of renal hypertension. Amer. J. Med. 20, 366–373 (1956).PubMedCrossRefGoogle Scholar
  17. Helander, E.: Primary thrombosis of both renal arteries. Cardiologia (Basel) 34, 366 (1959).CrossRefGoogle Scholar
  18. Hunter, R. A., and W. A. McElmoyle: Renal infarction with hypertension. Lancet 1956 II, 443–445.CrossRefGoogle Scholar
  19. La Pena, A. de: Infarto arterial renal (massivo bilateral y parcial unilateral). Rev. din. esp. 61, 216–228 (1956).Google Scholar
  20. Jansen, H. H., F. Portwich u. H. Reinwein: Zur Klinik des embolischen und thrombotischen Verschlusses der Arteria renahs. Dtsch. Arch. klin. Med. 208, 480–504 (1963).PubMedGoogle Scholar
  21. Kaplan, K., J. D. Miliar, and P. A. Cancilla: "Spontaneous" atheroembolic renal failure. Arch, intern. Med. 110, 218–221 (1962).CrossRefGoogle Scholar
  22. Eavelman, D. A.: Secondary renal hypertension. Canad. Med. Ass. J. 83, 382–384 (1960).Google Scholar
  23. Krueger, W.: Beitrag zum Krankheitsbild des großen Mereninfarktes. Dtsch. Gesundh.-Wes. 1957, 83–85.Google Scholar
  24. Markowitz, A. M,: Dissecting aneurysm presenting as occlusive disease of the lower aorta. Symposium. Amer. J. Surg. 103, 389–393 (1962).CrossRefGoogle Scholar
  25. Masuelli, L., e G. Gambetta: Infarto rénale con ipertensione. Urologia (Milano) 20, 568–574 (1954).Google Scholar
  26. Melnikov, A. F.: State of blood coagulation at different stages in arterial hypertension. Fed. Proc. 22, 1, II, T74-T75 (1963).Google Scholar
  27. Milliez, P., P. Samarcq, J. Himbert, G. Lagrue et H. Dncrot: Hypertension arterielle juvenile maligne. Rein droit aplasique, nephrectomie droite, obstruction de I’artère rénale gauche. Mort. Sem. Hop. Paris 1956,1362–1368.Google Scholar
  28. Mogg, R. A.: Renal infarction and its relationship to hypertension. Brit. J. Urol. 29, 374–380 (1957).PubMedCrossRefGoogle Scholar
  29. Muhger, H. v.: Renal thrombosis. J. Urol. (Baltimore) 71, 144–150 (1954).Google Scholar
  30. Nicola, P. de, u. L. Vercillo: Nierenfunktion und Antikoagulation. Med. Welt 1961, 296–301.Google Scholar
  31. Owen Jr., W. P., and C. K. Pearlman: Hypertension due to thrombosis of the renal artery: report of a case in which a cure was obtained by nephrectomy. J. Urol. (Baltimore) 68, 11–16 (1952).Google Scholar
  32. Palon, J.: Malignant hypertension caused by ascendent aortoiliac thrombosis. Angiology 11, 518–521 (1960).CrossRefGoogle Scholar
  33. Peabody, C. N., and D. C. Gates: Malignant renal hypertension (Wilson-Byrom syndrome). Lancet 1958 II, 291–294CrossRefGoogle Scholar
  34. Shncksmith, H. S., and G. Wilson: Aortic thrombosis causing hypertension. Lancet 1959 I, 75–76.CrossRefGoogle Scholar
  35. Smith, J. P., and M. L. Saylor: Renal vascular hypertension in children. J. Urol. (Baltimore) 84, 17–23 (1960).Google Scholar
  36. Steiness, L, and J. H. Thaysen: Bilateral traumatic renal-artery thrombosis. Lancet 1965 I, No 7384, 527–529.CrossRefGoogle Scholar
  37. Strandness Jr., D. E., J. H. Smith, and V. A. Pate: Acute hypertension and renal infarction. U.S. armed Forces med. J. 11, 584–586 (1960).PubMedGoogle Scholar
  38. Tallgren, L. G., and B. Kuhlbäck: Ruptured aneurysm of the abdominal aorta involving the kidneys. Acta med. scand. 174, 551–556 (1963).PubMedCrossRefGoogle Scholar
  39. Teplick, J. G., and W. Yarrow: Arterial infarction of the kidney. Ann. intern. Med. 42, 1041–1051 (1955).PubMedCrossRefGoogle Scholar
  40. Vahlensieck, W., u. W. Bettag: Niereninfarkte. Münch, med. Wschr. 101, 229–232 (1959).Google Scholar
  41. Wilkey, J. L., L. J. Barson, F. R. Portney, and B. Turbow: Acute renal artery thrombosis. J. Urol. (Baltimore) 84, 443–446 (1960).Google Scholar
  1. Edsman, G.: Accessory vessels of the kidney and their diagnosis in hydronephrosis. Acta radiol. (Stockh.) 42, 26–32 (1954).CrossRefGoogle Scholar
  2. Ferber, Chr.: Zur klinischen Bedeutung der Miß- und Fehlbildungen der oberen Harnorgane. Zbl. Chir. 88, 961–975, 975–987 (1963).Google Scholar
  3. Nathan, H.: Observations on aberrant renal arteries curving around and compressing the renal vein. Possible relationship to orthostatic hypertension. Circulation 18, 1131–1134 (1958).PubMedCrossRefGoogle Scholar
  4. Weissleder, H., J. Emmrich u. J. Schirmeister: Gefäßbedingte Kontrastmittelaussparungen im urographischen Bild. Fortschr. Röntgenstr. 97, 703–710 (1962).CrossRefGoogle Scholar

Aneurysma der Nierenarterie

  1. Abeshouse, B. B.: Aneurysm of the renal artery: report of two cases and review of the literature. Urol, cutan. Rev. 55, 451 (1951).Google Scholar
  2. Acker, E. D., J. V. Dooley, and W. F. Herman: Multiple aneurysms of the right renal artery. A case report. J. Urol. (Baltimore) 87, 759–761 (1962).Google Scholar
  3. Ardanza, F. J.: Aneurisma de la arteria renal (presentacion de un caso). Ginec. y Urol. 10, 414–421 (1956).Google Scholar
  4. Atkinson, R. L.: Aneurvsm of the renal artery. J. Urol. (Baltimore) 72, 117–119 (1954).Google Scholar
  5. Debré, R., P. Royer, C. Fauré, D. Pellerin, E. Habib et R. Habib: L’aneurysme congénital de l’artère rénale avec hypertension artérielle grave chez Fenfant. Arch. franç. Pédiat. 14, 1 (1957).PubMedGoogle Scholar
  6. Del Pobily-Bensusan: Aneurisma de rinon. Arch. esp. Urol. 11, 17–25 (1955).Google Scholar
  7. Dubost, Ch., et J. L. Chevrier: A propos d’un cas d’aneurysm de I’artère rénale avec hypertension artérielle. Presse med. 68, 331 (1960).PubMedGoogle Scholar
  8. Diix, A., u. P. Thum: Aneurysma der Arteria renalis. Fortschr. Röntgenstr. 96, 471–478 (1962).CrossRefGoogle Scholar
  9. Edsman, G.: Angionephrography and suprarenal angiography. A roetgenologic study of the normal kidney, expansive renal and suprarenal lesions and renal aneurysms. Acta radiol. (Stockh.), Suppl. 155, 3–141 (1957).Google Scholar
  10. Faure, C., R. Verspyck, R. Parienty et A. Salomon: Les aneursymes du pedicule renal. Revue generale et presentation de 11 cas. J. Radiol.]filectrol. 43, 583–595 (1962).Google Scholar
  11. Garritano, A. P.: Aneurysm of the renal artery. Amer. J. Surg. 94, 638 (1957).PubMedCrossRefGoogle Scholar
  12. Glanton, J. B., R. L. Parsons, and F. Mathers: Renal artery aneurysm producing renal infarction with resultant hypertension. J. Amer. med. Ass. 171, 2089–2091 (1959).CrossRefGoogle Scholar
  13. Harrow, B. R., and J. A. Sloane: Aneurysm of renal artery: report of five cases. J. Urol. (Baltimore) 81, 35–41 (1959).Google Scholar
  14. Harrow, B. R., and J. A. Sloane: Polycystic renal disease with renal and splenic artery aneurysma. J. Urol. (Baltimore) 84, 447–452 (1960).Google Scholar
  15. Herbut, P. A., and A. H. Price: Periarteriitis nodosa producing aneurysm of the renal arteries and hypertension. Arch. Path. 39, 274 (1945).Google Scholar
  16. Irmer, W., u. E. Wetzels: Poststenotisches Aneurysma der Nierenarterie mit Hochdruck. Zbl. Chir. 88, 594–602 (1963).Google Scholar
  17. Joseph, R., J.-C. Job et V. David: Hypertension arterielle juvenile par maKormations aneurysmales multiples des branches de l’aorte abdominale. Arch. franç. Pediat. 19, 115–128 (1962).PubMedGoogle Scholar
  18. Klein, R. L., and J. A. McCherney: Hypertension secondary to aneurysm of the renal artery. Report of a case of long duration cured by nephrectomy. Arch, intern. Med. 54,292–300 (1961).CrossRefGoogle Scholar
  19. Leger, J. L., J. Michon, P. Bourgeois et M. Belisle: Aneurysme de I’artère rénale. Presentation d’un cas. J. Canad. Ass. Radiol. 5, 19–22 (1954).Google Scholar
  20. Ljunggren, E.: Renal artery aneurysm. Acta chir. scand. 115, 120–131 (1958).PubMedGoogle Scholar
  21. Mathe, C. P.: Aneurysm of renal artery causing hypertension: report of three cases. J. Urol. (Baltimore) 82, 412–416 (1959).Google Scholar
  22. Mathe, C. P.: Renal hypertension. J. int. Coll. Surg. 34, 624–637 (1960).PubMedGoogle Scholar
  23. Milton, S. H.: Aneurysm of the renal artery and hypertension. Lancet 1962 II, 1024–1026.CrossRefGoogle Scholar
  24. Pastor, B. H., R. M. Myerson, G. T. Wohl, and P. V. Rouse: Hypertension associated with renal artery aneurysm and relieved by nephrectomy. Ann. intern. Med. 42, 1122 (1955).PubMedCrossRefGoogle Scholar
  25. Slaney, G., F. Ashton, and P. Dawson-Edwards: Renal artery aneurysmectomy with severe contralateral renal hypoplasia. Lancet 1964 II, 937–939.CrossRefGoogle Scholar
  26. Williams, D. W.: Massive renal aneurysm. J. Urol. (Baltimore) 86, 299–300 (1961).Google Scholar

Renale arteriovenöse Fistel

  1. Blake, S., S. Heffernan, and P. McCann: Renal arteriovenous fistula after percutaneous renal biopsy. Brit. med. J. 1963 I, 1458–1460.CrossRefGoogle Scholar
  2. Boijsen, E., u. R. Köhler: Renal arteriovenous fistulae. Acta radiol. (Stockh.) 57, 433–445 (1962).CrossRefGoogle Scholar
  3. Hilton, J. G., D. M. Kanter, D. R. Hays, E. H. Bowen, J. R. Golab, J. H. Keating, and R. Wegria: The effect of acute arteriovenous fistula on renal function. J. din. Invest. 34, 732–736 (1955).Google Scholar
  4. Hutch, J. A., and E. R. Chisholm: Intrarenal arteriovenous fistula. J. Urol. (Baltimore) 88, 150–152 (1962).Google Scholar
  5. Jouve, A., P. Angler, H. Payan, R. Gerard, J.-L. Medvedowsky et J. Guillemaud: Les communications arterioveineuses rénales. Presse med. 66, 1669–1672 (1958).PubMedGoogle Scholar
  6. Mangiardi, J. L., E. E. Santemma, and J. J. Sullivan Jr.: Arteriovenous fistula of the kidney. Case report. Amer. Heart J. 65, 549–554 (1963).CrossRefGoogle Scholar
  7. Nguyen-Huu, Ngo-Gia-Hy et Bui-Mong-Hung: Aneurysmes arterioveineux des vaisseaux renaux. Rein en place: leur role dans I’hypertension arterielle d’origine rénale. Presse med. 67, 1680–1683 (1959).Google Scholar
  8. Scheiffley, C. H.: A new clinical syndrome producing hypertension: arteriovenous fistula of the kidney. J. Amer. med. Ass. 174, 1625–1627 (1960).CrossRefGoogle Scholar
  9. Scheifly, C. H., G. W. Daugherty, L. F. Greene, and J. T. Priestley: Arteriovenous fistula of the kidney. New observations and report of three cases. Circulation 19, 662–671 (1959).CrossRefGoogle Scholar
  10. Slominski-Laws, M. D., J. A. Kiefer, and C. W. Vermeulen: Arteriovenous aneurysm of the kidney: case report. J. Urol. (Baltimore) 75, 586–591 (1956).Google Scholar
  11. Twigg, H. L., R. Pradhan, and J. K. Perloff: Arteriovenous fistula of the renal vessels. A case report. Amer. J. Roentgenol. 88, 1148–1151 (1962).PubMedGoogle Scholar
  12. Zukschwerdt, L.: Zur chirurgischen Behandlung der Hypertension infolge ungenügender Blutversorgung des Nierenparenchyms. Med. Klin. 56, 565–567 u. Abb. 546 (1961).Google Scholar

Periarteriitis nodosa

  1. Alarcon-Segovia, D., and A. L. Brown Jr.: Classification and etiologic aspects of necrotizing angits. Proc. Mayo Clin. 39, 205 (1964).PubMedGoogle Scholar
  2. Bank, N.: The relation of malignant hypertension to Periarteriitis nodosa in humans. J. Mt Sinai Hosp. 22, 290–305 (1955).Google Scholar
  3. Benitz, L., M. Mathews, and G. K. Mallory: Platelet thrombosis with polyarteritis nodosa. Report of a case. Arch. Path. 77, 116–125 (1964).Google Scholar
  4. Blankenborn, M. A., and H. C. Knowles Jr.: Periarteriitis nodosa: recognition and clinical symptomes. Ann. intern. Med. 41, 887 (1954).CrossRefGoogle Scholar
  5. Candreviotis, N.: Beitrag zur Kenntnis der Aetiologie und Pathogenese der lokalisierten Periarteriitis nodosa. Zbl. allg. Path. path. Anat. 102, 42–54 (1961).Google Scholar
  6. Conrad, V., et P. Oatez: Hematome perirénale, complication d’une periarterite noueuse. J. beige Urol. 20, 289 (1952).Google Scholar
  7. Cruchaud, A., C. A. Bouvier et L. Humair: Les arterites nerosautes par sensibih-sation. Schweiz, med. Wschr. 90, 258 (1960).Google Scholar
  8. Darmady, E. M., W. J. Griffiths, H. Spencer, D. Mattingly, F. Stranak, and H. E. de Wardener: Kenal tubular failure associated with Polyarteriitis nodosa. Lancet 1955 I, 378.CrossRefGoogle Scholar
  9. Davson, J., J. Ball, and R. Piatt: The kidney in Periarteriitis nodosa. Quart. J. Med. 17, 175 (1948).PubMedGoogle Scholar
  10. Dawson, D. L.: Acute Periarteriitis nodosa with chronic glomerulonephritis. Report of a case. Arch. Path. 68, 651–656 (1959).PubMedGoogle Scholar
  11. Dewar, H. A., and M. J. T. Peaston: Three cases resembling Polyarteriitis nodosa arising during treatment with guanethidine. Brit. med. J. 1964 II, 609–611.CrossRef